activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	34278	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		1.0	CHEMBL1955	Homo sapiens	Selectivity		1.0
	34278	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		1.0	CHEMBL1955	Homo sapiens	Selectivity		1.0
	37864	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	Cc1ccnc(Nc2ncc(-c3ccccc3)s2)c1		CHEMBL319065	=	Selectivity		2.0	CHEMBL1955	Homo sapiens	Selectivity		2.0
	40259	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	Cc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL98385	=	Selectivity		3.0	CHEMBL1955	Homo sapiens	Selectivity		3.0
	42685	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	O=C(Nc1ncc(-c2ccccc2)s1)c1ccccc1		CHEMBL98633	=	Selectivity		1.0	CHEMBL1955	Homo sapiens	Selectivity		1.0
	46270	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	Cc1cccnc1Nc1ncc(-c2ccccc2)s1		CHEMBL329713	=	Selectivity		3.0	CHEMBL1955	Homo sapiens	Selectivity		3.0
	48770	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	CCCCN(C)c1ccc(/N=N/c2ncc([N+](=O)[O-])s2)c(C)c1		CHEMBL100174	=	Selectivity		1.0	CHEMBL1955	Homo sapiens	Selectivity		1.0
	50204	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	c1ccc(-c2cnc(Nc3ccccn3)s2)cc1		CHEMBL98538	=	Selectivity		2.0	CHEMBL1955	Homo sapiens	Selectivity		2.0
	53969	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	Brc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL101464	=	Selectivity		3.0	CHEMBL1955	Homo sapiens	Selectivity		3.0
	55132	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	Clc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL319789	=	Selectivity		1.0	CHEMBL1955	Homo sapiens	Selectivity		1.0
	66859	CHEMBL820215	Selectivity for Vascular endothelial growth factor receptor 3 over (KDR) kinase insert domain receptor	B	N#Cc1cnc(Nc2ccccn2)s1		CHEMBL101544	=	Selectivity		4.0	CHEMBL1955	Homo sapiens	Selectivity		4.0
	506177	CHEMBL821012	Inhibition of Vascular endothelial growth factor receptor 3	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	690.0	CHEMBL1955	Homo sapiens	IC50	uM	0.69
	572153	CHEMBL770282	Inhibition of protein kinase Flt-4 at 10 uM	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Inhibition	%	30.0	CHEMBL1955	Homo sapiens	Inhibition	%	30.0
Not Active	675224	CHEMBL821011	Inhibition of Vascular endothelial growth factor receptor 3 (No effect)	B	COC1=CC(=O)C=C(/C=C2\CCCC3CCCCC23)C1=O		CHEMBL98934		NI			CHEMBL1955	Homo sapiens	NI		
Not Active	676636	CHEMBL821011	Inhibition of Vascular endothelial growth factor receptor 3 (No effect)	B	CC1=CCC[C@@H]2[C@]1(C)CC[C@@H](C)[C@@]2(C)CC1=C(O)C(O)=C/C(=N\[C@@H](CO)C(=O)O)C1=O		CHEMBL330608		NI			CHEMBL1955	Homo sapiens	NI		
	686001	CHEMBL820849	Inhibition of Vascular endothelial growth factor receptor 3	B	CC(O)C(/N=C1/C=C(O)/C(=N\C(C(=O)O)C(C)O)C=C1O)C(=O)O		CHEMBL327725	=	IC50	nM	3000.0	CHEMBL1955	Homo sapiens	IC50	uM	3.0
Not Active	692477	CHEMBL821011	Inhibition of Vascular endothelial growth factor receptor 3 (No effect)	B	COC1=CC(=O)C=CC1=O		CHEMBL430845		NI			CHEMBL1955	Homo sapiens	NI		
Not Active	702027	CHEMBL821011	Inhibition of Vascular endothelial growth factor receptor 3 (No effect)	B	CC(O)C(/N=C1\C(O)=CC(=O)C(O)=C1CC1CCCC2CCCCC21)C(=O)O		CHEMBL442388		NI			CHEMBL1955	Homo sapiens	NI		
Not Active	703252	CHEMBL821011	Inhibition of Vascular endothelial growth factor receptor 3 (No effect)	B	COC1=CC(=O)C(N[C@@H](CO)C(=O)O)=CC1=O		CHEMBL319347		NI			CHEMBL1955	Homo sapiens	NI		
Not Active	708486	CHEMBL821011	Inhibition of Vascular endothelial growth factor receptor 3 (No effect)	B	COC1=CC(=O)C=C(Cc2ccccc2)C1=O		CHEMBL99058		NI			CHEMBL1955	Homo sapiens	NI		
	750660	CHEMBL820850	Inhibition of Vascular endothelial growth factor receptor 3	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	1038864	CHEMBL811925	Inhibition of Vascular endothelial growth factor receptor 3	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
	1152811	CHEMBL820848	In vitro inhibition of Vascular endothelial growth factor receptor 3 [VEGFR-3(Flt-4)] expressed in baculovirus	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	18.0	CHEMBL1955	Homo sapiens	IC50	nM	18.0
	1175318	CHEMBL820848	In vitro inhibition of Vascular endothelial growth factor receptor 3 [VEGFR-3(Flt-4)] expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	233.0	CHEMBL1955	Homo sapiens	IC50	nM	233.0
	1175343	CHEMBL820848	In vitro inhibition of Vascular endothelial growth factor receptor 3 [VEGFR-3(Flt-4)] expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	50.0	CHEMBL1955	Homo sapiens	IC50	nM	50.0
	1180532	CHEMBL820848	In vitro inhibition of Vascular endothelial growth factor receptor 3 [VEGFR-3(Flt-4)] expressed in baculovirus	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	=	IC50	nM	195.0	CHEMBL1955	Homo sapiens	IC50	nM	195.0
	1183184	CHEMBL820848	In vitro inhibition of Vascular endothelial growth factor receptor 3 [VEGFR-3(Flt-4)] expressed in baculovirus	B	O=C(Nc1cccc(-c2cncc3ccccc23)c1)c1ccccc1NCc1ccncc1		CHEMBL347537	=	IC50	nM	52.0	CHEMBL1955	Homo sapiens	IC50	nM	52.0
	1516923	CHEMBL830767	Selectivity for Vascular endothelial growth factor receptor 3 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	=	Selectivity	uM	0.01	CHEMBL1955	Homo sapiens	Selectivity	uM	0.01
	1517057	CHEMBL830767	Selectivity for Vascular endothelial growth factor receptor 3 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Selectivity	uM	0.055	CHEMBL1955	Homo sapiens	Selectivity	uM	0.055
Not Determined	1517172	CHEMBL830772	Selectivity for Vascular endothelial growth factor receptor 3 by homologous time-resolved fluorescence assay; No data	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1		CHEMBL191993		Selectivity			CHEMBL1955	Homo sapiens	Selectivity	uM	
	1609151	CHEMBL882599	Inhibitory concentration against FLT4 with 4 uM Biotin-Ahx-AEEEYFFLFA-amide for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	13.0	CHEMBL1955	Homo sapiens	IC50	nM	13.0
	1609237	CHEMBL871635	Inhibitory concentration against Vascular endothelial growth factor receptor 3 with 4 uM Biotin-Ahx-AEEEYFFLFA-amide for 1 hr at ambient temperature with 1 mM ATP at pH 7.5	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL381207	=	IC50	nM	87.0	CHEMBL1955	Homo sapiens	IC50	nM	87.0
Not Active	1650243	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1650244	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL1955	Homo sapiens	Kd		
	1650245	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	190.0	CHEMBL1955	Homo sapiens	Kd	uM	0.19
	1650246	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	35.0	CHEMBL1955	Homo sapiens	Kd	uM	0.035
Not Active	1650247	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1650248	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL1955	Homo sapiens	Kd		
	1650249	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	16.0	CHEMBL1955	Homo sapiens	Kd	uM	0.016
Not Active	1650250	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1650251	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL1955	Homo sapiens	Kd		
	1651687	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	31.0	CHEMBL1955	Homo sapiens	Kd	uM	0.031
Not Active	1651688	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1651689	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1651690	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL1955	Homo sapiens	Kd		
	1651691	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	2500.0	CHEMBL1955	Homo sapiens	Kd	uM	2.5
Not Active	1651692	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1651693	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1651694	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL1955	Homo sapiens	Kd		
Not Active	1651695	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL1955	Homo sapiens	Kd		
	1651696	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	300.0	CHEMBL1955	Homo sapiens	Kd	uM	0.3
Not Active	1651697	CHEMBL860889	Average Binding Constant for FLT4; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL1955	Homo sapiens	Kd		
	1697187	CHEMBL869541	Inhibition of FLT4 using 1.0 mM ATP	B	N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL383541	>	IC50	nM	50000.0	CHEMBL1955	Homo sapiens	IC50	nM	50000.0
	1697188	CHEMBL869541	Inhibition of FLT4 using 1.0 mM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	58.0	CHEMBL1955	Homo sapiens	IC50	nM	58.0
	1704945	CHEMBL864428	Inhibition of FLt4 at 1.0 mM ATP	B	N[C@H](COc1cncc(/C=C/c2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL383541	>	IC50	nM	50000.0	CHEMBL1955	Homo sapiens	IC50	nM	50000.0
	1704973	CHEMBL864428	Inhibition of FLt4 at 1.0 mM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	58.0	CHEMBL1955	Homo sapiens	IC50	nM	58.0
	1704974	CHEMBL864428	Inhibition of FLt4 at 1.0 mM ATP	B	N[C@H](COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL383264	>	IC50	nM	50000.0	CHEMBL1955	Homo sapiens	IC50	nM	50000.0
	1708053	CHEMBL863818	Inhibition of VEGFR3 at 300 nM	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2cc3c(cc21)OCO3		CHEMBL206627	=	Inhibition	%	63.0	CHEMBL1955	Homo sapiens	Inhibition	%	63.0
	1723195	CHEMBL861299	Inhibition of Flt4	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	7100.0	CHEMBL1955	Homo sapiens	Ki	nM	7100.0
	1723213	CHEMBL861299	Inhibition of Flt4	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	7100.0	CHEMBL1955	Homo sapiens	Ki	nM	7100.0
	1723214	CHEMBL861299	Inhibition of Flt4	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	7100.0	CHEMBL1955	Homo sapiens	Ki	nM	7100.0
	1723215	CHEMBL861299	Inhibition of Flt4	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	7100.0	CHEMBL1955	Homo sapiens	Ki	nM	7100.0
	1723216	CHEMBL861299	Inhibition of Flt4	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	7100.0	CHEMBL1955	Homo sapiens	Ki	nM	7100.0
	1723217	CHEMBL861299	Inhibition of Flt4	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	7100.0	CHEMBL1955	Homo sapiens	Ki	nM	7100.0
	1744463	CHEMBL867315	Inhibition of Flt4	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	7000.0	CHEMBL1955	Homo sapiens	Ki	uM	7.0
	1752797	CHEMBL866109	Inhibition of FLT4 by HTRF assay	B	c1cn(Cc2ccc3c(c2)-c2[nH]nc(-c4ccsc4)c2C3)cn1		CHEMBL212084	=	IC50	nM	169.0	CHEMBL1955	Homo sapiens	IC50	nM	169.0
	1752979	CHEMBL866109	Inhibition of FLT4 by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2[nH]nc(-c4ccsc4)c2C3)CC1		CHEMBL213743	=	IC50	nM	1573.0	CHEMBL1955	Homo sapiens	IC50	nM	1573.0
	1753629	CHEMBL864252	Inhibition of FLT4	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	IC50	nM	68.0	CHEMBL1955	Homo sapiens	IC50	uM	0.068
	1753645	CHEMBL864252	Inhibition of FLT4	B	Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL214258	=	IC50	nM	23.0	CHEMBL1955	Homo sapiens	IC50	uM	0.023
	1753649	CHEMBL864252	Inhibition of FLT4	B	Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213504	<	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	uM	0.003
	1753653	CHEMBL864252	Inhibition of FLT4	B	Cc1cccc(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL376951	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	uM	0.004
	1753657	CHEMBL864252	Inhibition of FLT4	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	13.0	CHEMBL1955	Homo sapiens	IC50	uM	0.013
	1779358	CHEMBL854968	Inhibition of FLT4 by ELISA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	1779380	CHEMBL854968	Inhibition of FLT4 by ELISA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	1781992	CHEMBL911842	Inhibition of VEGFR3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	161.0	CHEMBL1955	Homo sapiens	IC50	uM	0.161
	1790441	CHEMBL912729	Inhibition of human VEGFR3	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	M	5E-9
	1824552	CHEMBL914316	Inhibition of Flt4	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL1955	Homo sapiens	Ki	uM	10.0
	1824723	CHEMBL914316	Inhibition of Flt4	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL1955	Homo sapiens	Ki	uM	10.0
	1824793	CHEMBL914316	Inhibition of Flt4	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL1955	Homo sapiens	Ki	uM	10.0
	1826431	CHEMBL919909	Inhibition of FLT4	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	190.0	CHEMBL1955	Homo sapiens	IC50	nM	190.0
	1849889	CHEMBL914194	Inhibition of Flt4	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1		CHEMBL390156	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
	1849901	CHEMBL914194	Inhibition of Flt4	B	COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(Cn4cncn4)cc2-3)cs1		CHEMBL223971	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
	1965883	CHEMBL897424	Inhibition of human VEGFR3	B	O=C(NCCCN1CCCC1=O)c1cnccc1Nc1nc(-c2cc(Br)ccc2F)nc2nccnc12		CHEMBL234655	=	IC50	nM	123.0	CHEMBL1955	Homo sapiens	IC50	nM	123.0
	1966314	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccccn1		CHEMBL232800	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966500	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nnnn1CCc1ccncc1		CHEMBL233829	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966501	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nnnn2CCc2ccncc2)cc1		CHEMBL233828	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966502	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL233827	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966503	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL234205	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966504	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nnnn1CCc1ccncc1		CHEMBL393001	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966505	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234013	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966506	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234012	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966507	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL233826	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966508	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nccn1CCc1ccncc1		CHEMBL233825	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966509	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nccn2CCc2ccncc2)cc1		CHEMBL233824	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966510	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL391104	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966511	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL234203	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966512	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nccn1CCc1ccncc1		CHEMBL234202	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966513	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL391103	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966514	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL234201	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966515	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(OC(F)(F)F)cc2)c1C		CHEMBL234011	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966516	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(Cl)cc2)c1C		CHEMBL391102	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966517	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	Cc1cc(C(=O)Nc2ccc(OC(F)(F)F)cc2)n(CCc2ccncc2)n1		CHEMBL392331	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966518	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	Cc1cc(C(=O)Nc2ccc(Cl)cc2)n(CCc2ccncc2)n1		CHEMBL234010	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966519	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	COc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1OC		CHEMBL234009	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966520	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL392330	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966521	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL233823	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966522	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL233822	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966523	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc2cn[nH]c2c1)c1ccnn1CCc1ccncc1		CHEMBL392329	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966524	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc2[nH]ncc2c1)c1ccnn1CCc1ccncc1		CHEMBL233821	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966525	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1		CHEMBL391069	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966526	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(OCc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL233631	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966527	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Oc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL392313	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966528	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(-c2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL399606	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966529	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	CC(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL236420	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966530	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL399605	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966531	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1cccc(OC(F)(F)Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL236419	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966532	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL236206	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966533	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL236205	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966534	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL392935	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966535	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL392934	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966536	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1c[nH]cn1		CHEMBL237680	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966537	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1noc2ccccc12		CHEMBL237679	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966538	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cnoc1		CHEMBL232802	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966539	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	COc1ccc(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)cc1OC		CHEMBL234864	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966540	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccc(F)c(F)c1		CHEMBL393006	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966541	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	CC1C=C2OCOC2=C(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)C1		CHEMBL234863	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966542	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccncc1		CHEMBL397323	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	1966543	CHEMBL897514	Inhibition of Flt4 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cccnc1		CHEMBL397322	>	Activity	%	30.0	CHEMBL1955	Homo sapiens	Activity	%	30.0
	2019929	CHEMBL903332	Inhibition of VEGFR3	B	CCOc1cccc2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C		CHEMBL398610	=	IC50	nM	16.0	CHEMBL1955	Homo sapiens	IC50	nM	16.0
	2021696	CHEMBL903572	Inhibition of human VGFR3	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	7.586	CHEMBL1955	Homo sapiens	Log IC50		-8.12
	2029836	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029936	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029937	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029938	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029939	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029940	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029941	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029942	CHEMBL886320	Inhibition of VEGFR3	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2029943	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029944	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029945	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029946	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029947	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029948	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2029949	CHEMBL886303	Inhibition of VEGFR3 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	Inhibition	%	40.0
	2051592	CHEMBL942733	Inhibition of FLT4	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	6846.0	CHEMBL1955	Homo sapiens	Ki	uM	6.846
	2081992	CHEMBL929892	Inhibition of VEGFR3	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258015	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
Not Active	2102899	CHEMBL931008	Inhibition of Flt4 upto 50 uM	B	CCOC(=O)c1cc2ccc3c4cccc(Cl)c4[nH]c3c2[nH]1		CHEMBL272186		Activity			CHEMBL1955	Homo sapiens	Activity		
Active	2120835	CHEMBL950233	Inhibition of human VEGFR3	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198		Activity			CHEMBL1955	Homo sapiens	Activity		
Active	2120837	CHEMBL950233	Inhibition of human VEGFR3	B	COCCNC(=O)c1cccc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12		CHEMBL412278		Activity			CHEMBL1955	Homo sapiens	Activity		
Active	2120838	CHEMBL950233	Inhibition of human VEGFR3	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271188		Activity			CHEMBL1955	Homo sapiens	Activity		
	2121173	CHEMBL934132	Inhibition of VEGFR3	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	=	IC50	nM	2.0	CHEMBL1955	Homo sapiens	IC50	nM	2.0
	2136889	CHEMBL939342	Inhibition of VEGFR3	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	Log IC50		-6.0
	2136933	CHEMBL939342	Inhibition of VEGFR3	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
	2137114	CHEMBL939342	Inhibition of VEGFR3	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	IC50	nM	125.0	CHEMBL1955	Homo sapiens	IC50	nM	125.0
	2147269	CHEMBL921859	Activity of human Flt4 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	6.0	CHEMBL1955	Homo sapiens	Activity	%	6.0
	2167936	CHEMBL924787	Inhibition of VEGFR3 at 100 nM	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Inhibition	%	100.0	CHEMBL1955	Homo sapiens	Inhibition	%	100.0
	2206826	CHEMBL990525	Inhibition of FLT4	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	35.0	CHEMBL1955	Homo sapiens	Kd	nM	35.0
	2206918	CHEMBL990525	Inhibition of FLT4	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	16.0	CHEMBL1955	Homo sapiens	Kd	nM	16.0
	2238315	CHEMBL976282	Inhibition of Flt4	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL488840	=	IC50	nM	151.0	CHEMBL1955	Homo sapiens	IC50	nM	151.0
	2238323	CHEMBL976290	Inhibition of Flt3	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL488840	>	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	nM	1000.0
	2240269	CHEMBL973567	Inhibition of Flt4 by radiometric assay	B	CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL518051	=	IC50	nM	14.0	CHEMBL1955	Homo sapiens	IC50	nM	14.0
	2250296	CHEMBL1011004	Inhibition of VEGFR3	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
	2250949	CHEMBL1011046	Inhibition of VEGFR3	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL1955	Homo sapiens	IC50	uM	4.0
	2251202	CHEMBL1009877	Inhibition of VEGFR3	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.0	CHEMBL1955	Homo sapiens	IC50	nM	1.0
	2270389	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]ccc23)cc(-c2nc3ccccc3s2)c1		CHEMBL490555	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270390	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2ccsc12		CHEMBL474347	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270391	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	Clc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL474346	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270392	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL514929	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270393	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5ccsc45)cc3)nc2c1		CHEMBL472946	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270394	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc[nH]c2n1		CHEMBL462338	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270395	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]ccc23)ccc1-c1nc2ccccc2s1		CHEMBL462162	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270396	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1cc(Nc2nccc(Nc3cc(C)[nH]n3)n2)ccc1-c1nc2ccccc2s1		CHEMBL461110	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270397	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	CNc1ccnc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL462160	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270399	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	CNC(=O)c1cc(Nc2ccc(-c3nc4ccccc4s3)cc2)ccn1		CHEMBL464210	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	2270442	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)c(OC)c2)c2cc[nH]c2n1		CHEMBL475351	=	IC50	nM	7700.0	CHEMBL1955	Homo sapiens	IC50	uM	7.7
	2270450	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	CNc1nccc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL512933	=	IC50	nM	6900.0	CHEMBL1955	Homo sapiens	IC50	uM	6.9
	2270455	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	Cc1cc(Nc2cc(Nc3ccc(-c4nc5ccccc5s4)cc3)ccn2)n[nH]1		CHEMBL461991	=	IC50	nM	6500.0	CHEMBL1955	Homo sapiens	IC50	uM	6.5
	2270459	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	CNc1cc(Nc2ccc(-c3nc4ccccc4s3)cc2)ccn1		CHEMBL464014	=	IC50	nM	6000.0	CHEMBL1955	Homo sapiens	IC50	uM	6.0
	2270465	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	CN1CCN(c2ccnc(Nc3ccc(-c4nc5ccccc5s4)cc3)n2)CC1		CHEMBL459886	=	IC50	nM	5200.0	CHEMBL1955	Homo sapiens	IC50	uM	5.2
	2270477	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]cnc23)ccc1-c1nc2ccccc2s1		CHEMBL475352	=	IC50	nM	3400.0	CHEMBL1955	Homo sapiens	IC50	uM	3.4
	2270495	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1		CHEMBL491686	=	IC50	nM	2500.0	CHEMBL1955	Homo sapiens	IC50	uM	2.5
	2270496	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	=	IC50	nM	2400.0	CHEMBL1955	Homo sapiens	IC50	uM	2.4
	2270500	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]ccc45)cc3)nc2c1		CHEMBL518803	=	IC50	nM	2100.0	CHEMBL1955	Homo sapiens	IC50	uM	2.1
	2270511	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC		CHEMBL522785	=	IC50	nM	1600.0	CHEMBL1955	Homo sapiens	IC50	uM	1.6
	2270531	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	O=C(NC(=S)Nc1ccc(O)c(-c2nc3ccccc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL460746	=	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	uM	1.0
Not Determined	2270581	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	CN(C)c1ccnc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL462161		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2270582	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3ccc(-c4nc5ccccc5s4)cc3)n2)n[nH]1		CHEMBL461109		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2270583	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]cnc45)cc3)nc2c1		CHEMBL515598		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2270584	CHEMBL964949	Inhibition of VEGFR3 by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1		CHEMBL443906		IC50			CHEMBL1955	Homo sapiens	IC50		
	2270711	CHEMBL955158	Inhibition of VEGFR3 at 100 nM	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccc(F)cc6)C5=O)cc4F)c3s2)c1		CHEMBL464211	=	Inhibition	%	99.0	CHEMBL1955	Homo sapiens	INH	%	99.0
	2298790	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	2298791	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
	2298792	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049	=	IC50	nM	32.0	CHEMBL1955	Homo sapiens	IC50	nM	32.0
	2298793	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)Cn2ccnc2)cc1)c1ccccc1		CHEMBL524453	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
	2298794	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CC(=O)N(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498088	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	nM	6.0
	2298795	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL525909	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
	2298796	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498265	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
	2298797	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL498266	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	2298798	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)N(C)CCN(C)C)cc1)c1ccccc1		CHEMBL525550	=	IC50	nM	59.0	CHEMBL1955	Homo sapiens	IC50	nM	59.0
	2298799	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL498105	=	IC50	nM	73.0	CHEMBL1955	Homo sapiens	IC50	nM	73.0
	2298800	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL465015	=	IC50	nM	24.0	CHEMBL1955	Homo sapiens	IC50	nM	24.0
Not Determined	2298801	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN(C)C)cc1)c1ccccc1		CHEMBL465016		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2298802	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL518867		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2298803	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCC2=O)cc1)c1ccccc1		CHEMBL465217		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2298804	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(C(=O)N(C)CCN(C)C)c1)c1ccccc1		CHEMBL485642		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2298805	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1		CHEMBL519213		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2298806	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1		CHEMBL485643		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Determined	2298807	CHEMBL1017195	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCC(NC(=O)CN(C)C)CC1)c1ccccc1		CHEMBL483781		IC50			CHEMBL1955	Homo sapiens	IC50		
Not Active	2301940	CHEMBL949888	Inhibition of VEGFR3	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	2301964	CHEMBL949888	Inhibition of VEGFR3	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976	=	IC50	nM	45000.0	CHEMBL1955	Homo sapiens	IC50	uM	45.0
Not Active	2301988	CHEMBL949888	Inhibition of VEGFR3	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	2302012	CHEMBL949888	Inhibition of VEGFR3	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	2302036	CHEMBL949889	Inhibition of VEGFR3 up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	2302060	CHEMBL949888	Inhibition of VEGFR3	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	2302084	CHEMBL949888	Inhibition of VEGFR3	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	2302108	CHEMBL949888	Inhibition of VEGFR3	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	2302132	CHEMBL949888	Inhibition of VEGFR3	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	2361181	CHEMBL970657	Inhibition of Flt4 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL505896	=	IC50	nM	120.0	CHEMBL1955	Homo sapiens	IC50	nM	120.0
	2361203	CHEMBL970657	Inhibition of Flt4 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL453737	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
Not Determined	2361226	CHEMBL970657	Inhibition of Flt4 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1		CHEMBL447602		IC50			CHEMBL1955	Homo sapiens	IC50		
	2379752	CHEMBL1000445	Inhibition of human VEGFR3 expressed in baculovirus insect cell system	B	CC(C)Oc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460990	=	IC50	nM	2459.0	CHEMBL1955	Homo sapiens	IC50	nM	2459.0
	2379761	CHEMBL1000445	Inhibition of human VEGFR3 expressed in baculovirus insect cell system	B	COc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460989	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	2379813	CHEMBL1000445	Inhibition of human VEGFR3 expressed in baculovirus insect cell system	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352	=	IC50	nM	39.0	CHEMBL1955	Homo sapiens	IC50	nM	39.0
Not Active	2381826	CHEMBL939554	Inhibition of VEGFR3 phosphorylation in human BT474 cells at 100 uM after 24 hrs by Western blotting	B	Cl.Nc1cc(N)c(N)cc1N		CHEMBL456559		Activity			CHEMBL1955	Homo sapiens	Activity		
Not Active	2381861	CHEMBL939570	Inhibition of recombinant Flt4 at 1 uM	B	Cl.Nc1cc(N)c(N)cc1N		CHEMBL456559		Activity			CHEMBL1955	Homo sapiens	Activity		
	2386934	CHEMBL1006968	Inhibition of VEGFR3 at 10 uM	B	Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1		CHEMBL380316	=	Inhibition	%	33.0	CHEMBL1955	Homo sapiens	INH	%	33.0
	2395442	CHEMBL961269	Binding affinity to FLT4 at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	0.0	CHEMBL1955	Homo sapiens	Activity	%	0.0
	2461797	CHEMBL962873	Inhibition of recombinant VEGFR3	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	1.3	CHEMBL1955	Homo sapiens	IC50	10'-6g/ml	1.3
	2461833	CHEMBL962873	Inhibition of recombinant VEGFR3	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	2.8	CHEMBL1955	Homo sapiens	IC50	10'-6g/ml	2.8
	2461834	CHEMBL962873	Inhibition of recombinant VEGFR3	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	=	IC50	ug.mL-1	3.7	CHEMBL1955	Homo sapiens	IC50	10'-6g/ml	3.7
	2461835	CHEMBL962873	Inhibition of recombinant VEGFR3	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL1955	Homo sapiens	IC50	10'-5g/ml	1.0
	2461836	CHEMBL962873	Inhibition of recombinant VEGFR3	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL1955	Homo sapiens	IC50	10'-5g/ml	1.0
	2461837	CHEMBL962873	Inhibition of recombinant VEGFR3	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	6.8	CHEMBL1955	Homo sapiens	IC50	10'-6g/ml	6.8
	2461838	CHEMBL962873	Inhibition of recombinant VEGFR3	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	>	IC50	ug.mL-1	10.0	CHEMBL1955	Homo sapiens	IC50	10'-5g/ml	1.0
	2461839	CHEMBL962873	Inhibition of recombinant VEGFR3	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	0.96	CHEMBL1955	Homo sapiens	IC50	10'-7g/ml	9.6
	2461840	CHEMBL962873	Inhibition of recombinant VEGFR3	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	1.7	CHEMBL1955	Homo sapiens	IC50	10'-6g/ml	1.7
	2462919	CHEMBL962873	Inhibition of recombinant VEGFR3	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	0.39	CHEMBL1955	Homo sapiens	IC50	10'-7g/ml	3.9
	2465002	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	uM	0.005
	2465085	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc1		CHEMBL507056	=	IC50	nM	18000.0	CHEMBL1955	Homo sapiens	IC50	uM	18.0
	2465086	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc1		CHEMBL452812	=	IC50	nM	8700.0	CHEMBL1955	Homo sapiens	IC50	uM	8.7
	2465087	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL509435	=	IC50	nM	11000.0	CHEMBL1955	Homo sapiens	IC50	uM	11.0
	2465088	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(CC(O)CO)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453593	=	IC50	nM	2500.0	CHEMBL1955	Homo sapiens	IC50	uM	2.5
	2465089	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(CC4COC(C)(C)O4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL509635	=	IC50	nM	3200.0	CHEMBL1955	Homo sapiens	IC50	uM	3.2
	2465090	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453336	=	IC50	nM	1700.0	CHEMBL1955	Homo sapiens	IC50	uM	1.7
	2465091	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(COc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488811	=	IC50	nM	2500.0	CHEMBL1955	Homo sapiens	IC50	uM	2.5
	2465092	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	4800.0	CHEMBL1955	Homo sapiens	IC50	uM	4.8
	2465093	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(COC(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488645	=	IC50	nM	5300.0	CHEMBL1955	Homo sapiens	IC50	uM	5.3
	2465094	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	CCOCn1cc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2)c2ccccc21		CHEMBL529217	=	IC50	nM	3600.0	CHEMBL1955	Homo sapiens	IC50	uM	3.6
	2465095	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COCn1cc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2)c2ccccc21		CHEMBL519590	=	IC50	nM	3200.0	CHEMBL1955	Homo sapiens	IC50	uM	3.2
	2465096	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL486437	=	IC50	nM	5600.0	CHEMBL1955	Homo sapiens	IC50	uM	5.6
	2465097	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(O)NC2=O)cc(OC)c1OC		CHEMBL505253	=	IC50	nM	3400.0	CHEMBL1955	Homo sapiens	IC50	uM	3.4
	2465098	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL521201	=	IC50	nM	9400.0	CHEMBL1955	Homo sapiens	IC50	uM	9.4
	2465099	CHEMBL957978	Inhibition of human recombinant VEGFR3	B	COc1cc(C2=C(c3c[nH]c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL529663	=	IC50	nM	37.0	CHEMBL1955	Homo sapiens	IC50	uM	0.037
	2470232	CHEMBL984518	Inhibition of FLT4 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL1955	Homo sapiens	INH	%	10.0
	2476627	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	3.7	CHEMBL1955	Homo sapiens	Activity	%	3.7
Not Evaluated	2476830	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL1955	Homo sapiens	Activity		
Not Evaluated	2478669	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL1955	Homo sapiens	Activity		
	2478872	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	26.1	CHEMBL1955	Homo sapiens	Activity	%	26.1
	2479727	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	16.3	CHEMBL1955	Homo sapiens	Activity	%	16.3
	2480726	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.1	CHEMBL1955	Homo sapiens	Activity	%	0.1
	2505606	CHEMBL941565	Inhibition of VEGFR3	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	IC50	nM	92.0	CHEMBL1955	Homo sapiens	IC50	nM	92.0
	2511585	CHEMBL972543	Inhibition of FLT4	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.9	CHEMBL1955	Homo sapiens	IC50	uM	0.0019
	2561551	CHEMBL981077	Inhibition of human GST-tagged VEGFR3 by HTRF assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	47.0	CHEMBL1955	Homo sapiens	IC50	nM	47.0
	2567244	CHEMBL974576	Inhibition of human Flt4 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	7.0	CHEMBL1955	Homo sapiens	Activity	%	7.0
Not Evaluated	2577348	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL1955	Homo sapiens	Activity		
Not Evaluated	2577551	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL1955	Homo sapiens	Activity		
	2582015	CHEMBL962249	Inhibition of human VEGFR3	B	N=C(Nc1ccccc1)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21		CHEMBL487254	=	IC50	nM	9600.0	CHEMBL1955	Homo sapiens	IC50	uM	9.6
	2582031	CHEMBL962249	Inhibition of human VEGFR3	B	N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL489083	=	IC50	nM	4700.0	CHEMBL1955	Homo sapiens	IC50	uM	4.7
	2593553	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	6.4	CHEMBL1955	Homo sapiens	Activity	%	6.4
	2593756	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.8	CHEMBL1955	Homo sapiens	Activity	%	0.8
	2594022	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	4.6	CHEMBL1955	Homo sapiens	Activity	%	4.6
Not Evaluated	2594965	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL1955	Homo sapiens	Activity		
Not Evaluated	2595168	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL1955	Homo sapiens	Activity		
	2595234	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	25.4	CHEMBL1955	Homo sapiens	Activity	%	25.4
	2596365	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	20.3	CHEMBL1955	Homo sapiens	Activity	%	20.3
Not Evaluated	2597634	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL1955	Homo sapiens	Activity		
Not Evaluated	2597837	CHEMBL1035891	Binding affinity to human FLT4 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL1955	Homo sapiens	Activity		
	2603063	CHEMBL1023858	Inhibition of VEGFR3	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	=	Kd	nM	27.0	CHEMBL1955	Homo sapiens	Kd	nM	27.0
Active	2645006	CHEMBL1026083	Inhibition of VEGFR3 phosphorylation in human MCF7 cells expressing VEGFR3 cells assessed as partial dephosphorylation at Tyr1063/1068 activation loop at 1 uM after 24 hrs by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
Active	2645007	CHEMBL1026084	Inhibition of VEGFR3 phosphorylation in human MCF7 cells expressing VEGFR3 assessed as complete dephosphorylation at Tyr1063/1068 activation loop at 10 uM by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
tde	2645008	CHEMBL1026085	Inhibition of VEGFR3 phosphorylation in human MCF7 cells expressing VEGFR3 assessed as partial dephosphorylation at Tyr1063/1068 activation loop at 1 to 10 uM by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
tde	2645009	CHEMBL1026086	Inhibition of VEGFR3 phosphorylation in human MCF7 cells expressing VEGFR3 assessed as complete dephosphorylation at Tyr1063/1068 activation loop at 1 to 10 uM by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
Dose-dependent effect	2645010	CHEMBL1026087	Inhibition of VEGFR3 phosphorylation in human MCF7 cells expressing VEGFR3 assessed as partial dephosphorylation at Tyr1063/1068 activation loop after 24 hrs by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
Dose-dependent effect	2645011	CHEMBL1032147	Inhibition of VEGFR3 phosphorylation in human MCF7 cells expressing VEGFR3 assessed as complete dephosphorylation at Tyr1063/1068 activation loop after 24 hrs by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
tde	2645012	CHEMBL1026079	Inhibition of VEGFR3 phosphorylation in human BT474 cells assessed as partial dephosphorylation at Tyr1063/1068 activation loop at 1 to 10 uM by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
tde	2645013	CHEMBL1026080	Inhibition of VEGFR3 phosphorylation in human BT474 cells assessed as complete dephosphorylation at Tyr1063/1068 activation loop at 1 to 10 uM by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
Dose-dependent effect	2645014	CHEMBL1026081	Inhibition of VEGFR3 phosphorylation in human BT474 cells assessed as partial dephosphorylation at Tyr1063/1068 activation loop after 24 hrs by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
Dose-dependent effect	2645015	CHEMBL1026082	Inhibition of VEGFR3 phosphorylation in human BT474 cells assessed as complete dephosphorylation at Tyr1063/1068 activation loop after 24 hrs by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
Active	2645018	CHEMBL1036232	Inhibition of VEGFR3 phosphorylation in human BT474 cells assessed as partial dephosphorylation at Tyr1063/1068 activation loop at 1 uM after 24 hrs by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
Active	2645019	CHEMBL1036233	Inhibition of VEGFR3 phosphorylation in human BT474 cells assessed as complete dephosphorylation at Tyr1063/1068 activation loop at 10 uM by Western blotting	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1.Cl		CHEMBL550011		Activity			CHEMBL1955	Homo sapiens	Activity		
	2661400	CHEMBL1058606	Inhibition of VEGFR3	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	920.0	CHEMBL1955	Homo sapiens	IC50	uM	0.92
	2671887	CHEMBL1026233	Inhibition of recombinant VEGFR3	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	>	IC50	ug.mL-1	10.0	CHEMBL1955	Homo sapiens	IC50	ug ml-1	10.0
	2672242	CHEMBL1026233	Inhibition of recombinant VEGFR3	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	=	IC50	ug.mL-1	9.9	CHEMBL1955	Homo sapiens	IC50	ug ml-1	9.9
	2672270	CHEMBL1026233	Inhibition of recombinant VEGFR3	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	4.0	CHEMBL1955	Homo sapiens	IC50	ug ml-1	4.0
	2672283	CHEMBL1026233	Inhibition of recombinant VEGFR3	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	=	IC50	ug.mL-1	2.7	CHEMBL1955	Homo sapiens	IC50	ug ml-1	2.7
	2721614	CHEMBL1057442	Inhibition of Flt4 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	2890881	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	16.0	CHEMBL1955	Homo sapiens	Kd	nM	16.0
	2890882	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	9.7	CHEMBL1955	Homo sapiens	Kd	nM	9.7
	2890883	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	120.0	CHEMBL1955	Homo sapiens	Kd	nM	120.0
	2890884	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890885	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	7100.0	CHEMBL1955	Homo sapiens	Kd	nM	7100.0
	2890886	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890887	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	580.0	CHEMBL1955	Homo sapiens	Kd	nM	580.0
	2890888	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	2000.0	CHEMBL1955	Homo sapiens	Kd	nM	2000.0
	2890889	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890890	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890891	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890892	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890893	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890894	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2100.0	CHEMBL1955	Homo sapiens	Kd	nM	2100.0
	2890895	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890896	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890897	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890898	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	27.0	CHEMBL1955	Homo sapiens	Kd	nM	27.0
	2890899	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890900	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1100.0	CHEMBL1955	Homo sapiens	Kd	nM	1100.0
	2890901	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890902	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890903	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890904	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3100.0	CHEMBL1955	Homo sapiens	Kd	nM	3100.0
	2890905	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890906	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	670.0	CHEMBL1955	Homo sapiens	Kd	nM	670.0
	2890907	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	330.0	CHEMBL1955	Homo sapiens	Kd	nM	330.0
	2890908	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890909	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890910	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890911	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890912	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	95.0	CHEMBL1955	Homo sapiens	Kd	nM	95.0
	2890913	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	28.0	CHEMBL1955	Homo sapiens	Kd	nM	28.0
	2890914	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	50.0	CHEMBL1955	Homo sapiens	Kd	nM	50.0
	2890915	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	50.0	CHEMBL1955	Homo sapiens	Kd	nM	50.0
	2890916	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1900.0	CHEMBL1955	Homo sapiens	Kd	nM	1900.0
	2890917	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	2890918	CHEMBL1060246	Binding constant for FLT4 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1100.0	CHEMBL1955	Homo sapiens	Kd	nM	1100.0
	2897240	CHEMBL1061127	Percent residual Flt-4 activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	80.0	CHEMBL1955	Homo sapiens	Activity	%	80.0
	2921325	CHEMBL1053740	Inhibition of FLT4 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	96.0	CHEMBL1955	Homo sapiens	Activity	%	96.0
	2928477	CHEMBL1049975	Binding affinity to FLT4 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	93.0	CHEMBL1955	Homo sapiens	Activity	%	93.0
	2929946	CHEMBL1057698	Binding affinity to FLT4	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1955	Homo sapiens	Kd	nM	41.0
	2938502	CHEMBL1041363	Inhibition of FLT-4 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	8.0	CHEMBL1955	Homo sapiens	INH	%	8.0
	2943677	CHEMBL1044063	Inhibition of Flt4	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	=	IC50	nM	2700.0	CHEMBL1955	Homo sapiens	IC50	microM	2.7
	2943679	CHEMBL1044063	Inhibition of Flt4	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	=	IC50	nM	4500.0	CHEMBL1955	Homo sapiens	IC50	microM	4.5
	2948617	CHEMBL1047372	Inhibition of VEGFR3 at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	93.0	CHEMBL1955	Homo sapiens	INH	%	93.0
	2989956	CHEMBL1039183	Inhibition of VEGFR3 at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	=	Inhibition	%	97.0	CHEMBL1955	Homo sapiens	INH	%	97.0
	2992491	CHEMBL1040924	Inhibition of human recombinant Flt4	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	4600.0	CHEMBL1955	Homo sapiens	IC50	nM	4600.0
	3052509	CHEMBL1047760	Residual activity of VEGFR3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	64.0	CHEMBL1955	Homo sapiens	Residual activity	%	64.0
	3052761	CHEMBL1043840	Residual activity of VEGFR3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	30.0	CHEMBL1955	Homo sapiens	Residual activity	%	30.0
	3054070	CHEMBL1073369	Residual activity of VEGFR3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	4.0	CHEMBL1955	Homo sapiens	Residual activity	%	4.0
	3055357	CHEMBL1047760	Residual activity of VEGFR3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	60.0	CHEMBL1955	Homo sapiens	Residual activity	%	60.0
	3055609	CHEMBL1043840	Residual activity of VEGFR3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	34.0	CHEMBL1955	Homo sapiens	Residual activity	%	34.0
	3056914	CHEMBL1073369	Residual activity of VEGFR3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	4.0	CHEMBL1955	Homo sapiens	Residual activity	%	4.0
	3057166	CHEMBL1047760	Residual activity of VEGFR3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	57.0	CHEMBL1955	Homo sapiens	Residual activity	%	57.0
	3058486	CHEMBL1043840	Residual activity of VEGFR3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	32.0	CHEMBL1955	Homo sapiens	Residual activity	%	32.0
	3059770	CHEMBL1073369	Residual activity of VEGFR3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	6.0	CHEMBL1955	Homo sapiens	Residual activity	%	6.0
	3059813	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	>	EC50	nM	10000.0	CHEMBL1955	Homo sapiens	EC50	uM	10.0
	3059814	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	=	EC50	nM	13000.0	CHEMBL1955	Homo sapiens	EC50	uM	13.0
	3059815	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	>	EC50	nM	10000.0	CHEMBL1955	Homo sapiens	EC50	uM	10.0
	3059816	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	>	EC50	nM	10000.0	CHEMBL1955	Homo sapiens	EC50	uM	10.0
	3059817	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	=	EC50	nM	26000.0	CHEMBL1955	Homo sapiens	EC50	uM	26.0
	3059818	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	=	EC50	nM	14000.0	CHEMBL1955	Homo sapiens	EC50	uM	14.0
	3059819	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	>	EC50	nM	10000.0	CHEMBL1955	Homo sapiens	EC50	uM	10.0
	3059820	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	>	EC50	nM	10000.0	CHEMBL1955	Homo sapiens	EC50	uM	10.0
	3059821	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	>	EC50	nM	10000.0	CHEMBL1955	Homo sapiens	EC50	uM	10.0
	3059822	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	EC50	nM	780.0	CHEMBL1955	Homo sapiens	EC50	uM	0.78
	3059823	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	EC50	nM	60.0	CHEMBL1955	Homo sapiens	EC50	uM	0.06
	3059824	CHEMBL1073387	Inhibition of VEGFR3 in human HCT116 cells by cellular phosphorylation assay	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	EC50	nM	800.0	CHEMBL1955	Homo sapiens	EC50	uM	0.8
	3072752	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595615	=	IC50	nM	69.0	CHEMBL1955	Homo sapiens	IC50	uM	0.069
	3072753	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3C)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595406	=	IC50	nM	340.0	CHEMBL1955	Homo sapiens	IC50	uM	0.34
	3072754	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3O)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595142	=	IC50	nM	4500.0	CHEMBL1955	Homo sapiens	IC50	uM	4.5
	3072755	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	=	IC50	nM	1700.0	CHEMBL1955	Homo sapiens	IC50	uM	1.7
	3072756	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3OC(F)(F)F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593245	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3072757	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	=	IC50	nM	350.0	CHEMBL1955	Homo sapiens	IC50	uM	0.35
	3072758	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(C)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596087	=	IC50	nM	1500.0	CHEMBL1955	Homo sapiens	IC50	uM	1.5
	3072759	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	=	IC50	nM	520.0	CHEMBL1955	Homo sapiens	IC50	uM	0.52
	3072760	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	=	IC50	nM	7100.0	CHEMBL1955	Homo sapiens	IC50	uM	7.1
	3072761	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	=	IC50	nM	210.0	CHEMBL1955	Homo sapiens	IC50	uM	0.21
	3072762	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	=	IC50	nM	470.0	CHEMBL1955	Homo sapiens	IC50	uM	0.47
	3072763	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1ccc2nc(-c3ccc(Nc4ncnc5cc(OCCCN6CCN(C)CC6)c(OC)cc45)cc3)sc2c1		CHEMBL593306	=	IC50	nM	1900.0	CHEMBL1955	Homo sapiens	IC50	uM	1.9
	3072764	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	=	IC50	nM	865.0	CHEMBL1955	Homo sapiens	IC50	uM	0.865
	3072765	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593275	=	IC50	nM	9300.0	CHEMBL1955	Homo sapiens	IC50	uM	9.3
	3072766	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	=	IC50	nM	1300.0	CHEMBL1955	Homo sapiens	IC50	uM	1.3
	3072767	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3072768	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593909	=	IC50	nM	3000.0	CHEMBL1955	Homo sapiens	IC50	uM	3.0
	3072769	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(N(C)c3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593770	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3072770	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	IC50	nM	190.0	CHEMBL1955	Homo sapiens	IC50	uM	0.19
	3072771	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	IC50	nM	121.0	CHEMBL1955	Homo sapiens	IC50	uM	0.121
	3072772	CHEMBL1073383	Inhibition of VEGFR3 by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	IC50	nM	140.0	CHEMBL1955	Homo sapiens	IC50	uM	0.14
	3084418	CHEMBL1073281	Inhibition of FLT4	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	5800.0	CHEMBL1955	Homo sapiens	IC50	uM	5.8
	3098413	CHEMBL1067019	Inhibition of human VEGFR3 at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	>	Inhibition	%	95.0	CHEMBL1955	Homo sapiens	INH	%	95.0
Active	3098420	CHEMBL1067045	Inhibition of human VEGFR3	B	O=C(CC(Nc1ccc(Oc2cc(NC(=O)N3CCCC3)ncn2)c(F)c1)C(F)(F)F)Nc1ccccc1		CHEMBL612137		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	3102180	CHEMBL1070755	Inhibition of VEGFR3 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(I)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL597492	=	IC50	nM	29.51	CHEMBL1955	Homo sapiens	IC50	nM	29.51
	3102181	CHEMBL1070755	Inhibition of VEGFR3 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL605957	=	IC50	nM	21.0	CHEMBL1955	Homo sapiens	IC50	nM	21.0
	3102182	CHEMBL1070755	Inhibition of VEGFR3 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	22.0	CHEMBL1955	Homo sapiens	IC50	nM	22.0
	3102183	CHEMBL1070755	Inhibition of VEGFR3 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(F)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL606168	=	IC50	nM	66.0	CHEMBL1955	Homo sapiens	IC50	nM	66.0
	3117956	CHEMBL1072232	Inhibition of VEGFR3	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3118009	CHEMBL1072232	Inhibition of VEGFR3	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3118062	CHEMBL1072232	Inhibition of VEGFR3	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3127405	CHEMBL1064457	Inhibition of VEGFR3 by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3127439	CHEMBL1064457	Inhibition of VEGFR3 by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3210375	CHEMBL1109444	Inhibition of VEGFR3 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	71.0	CHEMBL1955	Homo sapiens	IC50	uM	0.071
	3213819	CHEMBL1108406	Inhibition of FLT4 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	7.0	CHEMBL1955	Homo sapiens	INH	%	7.0
	3224828	CHEMBL1099665	Inhibition of FLT4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3225078	CHEMBL1099665	Inhibition of FLT4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3240806	CHEMBL1109698	Inhibition of Flt4	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	IC50	nM	65.0	CHEMBL1955	Homo sapiens	IC50	uM	0.065
	3288524	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NCCc1cn(CCCCCc2ccccc2)c2ccc(OCCc3ccc(O)cc3)cc12		CHEMBL1098119	=	IC50	nM	2680.0	CHEMBL1955	Homo sapiens	IC50	uM	2.68
	3288525	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccc2)C1		CHEMBL1098120	=	IC50	nM	2170.0	CHEMBL1955	Homo sapiens	IC50	uM	2.17
	3288526	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NCCc1c[nH]c2ccc(O)cc12		CHEMBL535832	>	IC50	nM	50000.0	CHEMBL1955	Homo sapiens	IC50	umol/L	50.0
	3288527	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	COc1ccc(CCCCCn2cc(CCN)c3cc(OCCc4ccc(O)cc4)ccc32)cc1.Cl		CHEMBL1098121	=	IC50	nM	2050.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.05
	3288528	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	CSc1ccc(CCCCCn2cc(CCN)c3cc(OCCc4ccc(O)cc4)ccc32)cc1.Cl		CHEMBL1094194	=	IC50	nM	2530.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.53
	3288529	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NCCc1cn(Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)c2ccc(OCCc3ccc(O)cc3)cc12		CHEMBL1094195	=	IC50	nM	3010.0	CHEMBL1955	Homo sapiens	IC50	umol/L	3.01
	3288530	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	COc1ccc(-c2ccc(Cn3cc(CCN)c4cc(OCCc5ccc(O)cc5)ccc43)cc2)cc1.Cl		CHEMBL1094196	=	IC50	nM	960.0	CHEMBL1955	Homo sapiens	IC50	umol/L	0.96
	3288531	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NCCc1cn(Cc2ccc(-c3ccccc3)cc2)c2ccc(OCCc3ccc(O)cc3)cc12		CHEMBL1095154	=	IC50	nM	4070.0	CHEMBL1955	Homo sapiens	IC50	umol/L	4.07
	3288532	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NCCc1c[nH]c2ccc(OCCc3ccc(O)cc3)cc12		CHEMBL1095957	=	IC50	nM	2640.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.64
	3288533	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	CSc1ccc(CCCCCn2cc(CCNC(=O)OC(C)(C)C)c3cc(OCCc4ccc(O)cc4)ccc32)cc1		CHEMBL1099339	>	IC50	nM	50000.0	CHEMBL1955	Homo sapiens	IC50	umol/L	50.0
	3288534	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	COc1ccc(CCOc2ccc3c(c2)c(CCN)cn3CCCCCc2ccc(SC)cc2)cc1.Cl		CHEMBL1094835	=	IC50	nM	1310.0	CHEMBL1955	Homo sapiens	IC50	umol/L	1.31
	3288535	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	CN(C)c1ccc(CCCCCn2c3c(c4cc(OCCc5ccc(O)cc5)ccc42)CC(N)CC3)cc1.Cl.Cl		CHEMBL3216254	=	IC50	nM	1660.0	CHEMBL1955	Homo sapiens	IC50	umol/L	1.66
	3288536	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	COc1ccc(CCCCCn2c3c(c4cc(OCCc5ccc(O)cc5)ccc42)CC(N)CC3)cc1.Cl		CHEMBL1094492	=	IC50	nM	1810.0	CHEMBL1955	Homo sapiens	IC50	umol/L	1.81
	3288537	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccc(C(F)(F)F)cc2)C1		CHEMBL1094825	=	IC50	nM	2270.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.27
	3288538	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccn2)C1		CHEMBL3216699	=	IC50	nM	2220.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.22
	3288539	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCc2ccccc2)C1		CHEMBL1097189	=	IC50	nM	2850.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.85
	3288540	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	Cl.NC1CCc2[nH]c3ccc(OCCc4ccc(O)cc4)cc3c2C1		CHEMBL1097190	=	IC50	nM	34570.0	CHEMBL1955	Homo sapiens	IC50	umol/L	34.57
	3288541	CHEMBL1105618	Inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA	B	COCCc1ccc(O)cc1		CHEMBL1094369	>	IC50	nM	50000.0	CHEMBL1955	Homo sapiens	IC50	umol/L	50.0
	3288548	CHEMBL1111031	Noncompetitive inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA in presence of 25 uM ATP	B	Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccc2)C1		CHEMBL1098120	=	IC50	nM	2170.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.17
	3288549	CHEMBL1111031	Noncompetitive inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA in presence of 25 uM ATP	B	Cl.NCCc1cn(Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)c2ccc(OCCc3ccc(O)cc3)cc12		CHEMBL1094195	=	IC50	nM	3010.0	CHEMBL1955	Homo sapiens	IC50	umol/L	3.01
	3288556	CHEMBL1111032	Noncompetitive inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA in presence of 50 uM ATP	B	Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccc2)C1		CHEMBL1098120	=	IC50	nM	2110.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.11
	3288557	CHEMBL1111032	Noncompetitive inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA in presence of 50 uM ATP	B	Cl.NCCc1cn(Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)c2ccc(OCCc3ccc(O)cc3)cc12		CHEMBL1094195	=	IC50	nM	2980.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.98
	3288564	CHEMBL1111033	Noncompetitive inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA in presence of 250 uM ATP	B	Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccc2)C1		CHEMBL1098120	=	IC50	nM	2190.0	CHEMBL1955	Homo sapiens	IC50	umol/L	2.19
	3288565	CHEMBL1111033	Noncompetitive inhibition of VEGFR3 after 30 mins by chemiluminescence ELISA in presence of 250 uM ATP	B	Cl.NCCc1cn(Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)c2ccc(OCCc3ccc(O)cc3)cc12		CHEMBL1094195	=	IC50	nM	3080.0	CHEMBL1955	Homo sapiens	IC50	umol/L	3.08
	3291441	CHEMBL1109155	Inhibition of VEGFR3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	=	IC50	nM	587.0	CHEMBL1955	Homo sapiens	IC50	uM	0.587
	3294243	CHEMBL1104800	Inhibition of FLT4	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	74.0	CHEMBL1955	Homo sapiens	IC50	nM	74.0
	3308387	CHEMBL1119653	Inhibition of VEGFR3 at 3 uM	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
	3308388	CHEMBL1119653	Inhibition of VEGFR3 at 3 uM	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337	=	IC50	nM	9.0	CHEMBL1955	Homo sapiens	IC50	nM	9.0
	3329243	CHEMBL1166750	Inhibition of VEGFR3	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	IC50	nM	940.0	CHEMBL1955	Homo sapiens	IC50	uM	0.94
	3331954	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3333369	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3334774	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3336194	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3337540	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3337790	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3339124	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3340426	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	84.5	CHEMBL1955	Homo sapiens	INH	%	84.5
	3340722	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3342138	CHEMBL1169244	Inhibition of FLT4 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	3344713	CHEMBL1167147	Inhibition of VEGFR3 assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	37.0	CHEMBL1955	Homo sapiens	Activity	%	37.0
	3344714	CHEMBL1167148	Inhibition of VEGFR3 assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	99.0	CHEMBL1955	Homo sapiens	Activity	%	99.0
	3358590	CHEMBL1174435	Inhibition of FLT4 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	3359032	CHEMBL1174435	Inhibition of FLT4 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.1	CHEMBL1955	Homo sapiens	INH	%	0.1
	3369991	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	81.3	CHEMBL1955	Homo sapiens	INH	%	81.3
	3369992	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)/C(=C\c1ccccc1)C(=O)N2		CHEMBL1173668	=	Inhibition	%	12.0	CHEMBL1955	Homo sapiens	INH	%	12.0
	3369993	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)/C(=C\c2ccccc2)C(=O)N3)cc1		CHEMBL1173669	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	3369994	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	O=C(Nc1ccccc1)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL1173732	=	Inhibition	%	48.0	CHEMBL1955	Homo sapiens	INH	%	48.0
	3369995	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc32)c(C)c1-c1ccccc1		CHEMBL1173733	=	Inhibition	%	35.0	CHEMBL1955	Homo sapiens	INH	%	35.0
Not Determined	3369996	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)/C(=C\c2ccc(-c4cccc([N+](=O)[O-])c4)o2)C(=O)N3)cc1		CHEMBL1172983		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Determined	3369997	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	C=CCc1ccc(NC(=O)Nc2ccc3c(c2)/C(=C/c2ccc[nH]2)C(=O)N3)cc1		CHEMBL1172984		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Determined	3369998	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2cccc3c2NC(=O)/C3=C\c2[nH]c(C)c(CC(=O)O)c2C)cc1		CHEMBL1173045		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Determined	3369999	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2cccc3c2NC(=O)/C3=C\c2ccsc2)cc1		CHEMBL1173757		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	3370000	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	O=C(Nc1ccccc1)Nc1ccc2c(c1)NC(=O)/C2=C/c1ccc(Cl)c(Cl)c1		CHEMBL1173158	=	Inhibition	%	23.0	CHEMBL1955	Homo sapiens	INH	%	23.0
	3370001	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	O=C(Nc1ccccc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc([N+](=O)[O-])cc1		CHEMBL1173159	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
Not Determined	3370002	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1cc(/C=C2\C(=O)Nc3cc(NC(=O)Nc4ccccc4)ccc32)ccc1O		CHEMBL1170854		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Determined	3370003	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc(O)c(OC)c2)cc1		CHEMBL1173230		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Determined	3370004	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2cccc(OC)c2)cc1		CHEMBL1173409		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	3370005	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(Cl)c(Cl)c2)cc1		CHEMBL1173046	=	Inhibition	%	42.0	CHEMBL1955	Homo sapiens	INH	%	42.0
	3370006	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(OC)c(OC)c2OC)cc1		CHEMBL1173047	=	Inhibition	%	15.0	CHEMBL1955	Homo sapiens	INH	%	15.0
	3370007	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	O=C(Nc1ccccc1)Nc1ccc2c(c1)NC(=O)/C2=C/c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL1173048	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	3370008	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)NC(=O)/C2=C/c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL1173589	=	Inhibition	%	20.0	CHEMBL1955	Homo sapiens	INH	%	20.0
	3370009	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C/c2ccc(-c3cccc([N+](=O)[O-])c3)o2)cc1		CHEMBL1173590	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	3370010	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccncc2)cc1		CHEMBL1173231	=	Inhibition	%	33.0	CHEMBL1955	Homo sapiens	INH	%	33.0
	3370011	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccccn2)cc1		CHEMBL1173232	=	Inhibition	%	4.0	CHEMBL1955	Homo sapiens	INH	%	4.0
	3370012	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccsc2)cc1		CHEMBL1173821	=	Inhibition	%	35.7	CHEMBL1955	Homo sapiens	INH	%	35.7
	3370013	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(-c3ccccc3)c2C)cc1		CHEMBL1173410	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	3370014	CHEMBL1176711	Inhibition of VEGFR3 at 0.1 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	52.0	CHEMBL1955	Homo sapiens	INH	%	52.0
	3370081	CHEMBL1176707	Inhibition of VEGFR3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	8.9	CHEMBL1955	Homo sapiens	IC50	nM	8.9
	3370082	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	IC50	nM	0.8	CHEMBL1955	Homo sapiens	IC50	nM	0.8
	3370083	CHEMBL1176707	Inhibition of VEGFR3	B	O=C(Nc1ccccc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL1173482	=	IC50	nM	22.4	CHEMBL1955	Homo sapiens	IC50	nM	22.4
	3370084	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL1173149	=	IC50	nM	12.8	CHEMBL1955	Homo sapiens	IC50	nM	12.8
	3370085	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1OC		CHEMBL1172814	=	IC50	nM	92.0	CHEMBL1955	Homo sapiens	IC50	nM	92.0
	3370086	CHEMBL1176707	Inhibition of VEGFR3	B	Cc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL1172815	=	IC50	nM	146.8	CHEMBL1955	Homo sapiens	IC50	nM	146.8
	3370087	CHEMBL1176707	Inhibition of VEGFR3	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL1172886	=	IC50	nM	8.7	CHEMBL1955	Homo sapiens	IC50	nM	8.7
	3370088	CHEMBL1176707	Inhibition of VEGFR3	B	O=C(Nc1ccc(Oc2ccccc2)cc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL1172887	=	IC50	nM	68.0	CHEMBL1955	Homo sapiens	IC50	nM	68.0
	3370089	CHEMBL1176707	Inhibition of VEGFR3	B	O=C(Nc1ccc(-c2ccccc2)cc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL1172837	=	IC50	nM	88.0	CHEMBL1955	Homo sapiens	IC50	nM	88.0
	3370090	CHEMBL1176707	Inhibition of VEGFR3	B	O=C(Nc1ccc(-c2ccc3ccccc3c2)cc1)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1		CHEMBL1172838	=	IC50	nM	13.0	CHEMBL1955	Homo sapiens	IC50	nM	13.0
	3370091	CHEMBL1176707	Inhibition of VEGFR3	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)Nc4ccccc4)ccc32)c(C)c1C(=O)O		CHEMBL1173107	=	IC50	nM	5.8	CHEMBL1955	Homo sapiens	IC50	nM	5.8
	3370092	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL1173174	=	IC50	nM	32.9	CHEMBL1955	Homo sapiens	IC50	nM	32.9
	3370093	CHEMBL1176707	Inhibition of VEGFR3	B	Cc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL1172420	=	IC50	nM	39.0	CHEMBL1955	Homo sapiens	IC50	nM	39.0
	3370094	CHEMBL1176707	Inhibition of VEGFR3	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)Nc4ccc(Cl)cc4)ccc32)c(C)c1C(=O)O		CHEMBL1172421	=	IC50	nM	42.0	CHEMBL1955	Homo sapiens	IC50	nM	42.0
	3370095	CHEMBL1176707	Inhibition of VEGFR3	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)Nc4ccccc4)ccc32)c(C)c1CC(=O)O		CHEMBL1172422	=	IC50	nM	34.0	CHEMBL1955	Homo sapiens	IC50	nM	34.0
	3370096	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CC(=O)O)c2C)cc1		CHEMBL1173150	=	IC50	nM	11.0	CHEMBL1955	Homo sapiens	IC50	nM	11.0
	3370097	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1		CHEMBL1173541	=	IC50	nM	13.0	CHEMBL1955	Homo sapiens	IC50	nM	13.0
	3370098	CHEMBL1176707	Inhibition of VEGFR3	B	Cc1cc(C(=O)O)[nH]c1/C=C1\C(=O)Nc2cc(NC(=O)Nc3ccccc3)ccc21		CHEMBL1173542	>	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	uM	1.0
	3370099	CHEMBL1176707	Inhibition of VEGFR3	B	Cc1cc(C(=O)O)[nH]c1/C=C1\C(=O)Nc2cc(NC(=O)Nc3ccc(Cl)cc3)ccc21		CHEMBL1173243	>	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	uM	1.0
	3370100	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc(C(=O)O)[nH]2)cc1		CHEMBL1173244	>	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	uM	1.0
	3370101	CHEMBL1176707	Inhibition of VEGFR3	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]ccc2-c2ccc(C(=O)O)s2)cc1		CHEMBL1172410	>	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	uM	1.0
Not Determined	3370102	CHEMBL1176707	Inhibition of VEGFR3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		IC50			CHEMBL1955	Homo sapiens	IC50		
	3370572	CHEMBL1176707	Inhibition of VEGFR3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
	3420254	CHEMBL1226950	Inhibition of VEGFR3	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	3441498	CHEMBL1244081	Inhibition of human VEGFR3	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	13.0	CHEMBL1955	Homo sapiens	IC50	nmol/L	13.0
	3443405	CHEMBL1244438	Inhibition of FLT4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	3443622	CHEMBL1244438	Inhibition of FLT4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	1.0	CHEMBL1955	Homo sapiens	INH	%	1.0
	3444777	CHEMBL1244438	Inhibition of FLT4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	3444987	CHEMBL1244851	Binding affinity to FLT4	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1955	Homo sapiens	Kd	nM	41.0
	3445129	CHEMBL1244851	Binding affinity to FLT4	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	17.0	CHEMBL1955	Homo sapiens	Kd	nM	17.0
	3445401	CHEMBL1244438	Inhibition of FLT4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-1.0	CHEMBL1955	Homo sapiens	INH	%	-1.0
	3445618	CHEMBL1244438	Inhibition of FLT4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	48.0	CHEMBL1955	Homo sapiens	INH	%	48.0
	3445826	CHEMBL1244438	Inhibition of FLT4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	79.0	CHEMBL1955	Homo sapiens	INH	%	79.0
	3446016	CHEMBL1244438	Inhibition of FLT4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	36.0	CHEMBL1955	Homo sapiens	INH	%	36.0
	3447165	CHEMBL1249725	Inhibition of VEGFR-3 kinase	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	18.0	CHEMBL1955	Homo sapiens	IC50	uM	0.018
	3448011	CHEMBL1249714	Inhibition of human Flt-4 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	30.0	CHEMBL1955	Homo sapiens	INH	%	30.0
	3448087	CHEMBL1249714	Inhibition of human Flt-4 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	79.0	CHEMBL1955	Homo sapiens	INH	%	79.0
	3448440	CHEMBL1244851	Binding affinity to FLT4	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	3448937	CHEMBL1244851	Binding affinity to FLT4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	670.0	CHEMBL1955	Homo sapiens	Kd	nM	670.0
	3449197	CHEMBL1244851	Binding affinity to FLT4	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	50.0	CHEMBL1955	Homo sapiens	Kd	nM	50.0
	3449198	CHEMBL1244851	Binding affinity to FLT4	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	95.0	CHEMBL1955	Homo sapiens	Kd	nM	95.0
	3451008	CHEMBL1244851	Binding affinity to FLT4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	uM	10.0
	3463238	CHEMBL1252426	Inhibition of FLT4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	1.0	CHEMBL1955	Homo sapiens	INH	%	1.0
	3463457	CHEMBL1252426	Inhibition of FLT4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	45.0	CHEMBL1955	Homo sapiens	INH	%	45.0
	3464001	CHEMBL1252426	Inhibition of FLT4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	70.0	CHEMBL1955	Homo sapiens	INH	%	70.0
	3504225	CHEMBL1260160	Inhibition of VEGFR3	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	19.0	CHEMBL1955	Homo sapiens	IC50	uM	0.019
	3526960	CHEMBL1274184	Inhibition of VEGFR3	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	3556521	CHEMBL1285587	Inhibition of FLT4 at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	17.0	CHEMBL1955	Homo sapiens	INH	%	17.0
	3590804	CHEMBL1292126	Inhibition of VEGFR3	B	c1cncc(CNc2ccnc3oc4ccccc4c23)c1	Outside typical range	CHEMBL1290178	>	Ki	nM	1000000.0	CHEMBL1955	Homo sapiens	Ki	uM	1000.0
	3590805	CHEMBL1292126	Inhibition of VEGFR3	B	Clc1ccc(CNc2ccnc3oc4ccccc4c23)cc1		CHEMBL1290177	=	Ki	nM	680.0	CHEMBL1955	Homo sapiens	Ki	uM	0.68
	3590806	CHEMBL1292126	Inhibition of VEGFR3	B	Clc1cccc(CNc2ccnc3oc4ccccc4c23)c1	Outside typical range	CHEMBL1290073	>	Ki	nM	1000000.0	CHEMBL1955	Homo sapiens	Ki	uM	1000.0
	3590807	CHEMBL1292126	Inhibition of VEGFR3	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL1955	Homo sapiens	Ki	uM	1000.0
	3590808	CHEMBL1292126	Inhibition of VEGFR3	B	c1ccc2c(CNc3ccnc4oc5ccccc5c34)cccc2c1		CHEMBL1290071	=	Ki	nM	1090.0	CHEMBL1955	Homo sapiens	Ki	uM	1.09
	3590809	CHEMBL1292126	Inhibition of VEGFR3	B	c1ccc(CCNc2ccnc3oc4ccccc4c23)cc1		CHEMBL1289977	=	Ki	nM	9390.0	CHEMBL1955	Homo sapiens	Ki	uM	9.39
	3590810	CHEMBL1292126	Inhibition of VEGFR3	B	c1ccc(CNc2ccnc3oc4ccccc4c23)cc1		CHEMBL1289976	=	Ki	nM	1090.0	CHEMBL1955	Homo sapiens	Ki	uM	1.09
	5089636	CHEMBL1633356	Inhibition of FLT4 at 10 uM	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	>=	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	5120289	CHEMBL1645972	Inhibition of human Flt4 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	95.0	CHEMBL1955	Homo sapiens	INH	%	95.0
	5203054	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	=	IC50	nM	0.5	CHEMBL1955	Homo sapiens	IC50	uM	0.0005
	5203055	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O		CHEMBL1668412	>	IC50	nM	100000.0	CHEMBL1955	Homo sapiens	IC50	uM	100.0
	5203056	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O		CHEMBL1668413	=	IC50	nM	17000.0	CHEMBL1955	Homo sapiens	IC50	uM	17.0
	5203057	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668414	=	IC50	nM	5500.0	CHEMBL1955	Homo sapiens	IC50	uM	5.5
	5203058	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668415	=	IC50	nM	5800.0	CHEMBL1955	Homo sapiens	IC50	uM	5.8
	5203059	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O		CHEMBL1668416	>	IC50	nM	100000.0	CHEMBL1955	Homo sapiens	IC50	uM	100.0
	5203060	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668417	=	IC50	nM	65000.0	CHEMBL1955	Homo sapiens	IC50	uM	65.0
	5203061	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668418	=	IC50	nM	1400.0	CHEMBL1955	Homo sapiens	IC50	uM	1.4
	5203062	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668419	=	IC50	nM	720.0	CHEMBL1955	Homo sapiens	IC50	uM	0.72
	5203063	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668420	=	IC50	nM	1600.0	CHEMBL1955	Homo sapiens	IC50	uM	1.6
	5203064	CHEMBL1670830	Inhibition of human recombinant VEGFR3 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	=	IC50	nM	1200.0	CHEMBL1955	Homo sapiens	IC50	uM	1.2
	5248424	CHEMBL1686637	Inhibition of FLT4	B	CCNC(=O)Nc1ccc(Oc2ncnc(N)c2/C=N/OC)cc1Cl		CHEMBL1681932	=	IC50	nM	1100.0	CHEMBL1955	Homo sapiens	IC50	nM	1100.0
	6167567	CHEMBL1769040	Binding affinity to human Flt4 assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	6167583	CHEMBL1769226	Binding affinity to human Flt4 assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	85.0	CHEMBL1955	Homo sapiens	Activity	%	85.0
	6198154	CHEMBL1775245	Inhibition of VEGFR3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	6219898	CHEMBL1785586	Inhibition of human VEGFR3 using poly[Glu:Tyr] by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	2.6	CHEMBL1955	Homo sapiens	IC50	nM	2.6
	6281547	CHEMBL1804346	Inhibition of human Flt4	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	IC50	nM	78.0	CHEMBL1955	Homo sapiens	IC50	nM	78.0
	6286552	CHEMBL1810337	Inhibition of VEGFR3 at 0.1 uM	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL1807483	=	Inhibition	%	31.0	CHEMBL1955	Homo sapiens	INH	%	31.0
	6341064	CHEMBL1828233	Activity of FLT4 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	6386449	CHEMBL1837859	Inhibition of VEGFR3 juxtamembrane domain-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	2072.0	CHEMBL1955	Homo sapiens	IC50	nM	2072.0
	7567249	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	4.3	CHEMBL1955	Homo sapiens	Kd	nM	4.3
	7567708	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7568179	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7568637	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	50.0	CHEMBL1955	Homo sapiens	Kd	nM	50.0
	7569222	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7569682	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7570175	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1400.0	CHEMBL1955	Homo sapiens	Kd	nM	1400.0
	7570602	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	50.0	CHEMBL1955	Homo sapiens	Kd	nM	50.0
	7571198	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7571655	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7571689	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7572152	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7572568	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	170.0	CHEMBL1955	Homo sapiens	Kd	nM	170.0
	7573179	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	95.0	CHEMBL1955	Homo sapiens	Kd	nM	95.0
	7573670	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	700.0	CHEMBL1955	Homo sapiens	Kd	nM	700.0
	7574139	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	670.0	CHEMBL1955	Homo sapiens	Kd	nM	670.0
	7574547	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7575176	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2100.0	CHEMBL1955	Homo sapiens	Kd	nM	2100.0
	7575647	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	390.0	CHEMBL1955	Homo sapiens	Kd	nM	390.0
	7576112	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7576520	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2000.0	CHEMBL1955	Homo sapiens	Kd	nM	2000.0
	7576689	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7577148	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1.5	CHEMBL1955	Homo sapiens	Kd	nM	1.5
	7577626	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1300.0	CHEMBL1955	Homo sapiens	Kd	nM	1300.0
	7578096	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	240.0	CHEMBL1955	Homo sapiens	Kd	nM	240.0
	7578501	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1100.0	CHEMBL1955	Homo sapiens	Kd	nM	1100.0
	7578697	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7579071	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	7100.0	CHEMBL1955	Homo sapiens	Kd	nM	7100.0
	7579521	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7579995	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7580464	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	330.0	CHEMBL1955	Homo sapiens	Kd	nM	330.0
	7580867	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1900.0	CHEMBL1955	Homo sapiens	Kd	nM	1900.0
	7581055	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7581440	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7581885	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7582356	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	3800.0	CHEMBL1955	Homo sapiens	Kd	nM	3800.0
	7582820	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	9.1	CHEMBL1955	Homo sapiens	Kd	nM	9.1
	7583401	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	16.0	CHEMBL1955	Homo sapiens	Kd	nM	16.0
	7583798	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7584243	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7584714	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7585138	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7585731	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1955	Homo sapiens	Kd	nM	41.0
	7586139	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	56.0	CHEMBL1955	Homo sapiens	Kd	nM	56.0
	7586585	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7587068	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7587692	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	170.0	CHEMBL1955	Homo sapiens	Kd	nM	170.0
	7588111	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	17.0	CHEMBL1955	Homo sapiens	Kd	nM	17.0
	7588593	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7589044	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7589657	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	9.7	CHEMBL1955	Homo sapiens	Kd	nM	9.7
	7590081	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	580.0	CHEMBL1955	Homo sapiens	Kd	nM	580.0
	7590106	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7590580	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	7200.0	CHEMBL1955	Homo sapiens	Kd	nM	7200.0
	7591031	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7592082	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7592555	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3100.0	CHEMBL1955	Homo sapiens	Kd	nM	3100.0
	7593008	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7593155	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	120.0	CHEMBL1955	Homo sapiens	Kd	nM	120.0
	7593590	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	2000.0	CHEMBL1955	Homo sapiens	Kd	nM	2000.0
	7594062	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7594535	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7594987	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	95.0	CHEMBL1955	Homo sapiens	Kd	nM	95.0
	7595123	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7595567	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7596041	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7596512	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	27.0	CHEMBL1955	Homo sapiens	Kd	nM	27.0
	7596959	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	28.0	CHEMBL1955	Homo sapiens	Kd	nM	28.0
	7597095	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	2900.0	CHEMBL1955	Homo sapiens	Kd	nM	2900.0
	7597548	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7598021	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	7598491	CHEMBL1908551	Binding constant for FLT4 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	740.0	CHEMBL1955	Homo sapiens	Kd	nM	740.0
	7922652	CHEMBL1918996	Inhibition of human recombinant FLT4 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	83.0	CHEMBL1955	Homo sapiens	INH	%	83.0
	7925725	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926615	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926623	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926631	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926639	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926647	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926655	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926663	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926671	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926679	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926687	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926695	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926703	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926711	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926719	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926727	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926735	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926743	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926751	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926759	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926824	CHEMBL1920423	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926829	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	7926836	CHEMBL1920330	Inhibition of VEGFR3 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1cnccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915326	=	Inhibition	%	41.0	CHEMBL1955	Homo sapiens	INH	%	41.0
	7931088	CHEMBL1919265	Inhibition of FLT4 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	6.0	CHEMBL1955	Homo sapiens	INH	%	6.0
	7948001	CHEMBL1924390	Inhibition of FLT4 at 10 uM	B	CNc1nc2[nH]c(-c3cccc(CNC(=O)COC)n3)cc2c2c1ncn2C		CHEMBL1923983	>	Inhibition	%	75.0	CHEMBL1955	Homo sapiens	INH	%	75.0
	7948008	CHEMBL1924439	Inhibition of FLT4	B	CNc1nc2[nH]c(-c3cccc(CNC(=O)COC)n3)cc2c2c1ncn2C		CHEMBL1923983	=	IC50	nM	360.0	CHEMBL1955	Homo sapiens	IC50	uM	0.36
	7959779	CHEMBL1932864	Inhibition of FLT4	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL1955	Homo sapiens	IC50	uM	30.0
	7959780	CHEMBL1932864	Inhibition of FLT4	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	270.0	CHEMBL1955	Homo sapiens	IC50	uM	0.27
	7984715	CHEMBL1936632	Inhibition of VEGFR3	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	7984716	CHEMBL1936632	Inhibition of VEGFR3	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	7991157	CHEMBL1937309	Inhibition of VEGFR3	B	CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1		CHEMBL1934327	=	IC50	nM	9.6	CHEMBL1955	Homo sapiens	IC50	nM	9.6
	7992188	CHEMBL1935891	Inhibition of FLT4 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	95.0	CHEMBL1955	Homo sapiens	INH	%	95.0
	8005073	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4cccc(F)c4)c3)c2cc1OC		CHEMBL1940103	=	IC50	nM	51.0	CHEMBL1955	Homo sapiens	IC50	uM	0.051
	8005074	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Nc3ncnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940104	=	IC50	nM	25.0	CHEMBL1955	Homo sapiens	IC50	uM	0.025
	8005075	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4ccc(N(C)C)cc4)c3)c2cc1OC		CHEMBL1940105	=	IC50	nM	101.0	CHEMBL1955	Homo sapiens	IC50	uM	0.101
	8005076	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4ccc(N(C)C)cn4)c3)c2cc1OC		CHEMBL1940106	=	IC50	nM	453.0	CHEMBL1955	Homo sapiens	IC50	uM	0.453
	8005077	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3cnn(CC(=O)Nc4ccc(N(C)C)cn4)c3)c2cc1OC		CHEMBL1940107	=	IC50	nM	39.0	CHEMBL1955	Homo sapiens	IC50	uM	0.039
	8005078	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940108	=	IC50	nM	0.4	CHEMBL1955	Homo sapiens	IC50	uM	0.0004
	8005079	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COCCOc1cc2ncnc(Oc3cnn(CC(=O)Nc4cccc(OC)c4)c3)c2cc1OC		CHEMBL1940109	=	IC50	nM	0.2	CHEMBL1955	Homo sapiens	IC50	uM	0.0002
	8005080	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COCCOc1cc2c(Oc3cnn(CC(=O)Nc4cccc(OC)c4)c3)ncnc2cc1OC		CHEMBL1940110	<	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	uM	0.005
	8005081	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OCCN5CCCCC5)cc34)cn2)c1		CHEMBL1940111	=	IC50	nM	31.0	CHEMBL1955	Homo sapiens	IC50	uM	0.031
	8005082	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OCCN5CCCC5)c(OC)cc34)cn2)c1		CHEMBL1940112	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	uM	0.007
	8005083	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)cc(OC)c34)cn2)c1		CHEMBL1940113	=	IC50	nM	30.0	CHEMBL1955	Homo sapiens	IC50	uM	0.03
	8005084	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ccnc4cc(OC)c(C#N)cc34)cn2)c1		CHEMBL1940114	=	IC50	nM	282.0	CHEMBL1955	Homo sapiens	IC50	uM	0.282
	8005085	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ccnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940115	=	IC50	nM	57.0	CHEMBL1955	Homo sapiens	IC50	uM	0.057
	8005086	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OC)cc34)cn2)cn1		CHEMBL1940116	=	IC50	nM	35.0	CHEMBL1955	Homo sapiens	IC50	uM	0.035
	8005087	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2cc(Oc3ccnc4cc(OC)c(OC)cc34)n[nH]2)cn1		CHEMBL1940117	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	8005088	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4ccc(N(C)C)cn4)cc3)c2cc1OC		CHEMBL1940118	=	IC50	nM	22.0	CHEMBL1955	Homo sapiens	IC50	uM	0.022
	8005089	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940259	=	IC50	nM	8.0	CHEMBL1955	Homo sapiens	IC50	uM	0.008
	8005090	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2ccc(Nc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940260	=	IC50	nM	175.0	CHEMBL1955	Homo sapiens	IC50	uM	0.175
	8005091	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)c1		CHEMBL1940261	=	IC50	nM	1009.0	CHEMBL1955	Homo sapiens	IC50	uM	1.009
	8005092	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(NC(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940262	=	IC50	nM	177.0	CHEMBL1955	Homo sapiens	IC50	uM	0.177
	8005093	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(S(=O)(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940263	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	8005094	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(C(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940264	=	IC50	nM	6144.0	CHEMBL1955	Homo sapiens	IC50	uM	6.144
	8005095	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(CNC(=O)c2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940265	=	IC50	nM	3063.0	CHEMBL1955	Homo sapiens	IC50	uM	3.063
	8005096	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(CC(=O)Nc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940266	=	IC50	nM	209.0	CHEMBL1955	Homo sapiens	IC50	uM	0.209
	8005097	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cccc(COc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940267	=	IC50	nM	128.0	CHEMBL1955	Homo sapiens	IC50	uM	0.128
	8005098	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	CCc1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)n[nH]1		CHEMBL1940268	<	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	uM	0.005
	8005099	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	CCn1ccc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)n1		CHEMBL1940269	=	IC50	nM	172.0	CHEMBL1955	Homo sapiens	IC50	uM	0.172
	8005100	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cn[nH]c4)cc3)c2cc1OC		CHEMBL1940270	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	8005101	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C)c4)cc3)c2cc1OC		CHEMBL1940271	=	IC50	nM	667.0	CHEMBL1955	Homo sapiens	IC50	uM	0.667
	8005102	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)cn1		CHEMBL1940272	=	IC50	nM	29.0	CHEMBL1955	Homo sapiens	IC50	uM	0.029
	8005103	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)cn1		CHEMBL1940273	=	IC50	nM	12.0	CHEMBL1955	Homo sapiens	IC50	uM	0.012
	8005104	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		CHEMBL1940274	=	IC50	nM	8.0	CHEMBL1955	Homo sapiens	IC50	uM	0.008
	8005105	CHEMBL1942930	Inhibition of VEGFR3 phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		CHEMBL1940275	=	IC50	nM	485.0	CHEMBL1955	Homo sapiens	IC50	uM	0.485
	8047122	CHEMBL1958948	Inhibition of FLT4 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	8060125	CHEMBL1961230	Inhibition of human recombinant VEGF-R3 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL1955	Homo sapiens	IC50	uM	35.0
	8060126	CHEMBL1961230	Inhibition of human recombinant VEGF-R3 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	1540.0	CHEMBL1955	Homo sapiens	IC50	uM	1.54
	8061563	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.41	CHEMBL1955	Homo sapiens	Inhibition	%	0.41
	8061670	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.02	CHEMBL1955	Homo sapiens	Inhibition	%	0.02
	8061894	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.32	CHEMBL1955	Homo sapiens	Inhibition	%	1.32
	8062085	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.88	CHEMBL1955	Homo sapiens	Inhibition	%	4.88
	8062425	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.31	CHEMBL1955	Homo sapiens	Inhibition	%	2.31
	8062587	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1	Outside typical range	CHEMBL261129	=	Inhibition	%	-13.48	CHEMBL1955	Homo sapiens	Inhibition	%	-13.48
	8062909	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.74	CHEMBL1955	Homo sapiens	Inhibition	%	2.74
	8063041	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	19.74	CHEMBL1955	Homo sapiens	Inhibition	%	19.74
	8063265	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	68.97	CHEMBL1955	Homo sapiens	Inhibition	%	68.97
	8063432	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.61	CHEMBL1955	Homo sapiens	Inhibition	%	-0.61
	8063764	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.44	CHEMBL1955	Homo sapiens	Inhibition	%	0.44
	8063946	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	30.27	CHEMBL1955	Homo sapiens	Inhibition	%	30.27
	8064285	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-0.12	CHEMBL1955	Homo sapiens	Inhibition	%	-0.12
	8064495	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.2	CHEMBL1955	Homo sapiens	Inhibition	%	-0.2
	8064857	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.08	CHEMBL1955	Homo sapiens	Inhibition	%	5.08
	8065023	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.27	CHEMBL1955	Homo sapiens	Inhibition	%	3.27
	8065363	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.31	CHEMBL1955	Homo sapiens	Inhibition	%	-0.31
	8065538	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.34	CHEMBL1955	Homo sapiens	Inhibition	%	3.34
	8065877	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.61	CHEMBL1955	Homo sapiens	Inhibition	%	0.61
	8066087	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.49	CHEMBL1955	Homo sapiens	Inhibition	%	0.49
	8066447	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	25.51	CHEMBL1955	Homo sapiens	Inhibition	%	25.51
	8066613	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.77	CHEMBL1955	Homo sapiens	Inhibition	%	1.77
	8066837	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.31	CHEMBL1955	Homo sapiens	Inhibition	%	1.31
	8066961	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.16	CHEMBL1955	Homo sapiens	Inhibition	%	3.16
	8067136	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	18.53	CHEMBL1955	Homo sapiens	Inhibition	%	18.53
	8067360	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.23	CHEMBL1955	Homo sapiens	Inhibition	%	0.23
	8067481	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.01	CHEMBL1955	Homo sapiens	Inhibition	%	2.01
	8067691	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.59	CHEMBL1955	Homo sapiens	Inhibition	%	-0.59
	8067915	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.19	CHEMBL1955	Homo sapiens	Inhibition	%	3.19
	8068050	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	10.41	CHEMBL1955	Homo sapiens	Inhibition	%	10.41
	8068438	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.11	CHEMBL1955	Homo sapiens	Inhibition	%	-0.11
	8068563	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	11.88	CHEMBL1955	Homo sapiens	Inhibition	%	11.88
	8068787	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.08	CHEMBL1955	Homo sapiens	Inhibition	%	0.08
	8068961	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.36	CHEMBL1955	Homo sapiens	Inhibition	%	0.36
	8069086	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.54	CHEMBL1955	Homo sapiens	Inhibition	%	-0.54
	8069310	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.83	CHEMBL1955	Homo sapiens	Inhibition	%	1.83
	8069381	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	45.44	CHEMBL1955	Homo sapiens	Inhibition	%	45.44
	8069605	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.43	CHEMBL1955	Homo sapiens	Inhibition	%	6.43
	8069766	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.1	CHEMBL1955	Homo sapiens	Inhibition	%	3.1
	8070116	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.81	CHEMBL1955	Homo sapiens	Inhibition	%	-0.81
	8070288	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.55	CHEMBL1955	Homo sapiens	Inhibition	%	1.55
	8070637	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.37	CHEMBL1955	Homo sapiens	Inhibition	%	1.37
	8070935	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	25.51	CHEMBL1955	Homo sapiens	Inhibition	%	25.51
	8071092	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.38	CHEMBL1955	Homo sapiens	Inhibition	%	1.38
	8071442	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.9	CHEMBL1955	Homo sapiens	Inhibition	%	4.9
	8071615	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.4	CHEMBL1955	Homo sapiens	Inhibition	%	0.4
	8071964	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.15	CHEMBL1955	Homo sapiens	Inhibition	%	5.15
	8072278	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.33	CHEMBL1955	Homo sapiens	Inhibition	%	1.33
	8072435	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.06	CHEMBL1955	Homo sapiens	Inhibition	%	1.06
	8072659	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.7	CHEMBL1955	Homo sapiens	Inhibition	%	1.7
	8072784	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	39.42	CHEMBL1955	Homo sapiens	Inhibition	%	39.42
	8072951	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.95	CHEMBL1955	Homo sapiens	Inhibition	%	1.95
	8073175	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	9.43	CHEMBL1955	Homo sapiens	Inhibition	%	9.43
	8073300	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	10.45	CHEMBL1955	Homo sapiens	Inhibition	%	10.45
	8073643	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.09	CHEMBL1955	Homo sapiens	Inhibition	%	2.09
	8073876	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	11.39	CHEMBL1955	Homo sapiens	Inhibition	%	11.39
	8074252	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.36	CHEMBL1955	Homo sapiens	Inhibition	%	-0.36
	8074382	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.79	CHEMBL1955	Homo sapiens	Inhibition	%	0.79
	8074763	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.36	CHEMBL1955	Homo sapiens	Inhibition	%	1.36
	8074890	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	52.77	CHEMBL1955	Homo sapiens	Inhibition	%	52.77
	8075114	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.19	CHEMBL1955	Homo sapiens	Inhibition	%	0.19
	8075225	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	14.56	CHEMBL1955	Homo sapiens	Inhibition	%	14.56
	8075462	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.61	CHEMBL1955	Homo sapiens	Inhibition	%	0.61
	8075827	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.32	CHEMBL1955	Homo sapiens	Inhibition	%	3.32
	8075969	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	15.25	CHEMBL1955	Homo sapiens	Inhibition	%	15.25
	8076193	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.9	CHEMBL1955	Homo sapiens	Inhibition	%	1.9
	8076341	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.28	CHEMBL1955	Homo sapiens	Inhibition	%	-0.28
	8076699	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.22	CHEMBL1955	Homo sapiens	Inhibition	%	0.22
	8076801	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.07	CHEMBL1955	Homo sapiens	Inhibition	%	0.07
	8077048	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	5.17	CHEMBL1955	Homo sapiens	Inhibition	%	5.17
	8077272	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	58.44	CHEMBL1955	Homo sapiens	Inhibition	%	58.44
	8077400	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	12.24	CHEMBL1955	Homo sapiens	Inhibition	%	12.24
	8077775	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	15.03	CHEMBL1955	Homo sapiens	Inhibition	%	15.03
	8077918	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.49	CHEMBL1955	Homo sapiens	Inhibition	%	1.49
	8078281	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.48	CHEMBL1955	Homo sapiens	Inhibition	%	0.48
	8078383	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.05	CHEMBL1955	Homo sapiens	Inhibition	%	0.05
	8078607	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.02	CHEMBL1955	Homo sapiens	Inhibition	%	-0.02
	8078857	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	93.81	CHEMBL1955	Homo sapiens	Inhibition	%	93.81
	8078973	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-1.08	CHEMBL1955	Homo sapiens	Inhibition	%	-1.08
	8079355	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.69	CHEMBL1955	Homo sapiens	Inhibition	%	3.69
	8079497	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	21.03	CHEMBL1955	Homo sapiens	Inhibition	%	21.03
	8079721	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.55	CHEMBL1955	Homo sapiens	Inhibition	%	-0.55
	8079860	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	16.53	CHEMBL1955	Homo sapiens	Inhibition	%	16.53
	8080189	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.4	CHEMBL1955	Homo sapiens	Inhibition	%	0.4
	8080441	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	30.06	CHEMBL1955	Homo sapiens	Inhibition	%	30.06
	8080556	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.02	CHEMBL1955	Homo sapiens	Inhibition	%	1.02
	8080780	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.47	CHEMBL1955	Homo sapiens	Inhibition	%	-0.47
	8080944	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	22.78	CHEMBL1955	Homo sapiens	Inhibition	%	22.78
	8081303	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.47	CHEMBL1955	Homo sapiens	Inhibition	%	0.47
	8081447	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	-1.93	CHEMBL1955	Homo sapiens	Inhibition	%	-1.93
	8081774	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.15	CHEMBL1955	Homo sapiens	Inhibition	%	1.15
	8082026	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	80.59	CHEMBL1955	Homo sapiens	Inhibition	%	80.59
	8082363	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.28	CHEMBL1955	Homo sapiens	Inhibition	%	0.28
	8082536	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.55	CHEMBL1955	Homo sapiens	Inhibition	%	0.55
	8082883	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.24	CHEMBL1955	Homo sapiens	Inhibition	%	1.24
	8083039	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.22	CHEMBL1955	Homo sapiens	Inhibition	%	2.22
	8083263	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.15	CHEMBL1955	Homo sapiens	Inhibition	%	4.15
	8083362	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	13.3	CHEMBL1955	Homo sapiens	Inhibition	%	13.3
	8083616	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.11	CHEMBL1955	Homo sapiens	Inhibition	%	4.11
	8083950	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.56	CHEMBL1955	Homo sapiens	Inhibition	%	1.56
	8084135	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.68	CHEMBL1955	Homo sapiens	Inhibition	%	-0.68
	8084359	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	43.94	CHEMBL1955	Homo sapiens	Inhibition	%	43.94
	8084477	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.0	CHEMBL1955	Homo sapiens	Inhibition	%	1.0
	8084862	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	26.69	CHEMBL1955	Homo sapiens	Inhibition	%	26.69
	8084960	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.41	CHEMBL1955	Homo sapiens	Inhibition	%	3.41
	8085184	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.96	CHEMBL1955	Homo sapiens	Inhibition	%	1.96
	8085216	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	16.74	CHEMBL1955	Homo sapiens	Inhibition	%	16.74
	8085440	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.12	CHEMBL1955	Homo sapiens	Inhibition	%	0.12
	8085548	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.31	CHEMBL1955	Homo sapiens	Inhibition	%	2.31
	8085961	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	85.96	CHEMBL1955	Homo sapiens	Inhibition	%	85.96
	8086076	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.71	CHEMBL1955	Homo sapiens	Inhibition	%	2.71
	8086300	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.4	CHEMBL1955	Homo sapiens	Inhibition	%	2.4
	8086462	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-8.86	CHEMBL1955	Homo sapiens	Inhibition	%	-8.86
	8086785	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.12	CHEMBL1955	Homo sapiens	Inhibition	%	2.12
	8086996	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-7.73	CHEMBL1955	Homo sapiens	Inhibition	%	-7.73
	8087154	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	11.74	CHEMBL1955	Homo sapiens	Inhibition	%	11.74
	8087378	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.63	CHEMBL1955	Homo sapiens	Inhibition	%	3.63
	8087492	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	103.71	CHEMBL1955	Homo sapiens	Inhibition	%	103.71
	8087854	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.14	CHEMBL1955	Homo sapiens	Inhibition	%	3.14
	8087996	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.86	CHEMBL1955	Homo sapiens	Inhibition	%	5.86
	8088220	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.52	CHEMBL1955	Homo sapiens	Inhibition	%	7.52
	8088368	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	11.7	CHEMBL1955	Homo sapiens	Inhibition	%	11.7
	8088496	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.05	CHEMBL1955	Homo sapiens	Inhibition	%	3.05
	8088720	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	19.74	CHEMBL1955	Homo sapiens	Inhibition	%	19.74
	8088813	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.92	CHEMBL1955	Homo sapiens	Inhibition	%	5.92
	8089037	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.29	CHEMBL1955	Homo sapiens	Inhibition	%	5.29
	8089165	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	12.26	CHEMBL1955	Homo sapiens	Inhibition	%	12.26
	8089313	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.4	CHEMBL1955	Homo sapiens	Inhibition	%	3.4
	8089537	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	4.82	CHEMBL1955	Homo sapiens	Inhibition	%	4.82
	8089657	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.98	CHEMBL1955	Homo sapiens	Inhibition	%	1.98
	8090061	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.18	CHEMBL1955	Homo sapiens	Inhibition	%	-1.18
	8090226	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.29	CHEMBL1955	Homo sapiens	Inhibition	%	-0.29
	8090617	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.75	CHEMBL1955	Homo sapiens	Inhibition	%	2.75
	8090756	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.46	CHEMBL1955	Homo sapiens	Inhibition	%	3.46
	8090961	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	10.18	CHEMBL1955	Homo sapiens	Inhibition	%	10.18
	8091185	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-0.25	CHEMBL1955	Homo sapiens	Inhibition	%	-0.25
	8091322	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1	Outside typical range	CHEMBL263796	=	Inhibition	%	-10.87	CHEMBL1955	Homo sapiens	Inhibition	%	-10.87
	8091701	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-1.74	CHEMBL1955	Homo sapiens	Inhibition	%	-1.74
	8091817	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.38	CHEMBL1955	Homo sapiens	Inhibition	%	3.38
	8092041	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	9.85	CHEMBL1955	Homo sapiens	Inhibition	%	9.85
	8092178	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-7.44	CHEMBL1955	Homo sapiens	Inhibition	%	-7.44
	8092553	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.58	CHEMBL1955	Homo sapiens	Inhibition	%	1.58
	8092701	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	14.69	CHEMBL1955	Homo sapiens	Inhibition	%	14.69
	8093054	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	67.58	CHEMBL1955	Homo sapiens	Inhibition	%	67.58
	8093366	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-2.7	CHEMBL1955	Homo sapiens	Inhibition	%	-2.7
	8093506	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	14.61	CHEMBL1955	Homo sapiens	Inhibition	%	14.61
	8093869	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	46.61	CHEMBL1955	Homo sapiens	Inhibition	%	46.61
	8093989	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	7.55	CHEMBL1955	Homo sapiens	Inhibition	%	7.55
	8094213	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	29.92	CHEMBL1955	Homo sapiens	Inhibition	%	29.92
	8094393	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.37	CHEMBL1955	Homo sapiens	Inhibition	%	1.37
	8094568	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.32	CHEMBL1955	Homo sapiens	Inhibition	%	4.32
	8094948	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.24	CHEMBL1955	Homo sapiens	Inhibition	%	2.24
	8095088	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	37.47	CHEMBL1955	Homo sapiens	Inhibition	%	37.47
	8095312	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	90.09	CHEMBL1955	Homo sapiens	Inhibition	%	90.09
	8095515	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.64	CHEMBL1955	Homo sapiens	Inhibition	%	4.64
	8095656	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	9.0	CHEMBL1955	Homo sapiens	Inhibition	%	9.0
	8095880	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	26.62	CHEMBL1955	Homo sapiens	Inhibition	%	26.62
	8096028	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.91	CHEMBL1955	Homo sapiens	Inhibition	%	4.91
	8096369	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.59	CHEMBL1955	Homo sapiens	Inhibition	%	5.59
	8096508	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1	Outside typical range	CHEMBL275798	=	Inhibition	%	-10.28	CHEMBL1955	Homo sapiens	Inhibition	%	-10.28
	8096888	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-1.31	CHEMBL1955	Homo sapiens	Inhibition	%	-1.31
	8097035	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.77	CHEMBL1955	Homo sapiens	Inhibition	%	3.77
	8097259	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.65	CHEMBL1955	Homo sapiens	Inhibition	%	3.65
	8097346	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.48	CHEMBL1955	Homo sapiens	Inhibition	%	4.48
	8097566	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.54	CHEMBL1955	Homo sapiens	Inhibition	%	2.54
	8097716	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	17.45	CHEMBL1955	Homo sapiens	Inhibition	%	17.45
	8097940	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	68.86	CHEMBL1955	Homo sapiens	Inhibition	%	68.86
	8098073	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl	Outside typical range	CHEMBL1909373	=	Inhibition	%	-12.0	CHEMBL1955	Homo sapiens	Inhibition	%	-12.0
	8098417	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.19	CHEMBL1955	Homo sapiens	Inhibition	%	-2.19
	8098597	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.25	CHEMBL1955	Homo sapiens	Inhibition	%	2.25
	8098782	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.45	CHEMBL1955	Homo sapiens	Inhibition	%	3.45
	8099006	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.68	CHEMBL1955	Homo sapiens	Inhibition	%	2.68
	8099150	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.45	CHEMBL1955	Homo sapiens	Inhibition	%	4.45
	8099516	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.53	CHEMBL1955	Homo sapiens	Inhibition	%	3.53
	8099710	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-1.37	CHEMBL1955	Homo sapiens	Inhibition	%	-1.37
	8100081	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.28	CHEMBL1955	Homo sapiens	Inhibition	%	3.28
	8100227	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	14.96	CHEMBL1955	Homo sapiens	Inhibition	%	14.96
	8100567	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.6	CHEMBL1955	Homo sapiens	Inhibition	%	5.6
	8100707	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	7.2	CHEMBL1955	Homo sapiens	Inhibition	%	7.2
	8100931	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	11.74	CHEMBL1955	Homo sapiens	Inhibition	%	11.74
	8101091	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.2	CHEMBL1955	Homo sapiens	Inhibition	%	3.2
	8101457	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	7.69	CHEMBL1955	Homo sapiens	Inhibition	%	7.69
	8101642	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-5.28	CHEMBL1955	Homo sapiens	Inhibition	%	-5.28
	8101895	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.35	CHEMBL1955	Homo sapiens	Inhibition	%	4.35
	8102274	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	5.01	CHEMBL1955	Homo sapiens	Inhibition	%	5.01
	8102405	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-5.74	CHEMBL1955	Homo sapiens	Inhibition	%	-5.74
	8102749	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	4.75	CHEMBL1955	Homo sapiens	Inhibition	%	4.75
	8102927	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.83	CHEMBL1955	Homo sapiens	Inhibition	%	1.83
	8103151	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.93	CHEMBL1955	Homo sapiens	Inhibition	%	0.93
	8103347	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	16.65	CHEMBL1955	Homo sapiens	Inhibition	%	16.65
	8103485	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.92	CHEMBL1955	Homo sapiens	Inhibition	%	2.92
	8103859	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.96	CHEMBL1955	Homo sapiens	Inhibition	%	5.96
	8104044	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	4.18	CHEMBL1955	Homo sapiens	Inhibition	%	4.18
	8104416	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.5	CHEMBL1955	Homo sapiens	Inhibition	%	4.5
	8104562	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-4.32	CHEMBL1955	Homo sapiens	Inhibition	%	-4.32
	8104786	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	25.81	CHEMBL1955	Homo sapiens	Inhibition	%	25.81
	8104900	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-3.29	CHEMBL1955	Homo sapiens	Inhibition	%	-3.29
	8105264	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.25	CHEMBL1955	Homo sapiens	Inhibition	%	0.25
	8105430	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.0	CHEMBL1955	Homo sapiens	Inhibition	%	2.0
	8105792	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	36.72	CHEMBL1955	Homo sapiens	Inhibition	%	36.72
	8106072	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.87	CHEMBL1955	Homo sapiens	Inhibition	%	2.87
	8106237	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	29.48	CHEMBL1955	Homo sapiens	Inhibition	%	29.48
	8106617	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	33.43	CHEMBL1955	Homo sapiens	Inhibition	%	33.43
	8106746	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	30.95	CHEMBL1955	Homo sapiens	Inhibition	%	30.95
	8106970	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	85.54	CHEMBL1955	Homo sapiens	Inhibition	%	85.54
	8107091	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.45	CHEMBL1955	Homo sapiens	Inhibition	%	-0.45
	8107487	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.24	CHEMBL1955	Homo sapiens	Inhibition	%	2.24
	8107688	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	62.64	CHEMBL1955	Homo sapiens	Inhibition	%	62.64
	8107823	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.81	CHEMBL1955	Homo sapiens	Inhibition	%	1.81
	8108047	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	30.6	CHEMBL1955	Homo sapiens	Inhibition	%	30.6
	8108205	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.76	CHEMBL1955	Homo sapiens	Inhibition	%	3.76
	8108380	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.07	CHEMBL1955	Homo sapiens	Inhibition	%	4.07
	8108604	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	9.34	CHEMBL1955	Homo sapiens	Inhibition	%	9.34
	8108751	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.35	CHEMBL1955	Homo sapiens	Inhibition	%	5.35
	8109117	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.04	CHEMBL1955	Homo sapiens	Inhibition	%	5.04
	8109231	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.83	CHEMBL1955	Homo sapiens	Inhibition	%	-0.83
	8109585	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.05	CHEMBL1955	Homo sapiens	Inhibition	%	1.05
	8109756	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-3.01	CHEMBL1955	Homo sapiens	Inhibition	%	-3.01
	8109980	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	13.82	CHEMBL1955	Homo sapiens	Inhibition	%	13.82
	8110112	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.25	CHEMBL1955	Homo sapiens	Inhibition	%	1.25
	8110391	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.83	CHEMBL1955	Homo sapiens	Inhibition	%	3.83
	8110557	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O	Outside typical range	CHEMBL1909405	=	Inhibition	%	-11.55	CHEMBL1955	Homo sapiens	Inhibition	%	-11.55
	8110781	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-6.61	CHEMBL1955	Homo sapiens	Inhibition	%	-6.61
	8110939	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.4	CHEMBL1955	Homo sapiens	Inhibition	%	-2.4
	8111286	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	7.64	CHEMBL1955	Homo sapiens	Inhibition	%	7.64
	8111413	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.67	CHEMBL1955	Homo sapiens	Inhibition	%	-0.67
	8111637	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	4.88	CHEMBL1955	Homo sapiens	Inhibition	%	4.88
	8111803	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.4	CHEMBL1955	Homo sapiens	Inhibition	%	4.4
	8112008	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.49	CHEMBL1955	Homo sapiens	Inhibition	%	5.49
	8112369	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.67	CHEMBL1955	Homo sapiens	Inhibition	%	1.67
	8112537	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	6.76	CHEMBL1955	Homo sapiens	Inhibition	%	6.76
	8112933	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.25	CHEMBL1955	Homo sapiens	Inhibition	%	2.25
	8113085	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	23.87	CHEMBL1955	Homo sapiens	Inhibition	%	23.87
	8113445	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	14.02	CHEMBL1955	Homo sapiens	Inhibition	%	14.02
	8113569	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.75	CHEMBL1955	Homo sapiens	Inhibition	%	0.75
	8113793	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.35	CHEMBL1955	Homo sapiens	Inhibition	%	2.35
	8113909	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.39	CHEMBL1955	Homo sapiens	Inhibition	%	0.39
	8114309	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	8.65	CHEMBL1955	Homo sapiens	Inhibition	%	8.65
	8114441	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	9.4	CHEMBL1955	Homo sapiens	Inhibition	%	9.4
	8114717	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.84	CHEMBL1955	Homo sapiens	Inhibition	%	3.84
	8115107	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	44.77	CHEMBL1955	Homo sapiens	Inhibition	%	44.77
	8115272	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.59	CHEMBL1955	Homo sapiens	Inhibition	%	1.59
	8115616	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	16.26	CHEMBL1955	Homo sapiens	Inhibition	%	16.26
	8115973	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	33.92	CHEMBL1955	Homo sapiens	Inhibition	%	33.92
	8116132	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	4.05	CHEMBL1955	Homo sapiens	Inhibition	%	4.05
	8116335	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	9.11	CHEMBL1955	Homo sapiens	Inhibition	%	9.11
	8116559	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	8.92	CHEMBL1955	Homo sapiens	Inhibition	%	8.92
	8116693	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.25	CHEMBL1955	Homo sapiens	Inhibition	%	1.25
	8116865	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.73	CHEMBL1955	Homo sapiens	Inhibition	%	5.73
	8117089	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	12.58	CHEMBL1955	Homo sapiens	Inhibition	%	12.58
	8117260	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.83	CHEMBL1955	Homo sapiens	Inhibition	%	2.83
	8117418	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.76	CHEMBL1955	Homo sapiens	Inhibition	%	1.76
	8117642	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	11.57	CHEMBL1955	Homo sapiens	Inhibition	%	11.57
	8117772	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.02	CHEMBL1955	Homo sapiens	Inhibition	%	3.02
	8118134	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-4.95	CHEMBL1955	Homo sapiens	Inhibition	%	-4.95
	8118250	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	3.67	CHEMBL1955	Homo sapiens	Inhibition	%	3.67
	8118474	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.5	CHEMBL1955	Homo sapiens	Inhibition	%	2.5
	8118646	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	15.41	CHEMBL1955	Homo sapiens	Inhibition	%	15.41
	8118782	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.58	CHEMBL1955	Homo sapiens	Inhibition	%	1.58
	8119006	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.49	CHEMBL1955	Homo sapiens	Inhibition	%	3.49
	8119053	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.49	CHEMBL1955	Homo sapiens	Inhibition	%	5.49
	8119277	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-3.04	CHEMBL1955	Homo sapiens	Inhibition	%	-3.04
	8119436	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	97.22	CHEMBL1955	Homo sapiens	Inhibition	%	97.22
	8119603	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.2	CHEMBL1955	Homo sapiens	Inhibition	%	-1.2
	8119827	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.96	CHEMBL1955	Homo sapiens	Inhibition	%	-2.96
	8119946	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.61	CHEMBL1955	Homo sapiens	Inhibition	%	3.61
	8120309	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.78	CHEMBL1955	Homo sapiens	Inhibition	%	-1.78
	8120469	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	44.27	CHEMBL1955	Homo sapiens	Inhibition	%	44.27
	8120894	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	26.57	CHEMBL1955	Homo sapiens	Inhibition	%	26.57
	8121022	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.38	CHEMBL1955	Homo sapiens	Inhibition	%	1.38
	8121418	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-2.62	CHEMBL1955	Homo sapiens	Inhibition	%	-2.62
	8121585	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	30.13	CHEMBL1955	Homo sapiens	Inhibition	%	30.13
	8121972	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.98	CHEMBL1955	Homo sapiens	Inhibition	%	2.98
	8122093	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.54	CHEMBL1955	Homo sapiens	Inhibition	%	2.54
	8122455	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-7.54	CHEMBL1955	Homo sapiens	Inhibition	%	-7.54
	8122799	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.39	CHEMBL1955	Homo sapiens	Inhibition	%	0.39
	8122966	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.84	CHEMBL1955	Homo sapiens	Inhibition	%	5.84
	8123332	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	6.89	CHEMBL1955	Homo sapiens	Inhibition	%	6.89
	8123610	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.77	CHEMBL1955	Homo sapiens	Inhibition	%	1.77
	8123760	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.09	CHEMBL1955	Homo sapiens	Inhibition	%	5.09
	8124151	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1	Outside typical range	CHEMBL204934	=	Inhibition	%	-13.03	CHEMBL1955	Homo sapiens	Inhibition	%	-13.03
	8124270	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	6.4	CHEMBL1955	Homo sapiens	Inhibition	%	6.4
	8124494	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-0.16	CHEMBL1955	Homo sapiens	Inhibition	%	-0.16
	8124633	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.51	CHEMBL1955	Homo sapiens	Inhibition	%	2.51
	8124798	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.1	CHEMBL1955	Homo sapiens	Inhibition	%	1.1
	8125022	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.5	CHEMBL1955	Homo sapiens	Inhibition	%	1.5
	8125223	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	6.35	CHEMBL1955	Homo sapiens	Inhibition	%	6.35
	8125353	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	5.37	CHEMBL1955	Homo sapiens	Inhibition	%	5.37
	8125577	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.27	CHEMBL1955	Homo sapiens	Inhibition	%	0.27
	8125745	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.62	CHEMBL1955	Homo sapiens	Inhibition	%	4.62
	8125909	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	47.9	CHEMBL1955	Homo sapiens	Inhibition	%	47.9
	8126133	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.09	CHEMBL1955	Homo sapiens	Inhibition	%	1.09
	8126297	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.24	CHEMBL1955	Homo sapiens	Inhibition	%	4.24
	8126412	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	23.59	CHEMBL1955	Homo sapiens	Inhibition	%	23.59
	8126636	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	75.49	CHEMBL1955	Homo sapiens	Inhibition	%	75.49
	8126772	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	38.22	CHEMBL1955	Homo sapiens	Inhibition	%	38.22
	8127118	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.28	CHEMBL1955	Homo sapiens	Inhibition	%	3.28
	8127285	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.46	CHEMBL1955	Homo sapiens	Inhibition	%	2.46
	8127509	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	36.42	CHEMBL1955	Homo sapiens	Inhibition	%	36.42
	8127651	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	53.11	CHEMBL1955	Homo sapiens	Inhibition	%	53.11
	8127939	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-1.15	CHEMBL1955	Homo sapiens	Inhibition	%	-1.15
	8128091	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	24.45	CHEMBL1955	Homo sapiens	Inhibition	%	24.45
	8128315	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.71	CHEMBL1955	Homo sapiens	Inhibition	%	4.71
	8128482	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-4.88	CHEMBL1955	Homo sapiens	Inhibition	%	-4.88
	8128825	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	30.21	CHEMBL1955	Homo sapiens	Inhibition	%	30.21
	8128962	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.47	CHEMBL1955	Homo sapiens	Inhibition	%	0.47
	8129357	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.84	CHEMBL1955	Homo sapiens	Inhibition	%	-0.84
	8129546	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.74	CHEMBL1955	Homo sapiens	Inhibition	%	4.74
	8129909	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.35	CHEMBL1955	Homo sapiens	Inhibition	%	3.35
	8130070	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.05	CHEMBL1955	Homo sapiens	Inhibition	%	2.05
	8130466	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.68	CHEMBL1955	Homo sapiens	Inhibition	%	0.68
	8130626	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-5.53	CHEMBL1955	Homo sapiens	Inhibition	%	-5.53
	8130966	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.77	CHEMBL1955	Homo sapiens	Inhibition	%	-0.77
	8131105	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	93.12	CHEMBL1955	Homo sapiens	Inhibition	%	93.12
	8131329	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.32	CHEMBL1955	Homo sapiens	Inhibition	%	2.32
	8131449	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.1	CHEMBL1955	Homo sapiens	Inhibition	%	1.1
	8131840	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	86.75	CHEMBL1955	Homo sapiens	Inhibition	%	86.75
	8131981	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	52.96	CHEMBL1955	Homo sapiens	Inhibition	%	52.96
	8132267	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.93	CHEMBL1955	Homo sapiens	Inhibition	%	0.93
	8132638	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.92	CHEMBL1955	Homo sapiens	Inhibition	%	3.92
	8132806	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	15.23	CHEMBL1955	Homo sapiens	Inhibition	%	15.23
	8133151	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-1.51	CHEMBL1955	Homo sapiens	Inhibition	%	-1.51
	8133289	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.54	CHEMBL1955	Homo sapiens	Inhibition	%	2.54
	8133513	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.01	CHEMBL1955	Homo sapiens	Inhibition	%	1.01
	8133685	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.94	CHEMBL1955	Homo sapiens	Inhibition	%	-0.94
	8133865	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	8.95	CHEMBL1955	Homo sapiens	Inhibition	%	8.95
	8134237	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.51	CHEMBL1955	Homo sapiens	Inhibition	%	0.51
	8134397	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.12	CHEMBL1955	Homo sapiens	Inhibition	%	2.12
	8134621	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.17	CHEMBL1955	Homo sapiens	Inhibition	%	0.17
	8134805	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	4.02	CHEMBL1955	Homo sapiens	Inhibition	%	4.02
	8134965	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.13	CHEMBL1955	Homo sapiens	Inhibition	%	0.13
	8135304	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-3.12	CHEMBL1955	Homo sapiens	Inhibition	%	-3.12
	8135669	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.71	CHEMBL1955	Homo sapiens	Inhibition	%	2.71
	8135790	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-4.49	CHEMBL1955	Homo sapiens	Inhibition	%	-4.49
	8136182	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.81	CHEMBL1955	Homo sapiens	Inhibition	%	1.81
	8136326	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	99.57	CHEMBL1955	Homo sapiens	Inhibition	%	99.57
	8136550	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.31	CHEMBL1955	Homo sapiens	Inhibition	%	3.31
	8136616	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1	Outside typical range	CHEMBL467581	=	Inhibition	%	-13.42	CHEMBL1955	Homo sapiens	Inhibition	%	-13.42
	8136975	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-2.61	CHEMBL1955	Homo sapiens	Inhibition	%	-2.61
	8137138	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	13.63	CHEMBL1955	Homo sapiens	Inhibition	%	13.63
	8137362	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	11.27	CHEMBL1955	Homo sapiens	Inhibition	%	11.27
	8137482	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.12	CHEMBL1955	Homo sapiens	Inhibition	%	1.12
	8137854	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.82	CHEMBL1955	Homo sapiens	Inhibition	%	1.82
	8138020	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.53	CHEMBL1955	Homo sapiens	Inhibition	%	-2.53
	8138199	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	37.55	CHEMBL1955	Homo sapiens	Inhibition	%	37.55
	8138423	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.13	CHEMBL1955	Homo sapiens	Inhibition	%	3.13
	8138571	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.44	CHEMBL1955	Homo sapiens	Inhibition	%	4.44
	8138953	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	6.22	CHEMBL1955	Homo sapiens	Inhibition	%	6.22
	8139138	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	30.61	CHEMBL1955	Homo sapiens	Inhibition	%	30.61
	8139297	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	9.28	CHEMBL1955	Homo sapiens	Inhibition	%	9.28
	8139521	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	14.42	CHEMBL1955	Homo sapiens	Inhibition	%	14.42
	8139635	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.59	CHEMBL1955	Homo sapiens	Inhibition	%	1.59
	8140000	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.68	CHEMBL1955	Homo sapiens	Inhibition	%	4.68
	8140123	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1	Outside typical range	CHEMBL269450	=	Inhibition	%	-10.15	CHEMBL1955	Homo sapiens	Inhibition	%	-10.15
	8140347	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	11.19	CHEMBL1955	Homo sapiens	Inhibition	%	11.19
	8140506	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.55	CHEMBL1955	Homo sapiens	Inhibition	%	-0.55
	8140873	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.76	CHEMBL1955	Homo sapiens	Inhibition	%	5.76
	8140951	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1	Outside typical range	CHEMBL467581	=	Inhibition	%	-10.79	CHEMBL1955	Homo sapiens	Inhibition	%	-10.79
	8141175	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	12.92	CHEMBL1955	Homo sapiens	Inhibition	%	12.92
	8141305	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.0	CHEMBL1955	Homo sapiens	Inhibition	%	1.0
	8141689	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	40.68	CHEMBL1955	Homo sapiens	Inhibition	%	40.68
	8141808	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1	Outside typical range	CHEMBL218859	=	Inhibition	%	-10.36	CHEMBL1955	Homo sapiens	Inhibition	%	-10.36
	8142193	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	8.62	CHEMBL1955	Homo sapiens	Inhibition	%	8.62
	8142361	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.3	CHEMBL1955	Homo sapiens	Inhibition	%	0.3
	8142761	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.21	CHEMBL1955	Homo sapiens	Inhibition	%	2.21
	8142910	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.2	CHEMBL1955	Homo sapiens	Inhibition	%	1.2
	8143289	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.01	CHEMBL1955	Homo sapiens	Inhibition	%	1.01
	8143476	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.19	CHEMBL1955	Homo sapiens	Inhibition	%	0.19
	8143859	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.59	CHEMBL1955	Homo sapiens	Inhibition	%	4.59
	8143973	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.31	CHEMBL1955	Homo sapiens	Inhibition	%	1.31
	8144197	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-7.55	CHEMBL1955	Homo sapiens	Inhibition	%	-7.55
	8144336	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.72	CHEMBL1955	Homo sapiens	Inhibition	%	7.72
	8144690	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	15.41	CHEMBL1955	Homo sapiens	Inhibition	%	15.41
	8144843	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.74	CHEMBL1955	Homo sapiens	Inhibition	%	0.74
	8145204	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.59	CHEMBL1955	Homo sapiens	Inhibition	%	4.59
	8145517	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	13.67	CHEMBL1955	Homo sapiens	Inhibition	%	13.67
	8145641	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-1.89	CHEMBL1955	Homo sapiens	Inhibition	%	-1.89
	8145865	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.09	CHEMBL1955	Homo sapiens	Inhibition	%	2.09
	8146026	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	22.96	CHEMBL1955	Homo sapiens	Inhibition	%	22.96
	8146146	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-8.92	CHEMBL1955	Homo sapiens	Inhibition	%	-8.92
	8146370	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	14.83	CHEMBL1955	Homo sapiens	Inhibition	%	14.83
	8146530	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	56.35	CHEMBL1955	Homo sapiens	Inhibition	%	56.35
	8146697	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.45	CHEMBL1955	Homo sapiens	Inhibition	%	1.45
	8146921	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	18.59	CHEMBL1955	Homo sapiens	Inhibition	%	18.59
	8147090	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.93	CHEMBL1955	Homo sapiens	Inhibition	%	1.93
	8147232	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.58	CHEMBL1955	Homo sapiens	Inhibition	%	2.58
	8147456	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.18	CHEMBL1955	Homo sapiens	Inhibition	%	-0.18
	8147609	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.86	CHEMBL1955	Homo sapiens	Inhibition	%	1.86
	8147796	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-3.58	CHEMBL1955	Homo sapiens	Inhibition	%	-3.58
	8148020	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.46	CHEMBL1955	Homo sapiens	Inhibition	%	1.46
	8148178	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	24.87	CHEMBL1955	Homo sapiens	Inhibition	%	24.87
	8148516	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-9.98	CHEMBL1955	Homo sapiens	Inhibition	%	-9.98
	8148655	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.78	CHEMBL1955	Homo sapiens	Inhibition	%	0.78
	8149017	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	7.32	CHEMBL1955	Homo sapiens	Inhibition	%	7.32
	8149176	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.49	CHEMBL1955	Homo sapiens	Inhibition	%	2.49
	8149400	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.53	CHEMBL1955	Homo sapiens	Inhibition	%	-3.53
	8149534	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.11	CHEMBL1955	Homo sapiens	Inhibition	%	7.11
	8149856	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.38	CHEMBL1955	Homo sapiens	Inhibition	%	2.38
	8150205	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-7.79	CHEMBL1955	Homo sapiens	Inhibition	%	-7.79
	8150365	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	41.67	CHEMBL1955	Homo sapiens	Inhibition	%	41.67
	8150709	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	21.66	CHEMBL1955	Homo sapiens	Inhibition	%	21.66
	8150874	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2	Outside typical range	CHEMBL456252	=	Inhibition	%	-14.07	CHEMBL1955	Homo sapiens	Inhibition	%	-14.07
	8151261	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.16	CHEMBL1955	Homo sapiens	Inhibition	%	-0.16
	8151438	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.2	CHEMBL1955	Homo sapiens	Inhibition	%	2.2
	8151800	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	6.91	CHEMBL1955	Homo sapiens	Inhibition	%	6.91
	8151954	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.62	CHEMBL1955	Homo sapiens	Inhibition	%	1.62
	8152366	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.65	CHEMBL1955	Homo sapiens	Inhibition	%	9.65
	8152524	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.79	CHEMBL1955	Homo sapiens	Inhibition	%	3.79
	8152862	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	94.85	CHEMBL1955	Homo sapiens	Inhibition	%	94.85
	8153001	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.42	CHEMBL1955	Homo sapiens	Inhibition	%	0.42
	8153225	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.97	CHEMBL1955	Homo sapiens	Inhibition	%	2.97
	8153362	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.57	CHEMBL1955	Homo sapiens	Inhibition	%	4.57
	8153743	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-8.49	CHEMBL1955	Homo sapiens	Inhibition	%	-8.49
	8153876	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.03	CHEMBL1955	Homo sapiens	Inhibition	%	1.03
	8154197	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.06	CHEMBL1955	Homo sapiens	Inhibition	%	3.06
	8154547	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	38.15	CHEMBL1955	Homo sapiens	Inhibition	%	38.15
	8154706	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-2.07	CHEMBL1955	Homo sapiens	Inhibition	%	-2.07
	8155050	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.09	CHEMBL1955	Homo sapiens	Inhibition	%	3.09
	8155226	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2	Outside typical range	CHEMBL456252	=	Inhibition	%	-16.57	CHEMBL1955	Homo sapiens	Inhibition	%	-16.57
	8155450	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.03	CHEMBL1955	Homo sapiens	Inhibition	%	0.03
	8155611	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.13	CHEMBL1955	Homo sapiens	Inhibition	%	1.13
	8155789	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.93	CHEMBL1955	Homo sapiens	Inhibition	%	4.93
	8156013	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.12	CHEMBL1955	Homo sapiens	Inhibition	%	4.12
	8156151	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.01	CHEMBL1955	Homo sapiens	Inhibition	%	2.01
	8156363	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.33	CHEMBL1955	Homo sapiens	Inhibition	%	0.33
	8156737	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	47.29	CHEMBL1955	Homo sapiens	Inhibition	%	47.29
	8156880	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.67	CHEMBL1955	Homo sapiens	Inhibition	%	3.67
	8157104	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	9.2	CHEMBL1955	Homo sapiens	Inhibition	%	9.2
	8157224	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.85	CHEMBL1955	Homo sapiens	Inhibition	%	5.85
	8157589	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-1.5	CHEMBL1955	Homo sapiens	Inhibition	%	-1.5
	8157719	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	36.22	CHEMBL1955	Homo sapiens	Inhibition	%	36.22
	8157943	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.54	CHEMBL1955	Homo sapiens	Inhibition	%	1.54
	8158104	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.86	CHEMBL1955	Homo sapiens	Inhibition	%	-0.86
	8158354	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	10.09	CHEMBL1955	Homo sapiens	Inhibition	%	10.09
	8158512	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-7.96	CHEMBL1955	Homo sapiens	Inhibition	%	-7.96
	8158736	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1	Outside typical range	CHEMBL477182	=	Inhibition	%	-12.81	CHEMBL1955	Homo sapiens	Inhibition	%	-12.81
	8158905	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.33	CHEMBL1955	Homo sapiens	Inhibition	%	0.33
	8159264	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.24	CHEMBL1955	Homo sapiens	Inhibition	%	6.24
	8159384	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-1.34	CHEMBL1955	Homo sapiens	Inhibition	%	-1.34
	8159739	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.9	CHEMBL1955	Homo sapiens	Inhibition	%	6.9
	8159880	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	13.3	CHEMBL1955	Homo sapiens	Inhibition	%	13.3
	8160104	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	15.8	CHEMBL1955	Homo sapiens	Inhibition	%	15.8
	8160241	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.77	CHEMBL1955	Homo sapiens	Inhibition	%	0.77
	8160615	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.39	CHEMBL1955	Homo sapiens	Inhibition	%	1.39
	8160685	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.84	CHEMBL1955	Homo sapiens	Inhibition	%	3.84
	8160909	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	9.25	CHEMBL1955	Homo sapiens	Inhibition	%	9.25
	8161059	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.1	CHEMBL1955	Homo sapiens	Inhibition	%	4.1
	8161426	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	8.6	CHEMBL1955	Homo sapiens	Inhibition	%	8.6
	8161551	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.72	CHEMBL1955	Homo sapiens	Inhibition	%	2.72
	8161913	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.6	CHEMBL1955	Homo sapiens	Inhibition	%	2.6
	8162267	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.56	CHEMBL1955	Homo sapiens	Inhibition	%	4.56
	8162427	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl	Outside typical range	CHEMBL1909372	=	Inhibition	%	-10.61	CHEMBL1955	Homo sapiens	Inhibition	%	-10.61
	8162680	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.85	CHEMBL1955	Homo sapiens	Inhibition	%	5.85
	8163052	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	63.86	CHEMBL1955	Homo sapiens	Inhibition	%	63.86
	8163221	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.03	CHEMBL1955	Homo sapiens	Inhibition	%	1.03
	8163579	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.14	CHEMBL1955	Homo sapiens	Inhibition	%	3.14
	8163702	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-5.59	CHEMBL1955	Homo sapiens	Inhibition	%	-5.59
	8163926	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1	Outside typical range	CHEMBL266707	=	Inhibition	%	-13.4	CHEMBL1955	Homo sapiens	Inhibition	%	-13.4
	8164060	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-0.55	CHEMBL1955	Homo sapiens	Inhibition	%	-0.55
	8164424	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.06	CHEMBL1955	Homo sapiens	Inhibition	%	3.06
	8164579	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.83	CHEMBL1955	Homo sapiens	Inhibition	%	3.83
	8164947	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.22	CHEMBL1955	Homo sapiens	Inhibition	%	-0.22
	8165241	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.84	CHEMBL1955	Homo sapiens	Inhibition	%	2.84
	8165382	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	20.65	CHEMBL1955	Homo sapiens	Inhibition	%	20.65
	8165749	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	21.76	CHEMBL1955	Homo sapiens	Inhibition	%	21.76
	8165875	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.25	CHEMBL1955	Homo sapiens	Inhibition	%	3.25
	8166099	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.79	CHEMBL1955	Homo sapiens	Inhibition	%	3.79
	8166237	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-0.78	CHEMBL1955	Homo sapiens	Inhibition	%	-0.78
	8166591	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	7.41	CHEMBL1955	Homo sapiens	Inhibition	%	7.41
	8166916	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	105.58	CHEMBL1955	Homo sapiens	Inhibition	%	105.58
	8167004	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	7.41	CHEMBL1955	Homo sapiens	Inhibition	%	7.41
	8167228	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-0.39	CHEMBL1955	Homo sapiens	Inhibition	%	-0.39
	8167369	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	102.35	CHEMBL1955	Homo sapiens	Inhibition	%	102.35
	8167533	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.07	CHEMBL1955	Homo sapiens	Inhibition	%	0.07
	8167757	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-3.88	CHEMBL1955	Homo sapiens	Inhibition	%	-3.88
	8167890	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.14	CHEMBL1955	Homo sapiens	Inhibition	%	6.14
	8168238	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	18.21	CHEMBL1955	Homo sapiens	Inhibition	%	18.21
	8168379	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.1	CHEMBL1955	Homo sapiens	Inhibition	%	4.1
	8168603	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.83	CHEMBL1955	Homo sapiens	Inhibition	%	2.83
	8168739	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.77	CHEMBL1955	Homo sapiens	Inhibition	%	2.77
	8168903	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.06	CHEMBL1955	Homo sapiens	Inhibition	%	5.06
	8169127	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	22.26	CHEMBL1955	Homo sapiens	Inhibition	%	22.26
	8169269	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.12	CHEMBL1955	Homo sapiens	Inhibition	%	-0.12
	8169573	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.27	CHEMBL1955	Homo sapiens	Inhibition	%	2.27
	8169707	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.13	CHEMBL1955	Homo sapiens	Inhibition	%	3.13
	8169931	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.9	CHEMBL1955	Homo sapiens	Inhibition	%	1.9
	8170076	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	9.31	CHEMBL1955	Homo sapiens	Inhibition	%	9.31
	8170425	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.59	CHEMBL1955	Homo sapiens	Inhibition	%	3.59
	8170565	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.02	CHEMBL1955	Homo sapiens	Inhibition	%	2.02
	8170789	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.47	CHEMBL1955	Homo sapiens	Inhibition	%	-2.47
	8170924	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	30.35	CHEMBL1955	Homo sapiens	Inhibition	%	30.35
	8171121	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.49	CHEMBL1955	Homo sapiens	Inhibition	%	-0.49
	8171345	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	78.81	CHEMBL1955	Homo sapiens	Inhibition	%	78.81
	8171562	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.92	CHEMBL1955	Homo sapiens	Inhibition	%	0.92
	8171703	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.15	CHEMBL1955	Homo sapiens	Inhibition	%	3.15
	8172080	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-8.81	CHEMBL1955	Homo sapiens	Inhibition	%	-8.81
	8172212	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.77	CHEMBL1955	Homo sapiens	Inhibition	%	6.77
	8172564	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	15.37	CHEMBL1955	Homo sapiens	Inhibition	%	15.37
	8172930	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.06	CHEMBL1955	Homo sapiens	Inhibition	%	1.06
	8173066	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.99	CHEMBL1955	Homo sapiens	Inhibition	%	2.99
	8173455	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.86	CHEMBL1955	Homo sapiens	Inhibition	%	9.86
	8173596	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.39	CHEMBL1955	Homo sapiens	Inhibition	%	2.39
	8173907	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.93	CHEMBL1955	Homo sapiens	Inhibition	%	6.93
	8174263	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.3	CHEMBL1955	Homo sapiens	Inhibition	%	4.3
	8174411	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	56.47	CHEMBL1955	Homo sapiens	Inhibition	%	56.47
	8174635	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.32	CHEMBL1955	Homo sapiens	Inhibition	%	1.32
	8174757	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-0.85	CHEMBL1955	Homo sapiens	Inhibition	%	-0.85
	8175124	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	34.82	CHEMBL1955	Homo sapiens	Inhibition	%	34.82
	8175260	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.79	CHEMBL1955	Homo sapiens	Inhibition	%	0.79
	8175516	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	16.78	CHEMBL1955	Homo sapiens	Inhibition	%	16.78
	8175903	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	15.61	CHEMBL1955	Homo sapiens	Inhibition	%	15.61
	8176056	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.12	CHEMBL1955	Homo sapiens	Inhibition	%	5.12
	8176280	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.13	CHEMBL1955	Homo sapiens	Inhibition	%	6.13
	8176429	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.89	CHEMBL1955	Homo sapiens	Inhibition	%	-1.89
	8176561	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.3	CHEMBL1955	Homo sapiens	Inhibition	%	4.3
	8176785	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	26.58	CHEMBL1955	Homo sapiens	Inhibition	%	26.58
	8176915	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	5.33	CHEMBL1955	Homo sapiens	Inhibition	%	5.33
	8177281	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-9.76	CHEMBL1955	Homo sapiens	Inhibition	%	-9.76
	8177419	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	5.11	CHEMBL1955	Homo sapiens	Inhibition	%	5.11
	8177643	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	18.46	CHEMBL1955	Homo sapiens	Inhibition	%	18.46
	8177807	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	38.42	CHEMBL1955	Homo sapiens	Inhibition	%	38.42
	8177947	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.46	CHEMBL1955	Homo sapiens	Inhibition	%	2.46
	8178171	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.42	CHEMBL1955	Homo sapiens	Inhibition	%	4.42
	8178259	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	26.41	CHEMBL1955	Homo sapiens	Inhibition	%	26.41
	8178483	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.38	CHEMBL1955	Homo sapiens	Inhibition	%	2.38
	8178610	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.63	CHEMBL1955	Homo sapiens	Inhibition	%	2.63
	8178983	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.97	CHEMBL1955	Homo sapiens	Inhibition	%	1.97
	8179106	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.21	CHEMBL1955	Homo sapiens	Inhibition	%	5.21
	8179474	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	16.66	CHEMBL1955	Homo sapiens	Inhibition	%	16.66
	8179611	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	9.77	CHEMBL1955	Homo sapiens	Inhibition	%	9.77
	8179835	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-1.86	CHEMBL1955	Homo sapiens	Inhibition	%	-1.86
	8179868	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	40.23	CHEMBL1955	Homo sapiens	Inhibition	%	40.23
	8180092	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.1	CHEMBL1955	Homo sapiens	Inhibition	%	2.1
	8180246	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	62.91	CHEMBL1955	Homo sapiens	Inhibition	%	62.91
	8180626	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.01	CHEMBL1955	Homo sapiens	Inhibition	%	7.01
	8180774	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%		CHEMBL1955	Homo sapiens	Inhibition	%	
	8181131	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	21.31	CHEMBL1955	Homo sapiens	Inhibition	%	21.31
	8181262	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	16.44	CHEMBL1955	Homo sapiens	Inhibition	%	16.44
	8181486	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	7.83	CHEMBL1955	Homo sapiens	Inhibition	%	7.83
	8181626	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl	Outside typical range	CHEMBL1909352	=	Inhibition	%	-10.24	CHEMBL1955	Homo sapiens	Inhibition	%	-10.24
	8181989	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	63.49	CHEMBL1955	Homo sapiens	Inhibition	%	63.49
	8182152	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.58	CHEMBL1955	Homo sapiens	Inhibition	%	4.58
	8182516	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.19	CHEMBL1955	Homo sapiens	Inhibition	%	0.19
	8182832	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.19	CHEMBL1955	Homo sapiens	Inhibition	%	1.19
	8182954	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	7.04	CHEMBL1955	Homo sapiens	Inhibition	%	7.04
	8183327	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	27.55	CHEMBL1955	Homo sapiens	Inhibition	%	27.55
	8183456	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-0.66	CHEMBL1955	Homo sapiens	Inhibition	%	-0.66
	8183680	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-2.47	CHEMBL1955	Homo sapiens	Inhibition	%	-2.47
	8183822	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	48.68	CHEMBL1955	Homo sapiens	Inhibition	%	48.68
	8184182	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.27	CHEMBL1955	Homo sapiens	Inhibition	%	-0.27
	8184448	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.3	CHEMBL1955	Homo sapiens	Inhibition	%	3.3
	8184595	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1	Outside typical range	CHEMBL1909415	=	Inhibition	%	-10.38	CHEMBL1955	Homo sapiens	Inhibition	%	-10.38
	8184976	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	7.5	CHEMBL1955	Homo sapiens	Inhibition	%	7.5
	8185125	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	55.05	CHEMBL1955	Homo sapiens	Inhibition	%	55.05
	8185349	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.27	CHEMBL1955	Homo sapiens	Inhibition	%	2.27
	8185480	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	68.77	CHEMBL1955	Homo sapiens	Inhibition	%	68.77
	8185835	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	32.91	CHEMBL1955	Homo sapiens	Inhibition	%	32.91
	8185974	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	16.25	CHEMBL1955	Homo sapiens	Inhibition	%	16.25
	8186339	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.09	CHEMBL1955	Homo sapiens	Inhibition	%	4.09
	8186503	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.57	CHEMBL1955	Homo sapiens	Inhibition	%	11.57
	8186727	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.33	CHEMBL1955	Homo sapiens	Inhibition	%	1.33
	8186866	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-1.91	CHEMBL1955	Homo sapiens	Inhibition	%	-1.91
	8187188	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.77	CHEMBL1955	Homo sapiens	Inhibition	%	1.77
	8187312	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.84	CHEMBL1955	Homo sapiens	Inhibition	%	6.84
	8187536	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.15	CHEMBL1955	Homo sapiens	Inhibition	%	4.15
	8187684	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	77.75	CHEMBL1955	Homo sapiens	Inhibition	%	77.75
	8188037	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.74	CHEMBL1955	Homo sapiens	Inhibition	%	4.74
	8188180	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.36	CHEMBL1955	Homo sapiens	Inhibition	%	4.36
	8188539	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.95	CHEMBL1955	Homo sapiens	Inhibition	%	-2.95
	8188813	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.96	CHEMBL1955	Homo sapiens	Inhibition	%	4.96
	8188961	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1	Outside typical range	CHEMBL1909415	=	Inhibition	%	-14.12	CHEMBL1955	Homo sapiens	Inhibition	%	-14.12
	8189185	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	13.8	CHEMBL1955	Homo sapiens	Inhibition	%	13.8
	8189341	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	47.74	CHEMBL1955	Homo sapiens	Inhibition	%	47.74
	8189714	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.6	CHEMBL1955	Homo sapiens	Inhibition	%	3.6
	8189846	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-5.89	CHEMBL1955	Homo sapiens	Inhibition	%	-5.89
	8190202	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.8	CHEMBL1955	Homo sapiens	Inhibition	%	1.8
	8190342	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	16.92	CHEMBL1955	Homo sapiens	Inhibition	%	16.92
	8190566	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.14	CHEMBL1955	Homo sapiens	Inhibition	%	2.14
	8190703	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	8.94	CHEMBL1955	Homo sapiens	Inhibition	%	8.94
	8191091	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.21	CHEMBL1955	Homo sapiens	Inhibition	%	3.21
	8191229	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.39	CHEMBL1955	Homo sapiens	Inhibition	%	2.39
	8191549	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.45	CHEMBL1955	Homo sapiens	Inhibition	%	0.45
	8191895	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.87	CHEMBL1955	Homo sapiens	Inhibition	%	5.87
	8192044	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.11	CHEMBL1955	Homo sapiens	Inhibition	%	1.11
	8192397	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-1.03	CHEMBL1955	Homo sapiens	Inhibition	%	-1.03
	8192541	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	9.79	CHEMBL1955	Homo sapiens	Inhibition	%	9.79
	8192765	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.74	CHEMBL1955	Homo sapiens	Inhibition	%	6.74
	8192901	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	31.4	CHEMBL1955	Homo sapiens	Inhibition	%	31.4
	8193173	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.22	CHEMBL1955	Homo sapiens	Inhibition	%	8.22
	8193542	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	22.15	CHEMBL1955	Homo sapiens	Inhibition	%	22.15
	8193699	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.98	CHEMBL1955	Homo sapiens	Inhibition	%	1.98
	8194072	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.79	CHEMBL1955	Homo sapiens	Inhibition	%	2.79
	8194203	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1	Outside typical range	CHEMBL517907	=	Inhibition	%	-12.97	CHEMBL1955	Homo sapiens	Inhibition	%	-12.97
	8194427	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	97.48	CHEMBL1955	Homo sapiens	Inhibition	%	97.48
	8194558	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.28	CHEMBL1955	Homo sapiens	Inhibition	%	4.28
	8194925	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.17	CHEMBL1955	Homo sapiens	Inhibition	%	6.17
	8195058	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.64	CHEMBL1955	Homo sapiens	Inhibition	%	4.64
	8195282	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	0.88	CHEMBL1955	Homo sapiens	Inhibition	%	0.88
	8195446	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.18	CHEMBL1955	Homo sapiens	Inhibition	%	6.18
	8195585	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.9	CHEMBL1955	Homo sapiens	Inhibition	%	4.9
	8195809	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.47	CHEMBL1955	Homo sapiens	Inhibition	%	1.47
	8195907	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.85	CHEMBL1955	Homo sapiens	Inhibition	%	1.85
	8196248	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.79	CHEMBL1955	Homo sapiens	Inhibition	%	0.79
	8196398	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.42	CHEMBL1955	Homo sapiens	Inhibition	%	2.42
	8196622	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	5.68	CHEMBL1955	Homo sapiens	Inhibition	%	5.68
	8196750	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-1.53	CHEMBL1955	Homo sapiens	Inhibition	%	-1.53
	8197115	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.1	CHEMBL1955	Homo sapiens	Inhibition	%	3.1
	8197252	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	15.84	CHEMBL1955	Homo sapiens	Inhibition	%	15.84
	8197476	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	22.84	CHEMBL1955	Homo sapiens	Inhibition	%	22.84
	8197527	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-0.28	CHEMBL1955	Homo sapiens	Inhibition	%	-0.28
	8197751	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.18	CHEMBL1955	Homo sapiens	Inhibition	%	0.18
	8197891	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	11.86	CHEMBL1955	Homo sapiens	Inhibition	%	11.86
	8198048	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	14.78	CHEMBL1955	Homo sapiens	Inhibition	%	14.78
	8198272	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-8.43	CHEMBL1955	Homo sapiens	Inhibition	%	-8.43
	8198410	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.38	CHEMBL1955	Homo sapiens	Inhibition	%	3.38
	8198764	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	106.9	CHEMBL1955	Homo sapiens	Inhibition	%	106.9
	8198895	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.62	CHEMBL1955	Homo sapiens	Inhibition	%	1.62
	8199119	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.97	CHEMBL1955	Homo sapiens	Inhibition	%	0.97
	8199267	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.56	CHEMBL1955	Homo sapiens	Inhibition	%	7.56
	8199625	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.04	CHEMBL1955	Homo sapiens	Inhibition	%	4.04
	8199788	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	12.3	CHEMBL1955	Homo sapiens	Inhibition	%	12.3
	8200150	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-0.57	CHEMBL1955	Homo sapiens	Inhibition	%	-0.57
	8200254	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.82	CHEMBL1955	Homo sapiens	Inhibition	%	0.82
	8200478	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.99	CHEMBL1955	Homo sapiens	Inhibition	%	4.99
	8200593	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.3	CHEMBL1955	Homo sapiens	Inhibition	%	2.3
	8200967	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	28.29	CHEMBL1955	Homo sapiens	Inhibition	%	28.29
	8201097	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-6.1	CHEMBL1955	Homo sapiens	Inhibition	%	-6.1
	8201321	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	34.66	CHEMBL1955	Homo sapiens	Inhibition	%	34.66
	8201456	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-1.68	CHEMBL1955	Homo sapiens	Inhibition	%	-1.68
	8201813	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.68	CHEMBL1955	Homo sapiens	Inhibition	%	2.68
	8202092	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.03	CHEMBL1955	Homo sapiens	Inhibition	%	-0.03
	8202232	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	54.79	CHEMBL1955	Homo sapiens	Inhibition	%	54.79
	8202623	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1	Outside typical range	CHEMBL1909406	=	Inhibition	%	-13.94	CHEMBL1955	Homo sapiens	Inhibition	%	-13.94
	8202748	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-1.38	CHEMBL1955	Homo sapiens	Inhibition	%	-1.38
	8203102	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.24	CHEMBL1955	Homo sapiens	Inhibition	%	6.24
	8203457	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	58.82	CHEMBL1955	Homo sapiens	Inhibition	%	58.82
	8203603	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	11.32	CHEMBL1955	Homo sapiens	Inhibition	%	11.32
	8203961	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.69	CHEMBL1955	Homo sapiens	Inhibition	%	0.69
	8204127	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.44	CHEMBL1955	Homo sapiens	Inhibition	%	1.44
	8204488	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	62.48	CHEMBL1955	Homo sapiens	Inhibition	%	62.48
	8204817	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	16.22	CHEMBL1955	Homo sapiens	Inhibition	%	16.22
	8204932	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.46	CHEMBL1955	Homo sapiens	Inhibition	%	2.46
	8205156	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	26.06	CHEMBL1955	Homo sapiens	Inhibition	%	26.06
	8205305	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.93	CHEMBL1955	Homo sapiens	Inhibition	%	5.93
	8205665	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	12.76	CHEMBL1955	Homo sapiens	Inhibition	%	12.76
	8205804	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.58	CHEMBL1955	Homo sapiens	Inhibition	%	1.58
	8206160	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	9.41	CHEMBL1955	Homo sapiens	Inhibition	%	9.41
	8206436	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-1.42	CHEMBL1955	Homo sapiens	Inhibition	%	-1.42
	8206579	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	4.68	CHEMBL1955	Homo sapiens	Inhibition	%	4.68
	8206803	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	6.47	CHEMBL1955	Homo sapiens	Inhibition	%	6.47
	8206983	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	15.44	CHEMBL1955	Homo sapiens	Inhibition	%	15.44
	8207109	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.05	CHEMBL1955	Homo sapiens	Inhibition	%	1.05
	8207333	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.27	CHEMBL1955	Homo sapiens	Inhibition	%	0.27
	8207463	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	11.56	CHEMBL1955	Homo sapiens	Inhibition	%	11.56
	8207819	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	93.75	CHEMBL1955	Homo sapiens	Inhibition	%	93.75
	8207964	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.01	CHEMBL1955	Homo sapiens	Inhibition	%	0.01
	8208188	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.07	CHEMBL1955	Homo sapiens	Inhibition	%	0.07
	8208320	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.28	CHEMBL1955	Homo sapiens	Inhibition	%	5.28
	8208486	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.34	CHEMBL1955	Homo sapiens	Inhibition	%	1.34
	8208710	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.27	CHEMBL1955	Homo sapiens	Inhibition	%	1.27
	8208843	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	88.79	CHEMBL1955	Homo sapiens	Inhibition	%	88.79
	8209172	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	41.04	CHEMBL1955	Homo sapiens	Inhibition	%	41.04
	8209512	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.06	CHEMBL1955	Homo sapiens	Inhibition	%	1.06
	8209662	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	29.88	CHEMBL1955	Homo sapiens	Inhibition	%	29.88
	8210022	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	19.29	CHEMBL1955	Homo sapiens	Inhibition	%	19.29
	8210163	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.87	CHEMBL1955	Homo sapiens	Inhibition	%	0.87
	8210387	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-0.77	CHEMBL1955	Homo sapiens	Inhibition	%	-0.77
	8210523	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.17	CHEMBL1955	Homo sapiens	Inhibition	%	1.17
	8210782	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-5.22	CHEMBL1955	Homo sapiens	Inhibition	%	-5.22
	8211150	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	8.44	CHEMBL1955	Homo sapiens	Inhibition	%	8.44
	8211320	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	15.31	CHEMBL1955	Homo sapiens	Inhibition	%	15.31
	8211667	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	9.77	CHEMBL1955	Homo sapiens	Inhibition	%	9.77
	8211796	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	18.29	CHEMBL1955	Homo sapiens	Inhibition	%	18.29
	8212020	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	60.87	CHEMBL1955	Homo sapiens	Inhibition	%	60.87
	8212152	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	15.19	CHEMBL1955	Homo sapiens	Inhibition	%	15.19
	8212517	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.27	CHEMBL1955	Homo sapiens	Inhibition	%	1.27
	8212650	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.26	CHEMBL1955	Homo sapiens	Inhibition	%	4.26
	8213044	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.27	CHEMBL1955	Homo sapiens	Inhibition	%	3.27
	8213173	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.27	CHEMBL1955	Homo sapiens	Inhibition	%	5.27
	8213397	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	21.85	CHEMBL1955	Homo sapiens	Inhibition	%	21.85
	8213501	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	82.8	CHEMBL1955	Homo sapiens	Inhibition	%	82.8
	8213838	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.46	CHEMBL1955	Homo sapiens	Inhibition	%	2.46
	8213985	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.96	CHEMBL1955	Homo sapiens	Inhibition	%	0.96
	8214209	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.51	CHEMBL1955	Homo sapiens	Inhibition	%	1.51
	8214346	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	31.82	CHEMBL1955	Homo sapiens	Inhibition	%	31.82
	8214704	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	64.05	CHEMBL1955	Homo sapiens	Inhibition	%	64.05
	8214856	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.51	CHEMBL1955	Homo sapiens	Inhibition	%	2.51
	8215107	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1	Outside typical range	CHEMBL402108	=	Inhibition	%	-15.44	CHEMBL1955	Homo sapiens	Inhibition	%	-15.44
	8215484	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	50.16	CHEMBL1955	Homo sapiens	Inhibition	%	50.16
	8215648	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.34	CHEMBL1955	Homo sapiens	Inhibition	%	4.34
	8215991	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-9.16	CHEMBL1955	Homo sapiens	Inhibition	%	-9.16
	8216334	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-1.7	CHEMBL1955	Homo sapiens	Inhibition	%	-1.7
	8216470	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	18.52	CHEMBL1955	Homo sapiens	Inhibition	%	18.52
	8216832	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.78	CHEMBL1955	Homo sapiens	Inhibition	%	1.78
	8216966	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.47	CHEMBL1955	Homo sapiens	Inhibition	%	4.47
	8217190	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-1.03	CHEMBL1955	Homo sapiens	Inhibition	%	-1.03
	8217364	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.08	CHEMBL1955	Homo sapiens	Inhibition	%	3.08
	8217719	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	26.76	CHEMBL1955	Homo sapiens	Inhibition	%	26.76
	8217820	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.23	CHEMBL1955	Homo sapiens	Inhibition	%	1.23
	8218044	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	6.6	CHEMBL1955	Homo sapiens	Inhibition	%	6.6
	8218159	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.85	CHEMBL1955	Homo sapiens	Inhibition	%	1.85
	8218510	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	12.14	CHEMBL1955	Homo sapiens	Inhibition	%	12.14
	8218653	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	81.31	CHEMBL1955	Homo sapiens	Inhibition	%	81.31
	8219008	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	95.01	CHEMBL1955	Homo sapiens	Inhibition	%	95.01
	8219168	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.95	CHEMBL1955	Homo sapiens	Inhibition	%	-0.95
	8219392	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	8.44	CHEMBL1955	Homo sapiens	Inhibition	%	8.44
	8219418	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	15.37	CHEMBL1955	Homo sapiens	Inhibition	%	15.37
	8219642	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	17.01	CHEMBL1955	Homo sapiens	Inhibition	%	17.01
	8219803	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.69	CHEMBL1955	Homo sapiens	Inhibition	%	0.69
	8219972	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.77	CHEMBL1955	Homo sapiens	Inhibition	%	4.77
	8220196	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.4	CHEMBL1955	Homo sapiens	Inhibition	%	4.4
	8220325	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1	Outside typical range	CHEMBL450071	=	Inhibition	%	-13.29	CHEMBL1955	Homo sapiens	Inhibition	%	-13.29
	8220663	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.99	CHEMBL1955	Homo sapiens	Inhibition	%	3.99
	8220801	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.22	CHEMBL1955	Homo sapiens	Inhibition	%	7.22
	8221025	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	24.62	CHEMBL1955	Homo sapiens	Inhibition	%	24.62
	8221161	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-4.56	CHEMBL1955	Homo sapiens	Inhibition	%	-4.56
	8221518	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.54	CHEMBL1955	Homo sapiens	Inhibition	%	2.54
	8221683	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.93	CHEMBL1955	Homo sapiens	Inhibition	%	1.93
	8222038	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	73.37	CHEMBL1955	Homo sapiens	Inhibition	%	73.37
	8222360	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	10.69	CHEMBL1955	Homo sapiens	Inhibition	%	10.69
	8222494	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.47	CHEMBL1955	Homo sapiens	Inhibition	%	3.47
	8222836	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	53.46	CHEMBL1955	Homo sapiens	Inhibition	%	53.46
	8222980	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	47.43	CHEMBL1955	Homo sapiens	Inhibition	%	47.43
	8223204	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	98.36	CHEMBL1955	Homo sapiens	Inhibition	%	98.36
	8223333	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	14.09	CHEMBL1955	Homo sapiens	Inhibition	%	14.09
	8223718	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-2.95	CHEMBL1955	Homo sapiens	Inhibition	%	-2.95
	8223968	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.4	CHEMBL1955	Homo sapiens	Inhibition	%	4.4
	8224130	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-0.08	CHEMBL1955	Homo sapiens	Inhibition	%	-0.08
	8224524	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.21	CHEMBL1955	Homo sapiens	Inhibition	%	2.21
	8224659	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	14.12	CHEMBL1955	Homo sapiens	Inhibition	%	14.12
	8224883	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	18.63	CHEMBL1955	Homo sapiens	Inhibition	%	18.63
	8224997	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-0.3	CHEMBL1955	Homo sapiens	Inhibition	%	-0.3
	8225355	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.76	CHEMBL1955	Homo sapiens	Inhibition	%	6.76
	8225493	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	17.54	CHEMBL1955	Homo sapiens	Inhibition	%	17.54
	8225852	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-0.47	CHEMBL1955	Homo sapiens	Inhibition	%	-0.47
	8226010	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.51	CHEMBL1955	Homo sapiens	Inhibition	%	1.51
	8226234	CHEMBL1962101	GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.04	CHEMBL1955	Homo sapiens	Inhibition	%	1.04
	8226359	CHEMBL1962100	GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.89	CHEMBL1955	Homo sapiens	Inhibition	%	3.89
inactive	9635379	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635380	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	79.43	CHEMBL1955	Homo sapiens	pKi		7.1
inactive	9635381	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635382	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635383	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	7.943	CHEMBL1955	Homo sapiens	pKi		8.1
inactive	9635384	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635385	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9635386	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635387	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635388	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
active	9635389	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
active	9635390	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
inactive	9635391	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635392	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635393	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635394	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635395	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635396	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)c2c(N)noc12		CHEMBL1973178	=	Ki	nM	12.59	CHEMBL1955	Homo sapiens	pKi		7.9
inactive	9635397	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635398	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635399	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1988778	=	Ki	nM	3.981	CHEMBL1955	Homo sapiens	pKi		8.4
inactive	9635400	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635401	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9635402	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635403	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
inactive	9635404	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635405	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635406	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	125.89	CHEMBL1955	Homo sapiens	pKi		6.9
active	9635407	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635408	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635409	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
inactive	9635410	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635411	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635412	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635413	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9635414	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
active	9635415	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9635416	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635417	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	10.0	CHEMBL1955	Homo sapiens	pKi		8.0
active	9635418	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	5.012	CHEMBL1955	Homo sapiens	pKi		8.3
active	9635419	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9635420	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635421	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635422	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635423	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635424	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635425	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9635426	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
active	9635427	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
active	9635428	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9635429	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9635430	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635431	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	5.012	CHEMBL1955	Homo sapiens	pKi		8.3
active	9635432	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
active	9635433	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635434	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635435	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
inactive	9635436	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635437	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635438	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635439	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635440	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635441	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9635442	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
inactive	9635443	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635444	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635445	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635446	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635447	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635448	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635449	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635450	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)c(F)c3)c12		CHEMBL2000652	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
active	9635451	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9635452	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
inactive	9635453	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635454	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635455	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	39.81	CHEMBL1955	Homo sapiens	pKi		7.4
active	9635456	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	6.31	CHEMBL1955	Homo sapiens	pKi		8.2
active	9635457	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9635458	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9635459	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	125.89	CHEMBL1955	Homo sapiens	pKi		6.9
active	9635460	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
active	9635461	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	7.943	CHEMBL1955	Homo sapiens	pKi		8.1
active	9635462	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9635463	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635464	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635465	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9635466	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635467	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9635468	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635469	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635470	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	6.31	CHEMBL1955	Homo sapiens	pKi		8.2
inactive	9635471	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635472	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635473	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635474	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
active	9635475	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9635476	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635477	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635478	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635479	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9635480	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
inactive	9635481	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9635482	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635483	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635484	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635485	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	630.96	CHEMBL1955	Homo sapiens	pKi		6.2
inactive	9635486	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635487	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635488	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635489	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635490	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635491	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	3.981	CHEMBL1955	Homo sapiens	pKi		8.4
inactive	9635492	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635493	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
active	9635494	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9635495	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635496	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635497	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635498	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9635499	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9635500	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635501	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9635502	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635503	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
inactive	9635504	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635505	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635506	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635507	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635508	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635509	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635510	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635511	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	25.12	CHEMBL1955	Homo sapiens	pKi		7.6
inactive	9635512	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635513	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635514	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635515	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635516	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	630.96	CHEMBL1955	Homo sapiens	pKi		6.2
active	9635517	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
active	9635518	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9635519	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9635520	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	630.96	CHEMBL1955	Homo sapiens	pKi		6.2
inactive	9635521	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635522	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
active	9635523	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
active	9635524	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9635525	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635526	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635527	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635528	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635529	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	12.59	CHEMBL1955	Homo sapiens	pKi		7.9
inactive	9635530	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635531	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
inactive	9635532	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635533	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	125.89	CHEMBL1955	Homo sapiens	pKi		6.9
inactive	9635534	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635535	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635536	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635537	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635538	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9635539	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
inactive	9635540	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635541	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635542	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
inactive	9635543	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635544	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635545	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635546	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
inactive	9635547	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635548	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635549	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9635550	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	2.512	CHEMBL1955	Homo sapiens	pKi		8.6
active	9635551	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
inactive	9635552	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635553	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9635554	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635555	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1993996	=	Ki	nM	0.3981	CHEMBL1955	Homo sapiens	pKi		9.4
inactive	9635556	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635557	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
inactive	9635558	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635559	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
active	9635560	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	31.62	CHEMBL1955	Homo sapiens	pKi		7.5
active	9635561	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
inactive	9635562	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635563	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635564	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635565	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635566	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	6.31	CHEMBL1955	Homo sapiens	pKi		8.2
active	9635567	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9635568	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9635569	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
active	9635570	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	3.981	CHEMBL1955	Homo sapiens	pKi		8.4
inactive	9635571	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635572	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
active	9635573	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635574	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635575	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635576	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9635577	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9635578	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
active	9635579	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9635580	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9635581	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635582	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9635583	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9635584	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635585	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635586	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635587	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635588	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635589	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9635590	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639590	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639591	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639592	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9639593	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639594	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639595	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639596	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639597	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639598	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
inactive	9639599	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639600	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
active	9639601	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL373798	=	Ki	nM	0.7943	CHEMBL1955	Homo sapiens	pKi		9.1
active	9639602	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	630.96	CHEMBL1955	Homo sapiens	pKi		6.2
inactive	9639603	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639604	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9639605	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639606	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
inactive	9639607	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639608	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	6.31	CHEMBL1955	Homo sapiens	pKi		8.2
active	9639609	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	5.012	CHEMBL1955	Homo sapiens	pKi		8.3
inactive	9639610	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639611	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639612	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639613	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639614	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639615	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9639616	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639617	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	0.7943	CHEMBL1955	Homo sapiens	pKi		9.1
inactive	9639618	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639619	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639620	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	10.0	CHEMBL1955	Homo sapiens	pKi		8.0
inactive	9639621	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639622	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639623	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639624	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639625	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
inactive	9639626	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639627	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639628	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639629	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639630	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
active	9639631	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9639632	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9639633	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639634	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639635	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9639636	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
active	9639637	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	15.85	CHEMBL1955	Homo sapiens	pKi		7.8
inactive	9639638	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639639	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639640	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639641	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	31.62	CHEMBL1955	Homo sapiens	pKi		7.5
inactive	9639642	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639643	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9639644	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639645	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639646	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639647	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)c1		CHEMBL1996255	=	Ki	nM	1.0	CHEMBL1955	Homo sapiens	pKi		9.0
inactive	9639648	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639649	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639650	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9639651	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9639652	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639653	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639654	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCn1c(=C(C#N)C(=O)O)sc(=CNc2ccccc2)c1=O		CHEMBL1986996	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
inactive	9639655	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639656	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
active	9639657	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
active	9639658	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
active	9639659	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
active	9639660	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639661	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639662	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
active	9639663	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
inactive	9639664	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639665	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
active	9639666	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	630.96	CHEMBL1955	Homo sapiens	pKi		6.2
inactive	9639667	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639668	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9639669	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9639670	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	31.62	CHEMBL1955	Homo sapiens	pKi		7.5
inactive	9639671	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639672	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639673	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639674	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
active	9639675	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9639676	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639677	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639678	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639679	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
active	9639680	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9639681	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639682	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
inactive	9639683	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639684	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9639685	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639686	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639687	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
active	9639688	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
active	9639689	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4c3c(N)nn4C)cc2)c1		CHEMBL1985491	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
inactive	9639690	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639691	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639692	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639693	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
inactive	9639694	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639695	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639696	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
active	9639697	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
inactive	9639698	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639699	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639700	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639701	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	3.981	CHEMBL1955	Homo sapiens	pKi		8.4
active	9639702	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	12.59	CHEMBL1955	Homo sapiens	pKi		7.9
active	9639703	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
inactive	9639704	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
inactive	9639705	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639706	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639707	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
active	9639708	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
active	9639709	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9639710	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
inactive	9639711	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639712	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	2.512	CHEMBL1955	Homo sapiens	pKi		8.6
inactive	9639713	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639714	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639715	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	3.981	CHEMBL1955	Homo sapiens	pKi		8.4
inactive	9639716	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639717	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639718	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9639719	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	19.95	CHEMBL1955	Homo sapiens	pKi		7.7
inactive	9639720	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639721	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
active	9639722	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
active	9639723	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	7.943	CHEMBL1955	Homo sapiens	pKi		8.1
inactive	9639724	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639725	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639726	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639727	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639728	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639729	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639730	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639731	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9639732	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639733	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639734	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639735	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9639736	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639737	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	12.59	CHEMBL1955	Homo sapiens	pKi		7.9
active	9639738	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
inactive	9639739	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639740	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639741	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639742	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c12		CHEMBL1980904	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
active	9639743	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	19.95	CHEMBL1955	Homo sapiens	pKi		7.7
inactive	9639744	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639745	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639746	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639747	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9639748	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639749	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL271441	=	Ki	nM	0.3162	CHEMBL1955	Homo sapiens	pKi		9.5
inactive	9639750	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639751	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639752	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639753	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639754	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639755	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639756	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
inactive	9639757	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639758	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639759	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639760	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
inactive	9639761	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639762	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639763	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
inactive	9639764	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639765	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639766	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL273187	=	Ki	nM	0.1259	CHEMBL1955	Homo sapiens	pKi		9.9
active	9639767	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639768	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639769	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639770	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)ccc1F		CHEMBL1986979	=	Ki	nM	0.3162	CHEMBL1955	Homo sapiens	pKi		9.5
inactive	9639771	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639772	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639773	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	7.943	CHEMBL1955	Homo sapiens	pKi		8.1
inactive	9639774	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639775	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639776	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639777	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639778	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639779	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
active	9639780	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9639781	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
active	9639782	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9639783	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
active	9639784	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
inactive	9639785	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639786	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9639787	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
active	9639788	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	63.1	CHEMBL1955	Homo sapiens	pKi		7.2
active	9639789	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	630.96	CHEMBL1955	Homo sapiens	pKi		6.2
inactive	9639790	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639791	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639792	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	2.512	CHEMBL1955	Homo sapiens	pKi		8.6
active	9639793	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639794	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639795	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639796	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
inactive	9639797	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639798	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639799	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
active	9639800	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	39.81	CHEMBL1955	Homo sapiens	pKi		7.4
active	9639801	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
inactive	9639802	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639803	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639804	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639805	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639806	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639807	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639808	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
inactive	9639809	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639810	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639811	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
inactive	9639812	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639813	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9639814	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639815	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639816	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	63.1	CHEMBL1955	Homo sapiens	pKi		7.2
inactive	9639817	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639818	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	79.43	CHEMBL1955	Homo sapiens	pKi		7.1
active	9639819	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639820	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9639821	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639822	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9639823	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9639824	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
active	9639825	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
active	9643825	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	0.7943	CHEMBL1955	Homo sapiens	pKi		9.1
inactive	9643826	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643827	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
active	9643828	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	39.81	CHEMBL1955	Homo sapiens	pKi		7.4
active	9643829	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9643830	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643831	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643832	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643833	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643834	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643835	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9643836	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643837	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9643838	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643839	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9643840	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
inactive	9643841	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643842	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643843	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643844	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643845	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
inactive	9643846	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643847	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
active	9643848	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
inactive	9643849	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643850	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	50.12	CHEMBL1955	Homo sapiens	pKi		7.3
active	9643851	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9643852	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643853	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643854	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643855	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643856	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1966836	=	Ki	nM	1.585	CHEMBL1955	Homo sapiens	pKi		8.8
inactive	9643857	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643858	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643859	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643860	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	125.89	CHEMBL1955	Homo sapiens	pKi		6.9
inactive	9643861	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643862	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643863	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	501.19	CHEMBL1955	Homo sapiens	pKi		6.3
inactive	9643864	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643865	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643866	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
active	9643867	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	5.012	CHEMBL1955	Homo sapiens	pKi		8.3
active	9643868	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	25.12	CHEMBL1955	Homo sapiens	pKi		7.6
active	9643869	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9643870	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
active	9643871	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9643872	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL272938	=	Ki	nM	0.3162	CHEMBL1955	Homo sapiens	pKi		9.5
inactive	9643873	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643874	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
active	9643875	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	125.89	CHEMBL1955	Homo sapiens	pKi		6.9
inactive	9643876	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643877	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643878	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9643879	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643880	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
inactive	9643881	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643882	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643883	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9643884	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
active	9643885	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	5.012	CHEMBL1955	Homo sapiens	pKi		8.3
inactive	9643886	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643887	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643888	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643889	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643890	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643891	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643892	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	6.31	CHEMBL1955	Homo sapiens	pKi		8.2
inactive	9643893	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643894	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643895	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
active	9643896	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL403402	=	Ki	nM	1.0	CHEMBL1955	Homo sapiens	pKi		9.0
inactive	9643897	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643898	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9643899	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
active	9643900	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
inactive	9643901	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643902	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	79.43	CHEMBL1955	Homo sapiens	pKi		7.1
inactive	9643903	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643904	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643905	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643906	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643907	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643908	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	6.31	CHEMBL1955	Homo sapiens	pKi		8.2
active	9643909	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
active	9643910	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
active	9643911	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
inactive	9643912	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643913	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643914	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643915	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643916	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643917	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643918	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643919	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643920	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643921	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	=	Ki	nM	63.1	CHEMBL1955	Homo sapiens	pKi		7.2
active	9643922	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9643923	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643924	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643925	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643926	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
inactive	9643927	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643928	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
active	9643929	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	63.1	CHEMBL1955	Homo sapiens	pKi		7.2
inactive	9643930	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643931	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643932	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643933	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9643934	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	=	Ki	nM	31.62	CHEMBL1955	Homo sapiens	pKi		7.5
active	9643935	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL273187	=	Ki	nM	0.1259	CHEMBL1955	Homo sapiens	pKi		9.9
active	9643936	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9643937	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643938	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9643939	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643940	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9643941	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	19.95	CHEMBL1955	Homo sapiens	pKi		7.7
inactive	9643942	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643943	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9643944	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
inactive	9643945	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643946	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643947	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643948	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643949	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643950	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643951	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
inactive	9643952	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643953	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)c1		CHEMBL409349	=	Ki	nM	1.995	CHEMBL1955	Homo sapiens	pKi		8.7
inactive	9643954	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643955	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643956	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9643957	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	25.12	CHEMBL1955	Homo sapiens	pKi		7.6
inactive	9643958	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643959	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643960	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	251.19	CHEMBL1955	Homo sapiens	pKi		6.6
inactive	9643961	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643962	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
inactive	9643963	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643964	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	3.981	CHEMBL1955	Homo sapiens	pKi		8.4
inactive	9643965	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643966	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1994638	=	Ki	nM	0.7943	CHEMBL1955	Homo sapiens	pKi		9.1
active	9643967	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1985888	=	Ki	nM	1.585	CHEMBL1955	Homo sapiens	pKi		8.8
inactive	9643968	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643969	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	199.53	CHEMBL1955	Homo sapiens	pKi		6.7
inactive	9643970	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643971	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643972	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9643973	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
active	9643974	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
active	9643975	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	63.1	CHEMBL1955	Homo sapiens	pKi		7.2
inactive	9643976	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643977	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643978	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	125.89	CHEMBL1955	Homo sapiens	pKi		6.9
active	9643979	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9643980	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	158.49	CHEMBL1955	Homo sapiens	pKi		6.8
active	9643981	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
inactive	9643982	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643983	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
active	9643984	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643985	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	316.23	CHEMBL1955	Homo sapiens	pKi		6.5
active	9643986	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9643987	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	630.96	CHEMBL1955	Homo sapiens	pKi		6.2
active	9643988	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9643989	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
active	9643990	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	31.62	CHEMBL1955	Homo sapiens	pKi		7.5
active	9643991	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	63.1	CHEMBL1955	Homo sapiens	pKi		7.2
inactive	9643992	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643993	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	79.43	CHEMBL1955	Homo sapiens	pKi		7.1
active	9643994	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
inactive	9643995	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643996	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9643997	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9643998	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9643999	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644000	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644001	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9644002	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9644003	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644004	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9644005	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	1000.0	CHEMBL1955	Homo sapiens	pKi		6.0
inactive	9644006	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644007	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644008	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644009	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644010	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	39.81	CHEMBL1955	Homo sapiens	pKi		7.4
inactive	9644011	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9644012	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644013	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644014	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644015	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644016	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
active	9644017	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	=	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
inactive	9644018	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	5011.87	CHEMBL1955	Homo sapiens	pKi		5.3
inactive	9644019	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644020	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644021	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
active	9644022	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	79.43	CHEMBL1955	Homo sapiens	pKi		7.1
inactive	9644023	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644024	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
active	9644025	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
active	9644026	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9644027	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644028	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9644029	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644030	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	=	Ki	nM	3162.28	CHEMBL1955	Homo sapiens	pKi		5.5
inactive	9644031	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644032	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	1584.89	CHEMBL1955	Homo sapiens	pKi		5.8
inactive	9644033	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644034	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
active	9644035	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	5.012	CHEMBL1955	Homo sapiens	pKi		8.3
active	9644036	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	=	Ki	nM	31.62	CHEMBL1955	Homo sapiens	pKi		7.5
active	9644037	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	1995.26	CHEMBL1955	Homo sapiens	pKi		5.7
inactive	9644038	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644039	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644040	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644041	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644042	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	2511.89	CHEMBL1955	Homo sapiens	pKi		5.6
inactive	9644043	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644044	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)c(F)c3)c12		CHEMBL2000652	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
active	9644045	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	100.0	CHEMBL1955	Homo sapiens	pKi		7.0
inactive	9644046	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644047	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644048	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644049	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644050	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644051	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	1258.93	CHEMBL1955	Homo sapiens	pKi		5.9
active	9644052	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
active	9644053	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	39.81	CHEMBL1955	Homo sapiens	pKi		7.4
inactive	9644054	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644055	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	31.62	CHEMBL1955	Homo sapiens	pKi		7.5
inactive	9644056	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644057	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9644058	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9644059	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	794.33	CHEMBL1955	Homo sapiens	pKi		6.1
active	9644060	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL374044	=	Ki	nM	0.3981	CHEMBL1955	Homo sapiens	pKi		9.4
active	9648070	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cncc21		CHEMBL404366	=	Ki	nM	0.1995	CHEMBL1955	Homo sapiens	pKi		9.7
active	9648071	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	3.162	CHEMBL1955	Homo sapiens	pKi		8.5
inactive	9648072	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9648073	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9648074	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	15.85	CHEMBL1955	Homo sapiens	pKi		7.8
active	9648075	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	=	Ki	nM	398.11	CHEMBL1955	Homo sapiens	pKi		6.4
inactive	9648076	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9648077	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
inactive	9648078	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
inactive	9648079	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	6309.57	CHEMBL1955	Homo sapiens	pKi		5.2
active	9648080	CHEMBL1963812	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT4	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	3981.07	CHEMBL1955	Homo sapiens	pKi		5.4
	10838591	CHEMBL2014431	Inhibition of FLT4 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	9.0	CHEMBL1955	Homo sapiens	INH	%	9.0
	10921372	CHEMBL2046176	Inhibition of FLT4 at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	100.0	CHEMBL1955	Homo sapiens	INH	%	100.0
	10921373	CHEMBL2046177	Inhibition of FLT4 at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	72.0	CHEMBL1955	Homo sapiens	INH	%	72.0
	10936269	CHEMBL2050062	Inhibition of human FLT4	B	Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4cc(OCCCN5CCOCC5)ccc34)s2)cc1		CHEMBL2046883	=	IC50	nM	3700.0	CHEMBL1955	Homo sapiens	IC50	uM	3.7
	10962877	CHEMBL2060391	Inhibition of FLT4 assessed as remaining enzyme activity at 0.4 uM	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	Activity	%	0.0	CHEMBL1955	Homo sapiens	Activity	%	0.0
	10981538	CHEMBL2067608	Inhibition of human Flt4 at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL1955	Homo sapiens	INH	%	90.0
	10981553	CHEMBL2067593	Inhibition of human Flt4	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	48.0	CHEMBL1955	Homo sapiens	IC50	nM	48.0
	11020074	CHEMBL2089886	Inhibition of Flt4	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	3.2	CHEMBL1955	Homo sapiens	IC50	nM	3.2
	12046311	CHEMBL2156641	Inhibition of Flt4 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-1.2	CHEMBL1955	Homo sapiens	INH	%	-1.2
	12051575	CHEMBL2154715	Inhibition of FLT4	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	=	IC50	nM	64.0	CHEMBL1955	Homo sapiens	IC50	nM	64.0
	12051597	CHEMBL2154976	Inhibition of FLT4 at 10 uM	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	>	Inhibition	%	30.0	CHEMBL1955	Homo sapiens	INH	%	30.0
	12081328	CHEMBL2167674	Inhibition of VEGFR3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	16.0	CHEMBL1955	Homo sapiens	IC50	nM	16.0
	12138531	CHEMBL2186467	Inhibition of VEGFR3	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	IC50	nM	1.1	CHEMBL1955	Homo sapiens	IC50	nM	1.1
	12138541	CHEMBL2186467	Inhibition of VEGFR3	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	nM	6.0
	12138544	CHEMBL2186467	Inhibition of VEGFR3	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
	12138546	CHEMBL2186467	Inhibition of VEGFR3	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	195.0	CHEMBL1955	Homo sapiens	IC50	nM	195.0
	12138551	CHEMBL2186467	Inhibition of VEGFR3	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12.Cl		CHEMBL2180605	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	12138554	CHEMBL2186467	Inhibition of VEGFR3	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	5.2	CHEMBL1955	Homo sapiens	IC50	nM	5.2
	12138556	CHEMBL2186467	Inhibition of VEGFR3	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	IC50	nM	0.24	CHEMBL1955	Homo sapiens	IC50	nM	0.24
	12138561	CHEMBL2186467	Inhibition of VEGFR3	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	2.8	CHEMBL1955	Homo sapiens	IC50	nM	2.8
	12138564	CHEMBL2186467	Inhibition of VEGFR3	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
	12173599	CHEMBL2213538	Inhibition of FLT4 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	88.0	CHEMBL1955	Homo sapiens	Activity	%	88.0
	12193804	CHEMBL2212845	Inhibition of FLT4	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCCN1		CHEMBL2208034	=	IC50	nM	554.5	CHEMBL1955	Homo sapiens	IC50	nM	554.5
	12242591	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	96.0	CHEMBL1955	Homo sapiens	Residual Activity	%	96.0
	12242592	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12242593	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL1955	Homo sapiens	Residual Activity	%	97.0
	12245196	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	105.0	CHEMBL1955	Homo sapiens	Residual Activity	%	105.0
	12245197	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	87.0	CHEMBL1955	Homo sapiens	Residual Activity	%	87.0
	12245198	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	99.0	CHEMBL1955	Homo sapiens	Residual Activity	%	99.0
	12245199	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	11.0	CHEMBL1955	Homo sapiens	Residual Activity	%	11.0
	12245200	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	47.0	CHEMBL1955	Homo sapiens	Residual Activity	%	47.0
	12245201	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	24.0	CHEMBL1955	Homo sapiens	Residual Activity	%	24.0
	12245202	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	40.0	CHEMBL1955	Homo sapiens	Residual Activity	%	40.0
	12245203	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	98.0	CHEMBL1955	Homo sapiens	Residual Activity	%	98.0
	12245204	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	36.0	CHEMBL1955	Homo sapiens	Residual Activity	%	36.0
	12245205	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	85.0	CHEMBL1955	Homo sapiens	Residual Activity	%	85.0
	12245206	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	42.0	CHEMBL1955	Homo sapiens	Residual Activity	%	42.0
	12245207	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	85.0	CHEMBL1955	Homo sapiens	Residual Activity	%	85.0
	12245208	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245209	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	89.0	CHEMBL1955	Homo sapiens	Residual Activity	%	89.0
	12245210	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	85.0	CHEMBL1955	Homo sapiens	Residual Activity	%	85.0
	12245211	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	10.0	CHEMBL1955	Homo sapiens	Residual Activity	%	10.0
	12245212	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	28.0	CHEMBL1955	Homo sapiens	Residual Activity	%	28.0
	12245213	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	73.0	CHEMBL1955	Homo sapiens	Residual Activity	%	73.0
	12245214	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	84.0	CHEMBL1955	Homo sapiens	Residual Activity	%	84.0
	12245215	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	88.0	CHEMBL1955	Homo sapiens	Residual Activity	%	88.0
	12245216	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245217	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	92.0	CHEMBL1955	Homo sapiens	Residual Activity	%	92.0
	12245218	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	36.0	CHEMBL1955	Homo sapiens	Residual Activity	%	36.0
	12245219	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	4.0	CHEMBL1955	Homo sapiens	Residual Activity	%	4.0
	12245220	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	14.0	CHEMBL1955	Homo sapiens	Residual Activity	%	14.0
	12245221	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	31.0	CHEMBL1955	Homo sapiens	Residual Activity	%	31.0
	12245222	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	58.0	CHEMBL1955	Homo sapiens	Residual Activity	%	58.0
	12245223	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	37.0	CHEMBL1955	Homo sapiens	Residual Activity	%	37.0
	12245224	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	-1.0
	12245225	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	100.0	CHEMBL1955	Homo sapiens	Residual Activity	%	100.0
	12245226	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL1955	Homo sapiens	Residual Activity	%	94.0
	12245227	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	95.0	CHEMBL1955	Homo sapiens	Residual Activity	%	95.0
	12245228	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	90.0	CHEMBL1955	Homo sapiens	Residual Activity	%	90.0
	12245229	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	42.0	CHEMBL1955	Homo sapiens	Residual Activity	%	42.0
	12245230	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL1955	Homo sapiens	Residual Activity	%	99.0
	12245231	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	99.0	CHEMBL1955	Homo sapiens	Residual Activity	%	99.0
	12245232	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245233	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	96.0	CHEMBL1955	Homo sapiens	Residual Activity	%	96.0
	12245234	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	93.0	CHEMBL1955	Homo sapiens	Residual Activity	%	93.0
	12245235	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245236	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245237	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245238	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	91.0	CHEMBL1955	Homo sapiens	Residual Activity	%	91.0
	12245239	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	99.0	CHEMBL1955	Homo sapiens	Residual Activity	%	99.0
	12245240	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245241	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	98.0	CHEMBL1955	Homo sapiens	Residual Activity	%	98.0
	12245242	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	79.0	CHEMBL1955	Homo sapiens	Residual Activity	%	79.0
	12245243	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245244	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245245	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245246	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	78.0	CHEMBL1955	Homo sapiens	Residual Activity	%	78.0
	12245247	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	95.0	CHEMBL1955	Homo sapiens	Residual Activity	%	95.0
	12245248	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	21.0	CHEMBL1955	Homo sapiens	Residual Activity	%	21.0
	12245249	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	76.0	CHEMBL1955	Homo sapiens	Residual Activity	%	76.0
	12245250	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	89.0	CHEMBL1955	Homo sapiens	Residual Activity	%	89.0
	12245251	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12245252	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	85.0	CHEMBL1955	Homo sapiens	Residual Activity	%	85.0
	12245253	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12245254	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245255	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL1955	Homo sapiens	Residual Activity	%	94.0
	12245256	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	87.0	CHEMBL1955	Homo sapiens	Residual Activity	%	87.0
	12245257	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	90.0	CHEMBL1955	Homo sapiens	Residual Activity	%	90.0
	12245258	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12245259	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL1955	Homo sapiens	Residual Activity	%	92.0
	12245260	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	96.0	CHEMBL1955	Homo sapiens	Residual Activity	%	96.0
	12245261	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	98.0	CHEMBL1955	Homo sapiens	Residual Activity	%	98.0
	12245262	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	7.0	CHEMBL1955	Homo sapiens	Residual Activity	%	7.0
	12245263	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	58.0	CHEMBL1955	Homo sapiens	Residual Activity	%	58.0
	12245264	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	55.0	CHEMBL1955	Homo sapiens	Residual Activity	%	55.0
	12245265	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	7.0	CHEMBL1955	Homo sapiens	Residual Activity	%	7.0
	12245266	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	6.0	CHEMBL1955	Homo sapiens	Residual Activity	%	6.0
	12245267	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245268	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	45.0	CHEMBL1955	Homo sapiens	Residual Activity	%	45.0
	12245269	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	98.0	CHEMBL1955	Homo sapiens	Residual Activity	%	98.0
	12245270	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245271	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	71.0	CHEMBL1955	Homo sapiens	Residual Activity	%	71.0
	12245272	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245273	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL1955	Homo sapiens	Residual Activity	%	101.0
	12245274	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245275	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	4.0	CHEMBL1955	Homo sapiens	Residual Activity	%	4.0
	12245276	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	100.0	CHEMBL1955	Homo sapiens	Residual Activity	%	100.0
	12245277	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	33.0	CHEMBL1955	Homo sapiens	Residual Activity	%	33.0
	12245278	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	101.0	CHEMBL1955	Homo sapiens	Residual Activity	%	101.0
	12245279	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	97.0	CHEMBL1955	Homo sapiens	Residual Activity	%	97.0
	12245280	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	93.0	CHEMBL1955	Homo sapiens	Residual Activity	%	93.0
	12245281	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	97.0	CHEMBL1955	Homo sapiens	Residual Activity	%	97.0
	12245282	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	-1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	-1.0
	12245283	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL1955	Homo sapiens	Residual Activity	%	89.0
	12245284	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	76.0	CHEMBL1955	Homo sapiens	Residual Activity	%	76.0
	12245285	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245286	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL1955	Homo sapiens	Residual Activity	%	95.0
	12245287	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	93.0	CHEMBL1955	Homo sapiens	Residual Activity	%	93.0
	12245288	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	94.0	CHEMBL1955	Homo sapiens	Residual Activity	%	94.0
	12245289	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	93.0	CHEMBL1955	Homo sapiens	Residual Activity	%	93.0
	12245290	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL1955	Homo sapiens	Residual Activity	%	98.0
	12245291	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL1955	Homo sapiens	Residual Activity	%	95.0
	12245292	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	89.0	CHEMBL1955	Homo sapiens	Residual Activity	%	89.0
	12245293	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245294	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245295	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	95.0	CHEMBL1955	Homo sapiens	Residual Activity	%	95.0
	12245296	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245297	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	29.0	CHEMBL1955	Homo sapiens	Residual Activity	%	29.0
	12245298	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL1955	Homo sapiens	Residual Activity	%	87.0
	12245299	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	83.0	CHEMBL1955	Homo sapiens	Residual Activity	%	83.0
	12245300	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	76.0	CHEMBL1955	Homo sapiens	Residual Activity	%	76.0
	12245301	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	76.0	CHEMBL1955	Homo sapiens	Residual Activity	%	76.0
	12245302	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	56.0	CHEMBL1955	Homo sapiens	Residual Activity	%	56.0
	12245303	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	78.0	CHEMBL1955	Homo sapiens	Residual Activity	%	78.0
	12245304	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	-1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	-1.0
	12245305	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	10.0	CHEMBL1955	Homo sapiens	Residual Activity	%	10.0
	12245306	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	64.0	CHEMBL1955	Homo sapiens	Residual Activity	%	64.0
	12245307	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	69.0	CHEMBL1955	Homo sapiens	Residual Activity	%	69.0
	12245308	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	85.0	CHEMBL1955	Homo sapiens	Residual Activity	%	85.0
	12245309	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	4.0	CHEMBL1955	Homo sapiens	Residual Activity	%	4.0
	12245310	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	90.0	CHEMBL1955	Homo sapiens	Residual Activity	%	90.0
	12245311	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	69.0	CHEMBL1955	Homo sapiens	Residual Activity	%	69.0
	12245312	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	89.0	CHEMBL1955	Homo sapiens	Residual Activity	%	89.0
	12245313	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	6.0	CHEMBL1955	Homo sapiens	Residual Activity	%	6.0
	12245314	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	50.0	CHEMBL1955	Homo sapiens	Residual Activity	%	50.0
	12245315	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	42.0	CHEMBL1955	Homo sapiens	Residual Activity	%	42.0
	12245316	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	22.0	CHEMBL1955	Homo sapiens	Residual Activity	%	22.0
	12245317	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	-1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	-1.0
	12245318	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	96.0	CHEMBL1955	Homo sapiens	Residual Activity	%	96.0
	12245319	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	42.0	CHEMBL1955	Homo sapiens	Residual Activity	%	42.0
	12245320	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	45.0	CHEMBL1955	Homo sapiens	Residual Activity	%	45.0
	12245321	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	6.0	CHEMBL1955	Homo sapiens	Residual Activity	%	6.0
	12245322	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245323	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	62.0	CHEMBL1955	Homo sapiens	Residual Activity	%	62.0
	12245324	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	59.0	CHEMBL1955	Homo sapiens	Residual Activity	%	59.0
	12245325	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245326	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL1955	Homo sapiens	Residual Activity	%	91.0
	12245327	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	-1.0
	12245328	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	11.0	CHEMBL1955	Homo sapiens	Residual Activity	%	11.0
	12245329	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	79.0	CHEMBL1955	Homo sapiens	Residual Activity	%	79.0
	12245330	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245331	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245332	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	57.0	CHEMBL1955	Homo sapiens	Residual Activity	%	57.0
	12245333	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	65.0	CHEMBL1955	Homo sapiens	Residual Activity	%	65.0
	12245334	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	81.0	CHEMBL1955	Homo sapiens	Residual Activity	%	81.0
	12245335	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	74.0	CHEMBL1955	Homo sapiens	Residual Activity	%	74.0
	12245336	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245337	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	79.0	CHEMBL1955	Homo sapiens	Residual Activity	%	79.0
	12245338	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	84.0	CHEMBL1955	Homo sapiens	Residual Activity	%	84.0
	12245339	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245340	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	68.0	CHEMBL1955	Homo sapiens	Residual Activity	%	68.0
	12245341	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	80.0	CHEMBL1955	Homo sapiens	Residual Activity	%	80.0
	12245342	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	100.0	CHEMBL1955	Homo sapiens	Residual Activity	%	100.0
	12245343	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	16.0	CHEMBL1955	Homo sapiens	Residual Activity	%	16.0
	12245344	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	79.0	CHEMBL1955	Homo sapiens	Residual Activity	%	79.0
	12245345	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	58.0	CHEMBL1955	Homo sapiens	Residual Activity	%	58.0
	12245346	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	28.0	CHEMBL1955	Homo sapiens	Residual Activity	%	28.0
	12245347	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL1955	Homo sapiens	Residual Activity	%	92.0
	12245348	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	15.0	CHEMBL1955	Homo sapiens	Residual Activity	%	15.0
	12245349	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	90.0	CHEMBL1955	Homo sapiens	Residual Activity	%	90.0
	12245350	CHEMBL2219080	Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	8.0	CHEMBL1955	Homo sapiens	Residual Activity	%	8.0
	12245351	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	83.0	CHEMBL1955	Homo sapiens	Residual Activity	%	83.0
	12245352	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245353	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	61.0	CHEMBL1955	Homo sapiens	Residual Activity	%	61.0
	12245354	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL1955	Homo sapiens	Residual Activity	%	93.0
	12245355	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	38.0	CHEMBL1955	Homo sapiens	Residual Activity	%	38.0
	12245356	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	82.0	CHEMBL1955	Homo sapiens	Residual Activity	%	82.0
	12245357	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12245358	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	6.0	CHEMBL1955	Homo sapiens	Residual Activity	%	6.0
	12245359	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245360	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	8.0	CHEMBL1955	Homo sapiens	Residual Activity	%	8.0
	12245361	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	93.0	CHEMBL1955	Homo sapiens	Residual Activity	%	93.0
	12245362	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	40.0	CHEMBL1955	Homo sapiens	Residual Activity	%	40.0
	12245363	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	65.0	CHEMBL1955	Homo sapiens	Residual Activity	%	65.0
	12245364	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	5.0	CHEMBL1955	Homo sapiens	Residual Activity	%	5.0
	12245365	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	48.0	CHEMBL1955	Homo sapiens	Residual Activity	%	48.0
	12245366	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12245367	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	52.0	CHEMBL1955	Homo sapiens	Residual Activity	%	52.0
	12245368	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	62.0	CHEMBL1955	Homo sapiens	Residual Activity	%	62.0
	12245369	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	12.0	CHEMBL1955	Homo sapiens	Residual Activity	%	12.0
	12245370	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	16.0	CHEMBL1955	Homo sapiens	Residual Activity	%	16.0
	12245371	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	68.0	CHEMBL1955	Homo sapiens	Residual Activity	%	68.0
	12245372	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	65.0	CHEMBL1955	Homo sapiens	Residual Activity	%	65.0
	12245373	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	95.0	CHEMBL1955	Homo sapiens	Residual Activity	%	95.0
	12245374	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245375	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	91.0	CHEMBL1955	Homo sapiens	Residual Activity	%	91.0
	12245376	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	4.0	CHEMBL1955	Homo sapiens	Residual Activity	%	4.0
	12245377	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245378	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245379	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	7.0	CHEMBL1955	Homo sapiens	Residual Activity	%	7.0
	12245380	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	9.0	CHEMBL1955	Homo sapiens	Residual Activity	%	9.0
	12245381	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	10.0	CHEMBL1955	Homo sapiens	Residual Activity	%	10.0
	12245382	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	-1.0
	12245383	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	59.0	CHEMBL1955	Homo sapiens	Residual Activity	%	59.0
	12245384	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	92.0	CHEMBL1955	Homo sapiens	Residual Activity	%	92.0
	12245385	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	115.0	CHEMBL1955	Homo sapiens	Residual Activity	%	115.0
	12245386	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	83.0	CHEMBL1955	Homo sapiens	Residual Activity	%	83.0
	12245387	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	8.0	CHEMBL1955	Homo sapiens	Residual Activity	%	8.0
	12245388	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	106.0	CHEMBL1955	Homo sapiens	Residual Activity	%	106.0
	12245389	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	90.0	CHEMBL1955	Homo sapiens	Residual Activity	%	90.0
	12245390	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245391	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	102.0	CHEMBL1955	Homo sapiens	Residual Activity	%	102.0
	12245392	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	88.0	CHEMBL1955	Homo sapiens	Residual Activity	%	88.0
	12245393	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12245394	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245395	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245396	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	60.0	CHEMBL1955	Homo sapiens	Residual Activity	%	60.0
	12245397	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	100.0	CHEMBL1955	Homo sapiens	Residual Activity	%	100.0
	12245398	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245399	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	70.0	CHEMBL1955	Homo sapiens	Residual Activity	%	70.0
	12245400	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL1955	Homo sapiens	Residual Activity	%	102.0
	12245401	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245402	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245403	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245404	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	51.0	CHEMBL1955	Homo sapiens	Residual Activity	%	51.0
	12245405	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	90.0	CHEMBL1955	Homo sapiens	Residual Activity	%	90.0
	12245406	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	7.0	CHEMBL1955	Homo sapiens	Residual Activity	%	7.0
	12245407	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	14.0	CHEMBL1955	Homo sapiens	Residual Activity	%	14.0
	12245408	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	92.0	CHEMBL1955	Homo sapiens	Residual Activity	%	92.0
	12245409	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245410	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	72.0	CHEMBL1955	Homo sapiens	Residual Activity	%	72.0
	12245411	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245412	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12245413	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	95.0	CHEMBL1955	Homo sapiens	Residual Activity	%	95.0
	12245414	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	85.0	CHEMBL1955	Homo sapiens	Residual Activity	%	85.0
	12245415	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	81.0	CHEMBL1955	Homo sapiens	Residual Activity	%	81.0
	12245416	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245417	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	89.0	CHEMBL1955	Homo sapiens	Residual Activity	%	89.0
	12245418	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	90.0	CHEMBL1955	Homo sapiens	Residual Activity	%	90.0
	12245419	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	70.0	CHEMBL1955	Homo sapiens	Residual Activity	%	70.0
	12245420	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245421	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	26.0	CHEMBL1955	Homo sapiens	Residual Activity	%	26.0
	12245422	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	6.0	CHEMBL1955	Homo sapiens	Residual Activity	%	6.0
	12245423	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245424	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12245425	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245426	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	6.0	CHEMBL1955	Homo sapiens	Residual Activity	%	6.0
	12245427	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	83.0	CHEMBL1955	Homo sapiens	Residual Activity	%	83.0
	12245428	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12245429	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	17.0	CHEMBL1955	Homo sapiens	Residual Activity	%	17.0
	12245430	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12245431	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	94.0	CHEMBL1955	Homo sapiens	Residual Activity	%	94.0
	12248022	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248023	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12248024	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	104.0	CHEMBL1955	Homo sapiens	Residual Activity	%	104.0
	12248025	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	46.0	CHEMBL1955	Homo sapiens	Residual Activity	%	46.0
	12248026	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	83.0	CHEMBL1955	Homo sapiens	Residual Activity	%	83.0
	12248027	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	64.0	CHEMBL1955	Homo sapiens	Residual Activity	%	64.0
	12248028	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	42.0	CHEMBL1955	Homo sapiens	Residual Activity	%	42.0
	12248029	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	69.0	CHEMBL1955	Homo sapiens	Residual Activity	%	69.0
	12248030	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12248031	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	60.0	CHEMBL1955	Homo sapiens	Residual Activity	%	60.0
	12248032	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	23.0	CHEMBL1955	Homo sapiens	Residual Activity	%	23.0
	12248033	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12248034	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	64.0	CHEMBL1955	Homo sapiens	Residual Activity	%	64.0
	12248035	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	20.0	CHEMBL1955	Homo sapiens	Residual Activity	%	20.0
	12248036	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	52.0	CHEMBL1955	Homo sapiens	Residual Activity	%	52.0
	12248037	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	76.0	CHEMBL1955	Homo sapiens	Residual Activity	%	76.0
	12248038	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	89.0	CHEMBL1955	Homo sapiens	Residual Activity	%	89.0
	12248039	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	84.0	CHEMBL1955	Homo sapiens	Residual Activity	%	84.0
	12248040	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	60.0	CHEMBL1955	Homo sapiens	Residual Activity	%	60.0
	12248041	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12248042	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12248043	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	80.0	CHEMBL1955	Homo sapiens	Residual Activity	%	80.0
	12248044	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12248045	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	32.0	CHEMBL1955	Homo sapiens	Residual Activity	%	32.0
	12248046	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	68.0	CHEMBL1955	Homo sapiens	Residual Activity	%	68.0
	12248047	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	65.0	CHEMBL1955	Homo sapiens	Residual Activity	%	65.0
	12248048	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	25.0	CHEMBL1955	Homo sapiens	Residual Activity	%	25.0
	12248049	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	74.0	CHEMBL1955	Homo sapiens	Residual Activity	%	74.0
	12248050	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	22.0	CHEMBL1955	Homo sapiens	Residual Activity	%	22.0
	12248051	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	71.0	CHEMBL1955	Homo sapiens	Residual Activity	%	71.0
	12248052	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248053	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12248054	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	8.0	CHEMBL1955	Homo sapiens	Residual Activity	%	8.0
	12248055	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	22.0	CHEMBL1955	Homo sapiens	Residual Activity	%	22.0
	12248056	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	79.0	CHEMBL1955	Homo sapiens	Residual Activity	%	79.0
	12248057	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248058	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	93.0	CHEMBL1955	Homo sapiens	Residual Activity	%	93.0
	12248059	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	10.0	CHEMBL1955	Homo sapiens	Residual Activity	%	10.0
	12248060	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	43.0	CHEMBL1955	Homo sapiens	Residual Activity	%	43.0
	12248061	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12248062	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12248063	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	5.0	CHEMBL1955	Homo sapiens	Residual Activity	%	5.0
	12248064	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	15.0	CHEMBL1955	Homo sapiens	Residual Activity	%	15.0
	12248065	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248066	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	72.0	CHEMBL1955	Homo sapiens	Residual Activity	%	72.0
	12248067	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12248068	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	21.0	CHEMBL1955	Homo sapiens	Residual Activity	%	21.0
	12248069	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12248070	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	-1.0
	12248071	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	30.0	CHEMBL1955	Homo sapiens	Residual Activity	%	30.0
	12248072	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	17.0	CHEMBL1955	Homo sapiens	Residual Activity	%	17.0
	12248073	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248074	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	80.0	CHEMBL1955	Homo sapiens	Residual Activity	%	80.0
	12248075	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248076	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	3.0	CHEMBL1955	Homo sapiens	Residual Activity	%	3.0
	12248077	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	44.0	CHEMBL1955	Homo sapiens	Residual Activity	%	44.0
	12248078	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248079	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12248080	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	16.0	CHEMBL1955	Homo sapiens	Residual Activity	%	16.0
	12248081	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	64.0	CHEMBL1955	Homo sapiens	Residual Activity	%	64.0
	12248082	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	26.0	CHEMBL1955	Homo sapiens	Residual Activity	%	26.0
	12248083	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	43.0	CHEMBL1955	Homo sapiens	Residual Activity	%	43.0
	12248084	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	0.0	CHEMBL1955	Homo sapiens	Residual Activity	%	0.0
	12248085	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	46.0	CHEMBL1955	Homo sapiens	Residual Activity	%	46.0
	12248086	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	56.0	CHEMBL1955	Homo sapiens	Residual Activity	%	56.0
	12248087	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12248088	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	22.0	CHEMBL1955	Homo sapiens	Residual Activity	%	22.0
	12248089	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	41.0	CHEMBL1955	Homo sapiens	Residual Activity	%	41.0
	12248090	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	77.0	CHEMBL1955	Homo sapiens	Residual Activity	%	77.0
	12248091	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	1.0	CHEMBL1955	Homo sapiens	Residual Activity	%	1.0
	12248092	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	27.0	CHEMBL1955	Homo sapiens	Residual Activity	%	27.0
	12248093	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	42.0	CHEMBL1955	Homo sapiens	Residual Activity	%	42.0
	12248094	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	30.0	CHEMBL1955	Homo sapiens	Residual Activity	%	30.0
	12248095	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	86.0	CHEMBL1955	Homo sapiens	Residual Activity	%	86.0
	12248096	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	6.0	CHEMBL1955	Homo sapiens	Residual Activity	%	6.0
	12248097	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	29.0	CHEMBL1955	Homo sapiens	Residual Activity	%	29.0
	12248098	CHEMBL2219081	Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	2.0	CHEMBL1955	Homo sapiens	Residual Activity	%	2.0
	12626735	CHEMBL2317006	Inhibition of VEGFR3 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL1955	Homo sapiens	INH	%	95.0
	12650028	CHEMBL2327555	Inhibition of FLT4 (unknown origin) relative to control	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	=	Inhibition	%	60.0	CHEMBL1955	Homo sapiens	INH	%	60.0
	12674108	CHEMBL2345553	Inhibition of VEGFR3 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	1600.0	CHEMBL1955	Homo sapiens	IC50	uM	1.6
	12674109	CHEMBL2345553	Inhibition of VEGFR3 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	2800.0	CHEMBL1955	Homo sapiens	IC50	uM	2.8
	12674110	CHEMBL2345553	Inhibition of VEGFR3 (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	3200.0	CHEMBL1955	Homo sapiens	IC50	uM	3.2
	12697475	CHEMBL2343629	Inhibition of Flt4 (unknown origin) after 20 mins by scintillation counting	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	500.0	CHEMBL1955	Homo sapiens	IC50	uM	0.5
	12697487	CHEMBL2343629	Inhibition of Flt4 (unknown origin) after 20 mins by scintillation counting	B	NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O		CHEMBL2332119	=	IC50	nM	1.8	CHEMBL1955	Homo sapiens	IC50	uM	0.0018
	12728825	CHEMBL2352898	Inhibition of FLT4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	69.0	CHEMBL1955	Homo sapiens	Activity	%	69.0
	12729070	CHEMBL2352248	Inhibition of FLT4 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL1955	Homo sapiens	Activity	%	94.0
	12729954	CHEMBL2352190	Inhibition of FLT4 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	80.0	CHEMBL1955	Homo sapiens	Activity	%	80.0
	12730213	CHEMBL2352898	Inhibition of FLT4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	78.0	CHEMBL1955	Homo sapiens	Activity	%	78.0
	12730628	CHEMBL2353586	Inhibition of VEGFR3 (unknown origin) by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	IC50	nM	1.1	CHEMBL1955	Homo sapiens	IC50	nM	1.1
	13301294	CHEMBL2382830	Inhibition of Flt4 (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1C(F)(F)F		CHEMBL2380834	=	IC50	nM	867.0	CHEMBL1955	Homo sapiens	IC50	nM	867.0
	13301295	CHEMBL2382830	Inhibition of Flt4 (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	417.0	CHEMBL1955	Homo sapiens	IC50	nM	417.0
	13301915	CHEMBL2383375	Inhibition of human FLT4 at 1 uM relative to control	B	Cn1cc(-c2cc3[nH]nc(-c4cccc(S(N)(=O)=O)c4)c3cc2NC2CCCCC2)cn1		CHEMBL2380586	>	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	13327620	CHEMBL2389803	Inhibition of FLT4 (unknown origin) at 1 uM by kinase Glo assay	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	86.0	CHEMBL1955	Homo sapiens	INH	%	86.0
	13327621	CHEMBL2389803	Inhibition of FLT4 (unknown origin) at 1 uM by kinase Glo assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	102.0	CHEMBL1955	Homo sapiens	INH	%	102.0
	13327677	CHEMBL2389833	Inhibition of FLT4 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	93.0	CHEMBL1955	Homo sapiens	INH	%	93.0
Not Active	13335986	CHEMBL2394043	Inhibition of FLT4 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	13335987	CHEMBL2394043	Inhibition of FLT4 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	13336047	CHEMBL2394067	Inhibition of FLT4 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	13336048	CHEMBL2394067	Inhibition of FLT4 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Not Active	13336049	CHEMBL2394067	Inhibition of FLT4 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	13375857	CHEMBL2405119	Inhibition of FLT4 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
Active	13376813	CHEMBL2404398	Inhibition of FLT4 (unknown origin) at 0.5 uM	B	COc1cc(Nc2ncc(Br)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)[C@@H](C)C1		CHEMBL2403079		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	13418833	CHEMBL2422664	Inhibition of FLT4 (unknown origin)	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	12.59	CHEMBL1955	Homo sapiens	pIC50		7.9
	13418834	CHEMBL2422664	Inhibition of FLT4 (unknown origin)	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	2.512	CHEMBL1955	Homo sapiens	pIC50		8.6
	13442354	CHEMBL2427786	Competitive binding affinity to FLT4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	13445489	CHEMBL2427786	Competitive binding affinity to FLT4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	87.0	CHEMBL1955	Homo sapiens	INH	%	87.0
	13448544	CHEMBL2427786	Competitive binding affinity to FLT4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	13448680	CHEMBL2427786	Competitive binding affinity to FLT4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	13451475	CHEMBL2427786	Competitive binding affinity to FLT4 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	13454660	CHEMBL2427786	Competitive binding affinity to FLT4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	13461862	CHEMBL2434169	Inhibition of VEGFR3 (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2180602	=	IC50	nM	1.3	CHEMBL1955	Homo sapiens	IC50	nM	1.3
	13506593	CHEMBL2443722	Inhibition of VEGFR3 (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	13506594	CHEMBL2443722	Inhibition of VEGFR3 (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	13506595	CHEMBL2443722	Inhibition of VEGFR3 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	13506596	CHEMBL2443722	Inhibition of VEGFR3 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	13872140	CHEMBL3101765	Inhibition of human Flt4 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	68.0	CHEMBL1955	Homo sapiens	Activity	%	68.0
	13872213	CHEMBL3102400	Inhibition of VEGF-R3 (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	73.0	CHEMBL1955	Homo sapiens	Activity	%	73.0
	13872243	CHEMBL3102549	Inhibition of VEGF-R3 (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	82.0	CHEMBL1955	Homo sapiens	Activity	%	82.0
	13918700	CHEMBL3118219	Inhibition of human Flt4	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	40.0	CHEMBL1955	Homo sapiens	IC50	uM	0.04
	14553624	CHEMBL3225764	Inhibition of VEGFR3 (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	101.2	CHEMBL1955	Homo sapiens	Activity	%	101.2
	14582506	CHEMBL3242358	Inhibition of human Flt4 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	79.5	CHEMBL1955	Homo sapiens	Activity	%	79.5
	14659732	CHEMBL3270789	Inhibition of VEGFR3 (unknown origin) assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	98.0	CHEMBL1955	Homo sapiens	Activity	%	98.0
	14659733	CHEMBL3270790	Inhibition of VEGFR3 (unknown origin) assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	75.0	CHEMBL1955	Homo sapiens	Activity	%	75.0
	14659734	CHEMBL3270791	Inhibition of VEGFR3 (unknown origin) assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	28.0	CHEMBL1955	Homo sapiens	Activity	%	28.0
	14659735	CHEMBL3270792	Inhibition of VEGFR3 (unknown origin) assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	3.0	CHEMBL1955	Homo sapiens	Activity	%	3.0
	14672865	CHEMBL3266377	Inhibition of FLT4 (unknown origin) at 1 uM by Z'-LYTE assay relative to control	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccc2ccccc2n1		CHEMBL3265344	=	Inhibition	%	4.0	CHEMBL1955	Homo sapiens	INH	%	4.0
	14713692	CHEMBL3296756	Binding affinity to VEGFR3 (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Ki	nM	17.0	CHEMBL1955	Homo sapiens	Ki	uM	0.017
	14713747	CHEMBL3296776	Inhibition of VEGFR3 (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	99.0	CHEMBL1955	Homo sapiens	INH	%	99.0
	14713751	CHEMBL3296756	Binding affinity to VEGFR3 (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	<	Ki	nM	0.3	CHEMBL1955	Homo sapiens	Ki	uM	0.0003
	14751831	CHEMBL3300849	Inhibition of VGFR3 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	14751832	CHEMBL3300849	Inhibition of VGFR3 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	14979244	CHEMBL3379613	Inhibition of Flt4 (unknown origin) at 1 uM	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	Inhibition	%	98.0	CHEMBL1955	Homo sapiens	INH	%	98.0
	14979245	CHEMBL3379614	Inhibition of Flt4 (unknown origin)	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	IC50	nM	30.0	CHEMBL1955	Homo sapiens	IC50	nM	30.0
	14992860	CHEMBL3372229	Inhibition of recombinant FLT4 (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	5190.0	CHEMBL1955	Homo sapiens	IC50	uM	5.19
	15018599	CHEMBL3362263	Inhibition of FLT4 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	0.3	CHEMBL1955	Homo sapiens	INH	%	0.3
	15036973	CHEMBL3375008	Inhibition of VGFR3 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	15036974	CHEMBL3375008	Inhibition of VGFR3 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	15036975	CHEMBL3375008	Inhibition of VGFR3 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	15036976	CHEMBL3375008	Inhibition of VGFR3 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	15036977	CHEMBL3375008	Inhibition of VGFR3 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	15055296	CHEMBL3376850	Inhibition of human recombinant VEGFR3 using poly(Glu,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	=	IC50	nM	5000.0	CHEMBL1955	Homo sapiens	IC50	uM	5.0
	15058846	CHEMBL3371400	Inhibition of VEGFR3 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	41.0	CHEMBL1955	Homo sapiens	Activity	%	41.0
	15116721	CHEMBL3382756	Inhibition of human FLT4 (unknown origin)	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	274.0	CHEMBL1955	Homo sapiens	IC50	nM	274.0
	15193437	CHEMBL3411883	Inhibition of human VEGFR3	B	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3039504	=	IC50	nM	13.0	CHEMBL1955	Homo sapiens	IC50	nM	13.0
	15249765	CHEMBL3429405	Inhibition of recombinant VEGFR3 (unknown origin) by cell-free assay	B	[2H]C([2H])([2H])Oc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC([2H])([2H])[2H]		CHEMBL3426917	=	IC50	nM	4.55	CHEMBL1955	Homo sapiens	IC50	nM	4.55
	15249766	CHEMBL3429405	Inhibition of recombinant VEGFR3 (unknown origin) by cell-free assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	IC50	nM	3.11	CHEMBL1955	Homo sapiens	IC50	nM	3.11
	15632706	CHEMBL3587470	Inhibition of Flt4 (unknown origin)	B	CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1		CHEMBL3586404	=	IC50	nM	651.0	CHEMBL1955	Homo sapiens	IC50	uM	0.651
	15650132	CHEMBL3595398	Inhibition of human FLT4 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	80.0	CHEMBL1955	Homo sapiens	INH	%	80.0
Not Active	15723462	CHEMBL3620315	Inhibition of FLT4 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	15736633	CHEMBL3625818	Inhibition of human recombinant Flt4	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	=	IC50	nM	1188.0	CHEMBL1955	Homo sapiens	IC50	uM	1.188
	15756980	CHEMBL3630503	Inhibition of FLT4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	98.91	CHEMBL1955	Homo sapiens	INH	%	98.91
	15757743	CHEMBL3630503	Inhibition of FLT4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.51	CHEMBL1955	Homo sapiens	INH	%	99.51
	15758722	CHEMBL3630503	Inhibition of FLT4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	13.69	CHEMBL1955	Homo sapiens	INH	%	13.69
Not Determined	15760031	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Nc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL3628796		IC50			CHEMBL1955	Homo sapiens	IC50		
	15760032	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628797	=	IC50	nM	47.0	CHEMBL1955	Homo sapiens	IC50	nM	47.0
	15760033	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628798	=	IC50	nM	1980.0	CHEMBL1955	Homo sapiens	IC50	nM	1980.0
	15760034	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628799	=	IC50	nM	420.0	CHEMBL1955	Homo sapiens	IC50	nM	420.0
	15760035	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL2018882	=	IC50	nM	9.0	CHEMBL1955	Homo sapiens	IC50	nM	9.0
	15760036	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628807	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
	15760037	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628808	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	nM	6.0
	15760038	CHEMBL3631061	Inhibition of VEGFR3 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628811	=	IC50	nM	1020.0	CHEMBL1955	Homo sapiens	IC50	nM	1020.0
254315	16297265	CHEMBL3707562	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	B	Cc1nc(Nc2nc3ccc(-c4cccc(C(=O)Nc5cccc(C(F)(F)F)c5)c4)nc3s2)cc(N2CCNCC2)n1		CHEMBL2148120	=	Kd	nM	31.0	CHEMBL1955	Homo sapiens	Kd	nM	31.0
	16413452	CHEMBL3743692	Inhibition of FLT4 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	16425309	CHEMBL3751075	Inhibition of Flt4 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	2.7	CHEMBL1955	Homo sapiens	INH	%	2.7
	16431839	CHEMBL3748193	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	uM	10.0
	16446721	CHEMBL3756082	Inhibition of recombinant human FLT4 assessed as residual activity at 1 uM by radiometric assay in presence of [gamma-33P]-ATP relative to control	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Activity	%	7.61	CHEMBL1955	Homo sapiens	Activity	%	7.61
	16446730	CHEMBL3756063	Inhibition of recombinant human FLT4 by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	72.0	CHEMBL1955	Homo sapiens	IC50	nM	72.0
	16450852	CHEMBL3762708	Inhibition of FLT4 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	95.8	CHEMBL1955	Homo sapiens	INH	%	95.8
	16457744	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	2.0	CHEMBL1955	Homo sapiens	INH	%	2.0
	16457745	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	13.0	CHEMBL1955	Homo sapiens	INH	%	13.0
	16457746	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	4.0	CHEMBL1955	Homo sapiens	INH	%	4.0
	16457747	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	13.0	CHEMBL1955	Homo sapiens	INH	%	13.0
	16457748	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	3.0	CHEMBL1955	Homo sapiens	INH	%	3.0
	16457749	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	3.0	CHEMBL1955	Homo sapiens	INH	%	3.0
	16457750	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	1.0	CHEMBL1955	Homo sapiens	INH	%	1.0
	16457751	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	9.0	CHEMBL1955	Homo sapiens	INH	%	9.0
	16457752	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	7.0	CHEMBL1955	Homo sapiens	INH	%	7.0
	16457753	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	8.0	CHEMBL1955	Homo sapiens	INH	%	8.0
	16457754	CHEMBL3761574	Inhibition of FLT4 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	44.0	CHEMBL1955	Homo sapiens	INH	%	44.0
	16465587	CHEMBL3766495	Inhibition of Flt-4 (unknown origin) using poly(Glu, Tyr) 4:1 as substrate preincubated for 60 mins followed by substrate addition measured after 1 hr by AlphaScreen assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	2.8	CHEMBL1955	Homo sapiens	IC50	nM	2.8
	16466199	CHEMBL3767458	Inhibition of VEGFR-3 (unknown origin) by tumor cell growth inhibition assay	B	Cn1ccnc1-c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2s1		CHEMBL3764474	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
	16466203	CHEMBL3767600	Inhibition of VEGFR-3 (unknown origin) by AlphaScreen assay	B	CC1=[N+](c2ccccc2)C(=O)C(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c(F)c2)C=C1.Cl		CHEMBL3765306	=	IC50	nM	5.5	CHEMBL1955	Homo sapiens	IC50	nM	5.5
	16496001	CHEMBL3779696	Inhibition of N-terminal His6-tagged recombinant human FLT4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-21.0	CHEMBL1955	Homo sapiens	Activity	%	-21.0
	16508188	CHEMBL3779696	Inhibition of N-terminal His6-tagged recombinant human FLT4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-41.0	CHEMBL1955	Homo sapiens	Activity	%	-41.0
	16509165	CHEMBL3779696	Inhibition of N-terminal His6-tagged recombinant human FLT4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-46.0	CHEMBL1955	Homo sapiens	Activity	%	-46.0
	16577534	CHEMBL3801864	Inhibition of human recombinant FLT4 using Ulight-CAGAGAIETDKEYYTVKD as substrate after 90 mins by LANCE assay in presence of ATP	B	CN1CCN(c2ccc(-c3cnc4ccccc4c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1		CHEMBL3799275	=	IC50	nM	600.0	CHEMBL1955	Homo sapiens	IC50	uM	0.6
	16587012	CHEMBL3807424	Inhibition of VEGFR3 (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	uM	1.0
	16593535	CHEMBL3811538	Inhibition of GST-tagged human recombinant VEGFR3 (800 to 1297 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL1955	Homo sapiens	INH	%	40.0
	16614482	CHEMBL3816680	Inhibition of human FLT4 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-23.0	CHEMBL1955	Homo sapiens	INH	%	-23.0
	16618211	CHEMBL3816343	Inhibition of recombinant human GST-tagged cytoplasmic FLT4 receptor (800 to 1297 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	16621497	CHEMBL3820490	Inhibition of FLT4 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL1955	Homo sapiens	IC50	nM	30000.0
	16622212	CHEMBL3820490	Inhibition of FLT4 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.9	CHEMBL1955	Homo sapiens	IC50	nM	0.9
	16650927	CHEMBL3830322	Inhibition of N-terminal GST-tagged recombinant human Flt4 (800 to end residues) expressed in baculovirus infected in Sf21 cells at 1 uM	B	COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1		CHEMBL3828553	=	Inhibition	%	54.0	CHEMBL1955	Homo sapiens	INH	%	54.0
	16650928	CHEMBL3830322	Inhibition of N-terminal GST-tagged recombinant human Flt4 (800 to end residues) expressed in baculovirus infected in Sf21 cells at 1 uM	B	COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1		CHEMBL3827758	=	Inhibition	%	62.0	CHEMBL1955	Homo sapiens	INH	%	62.0
	16737941	CHEMBL3856658	Inhibition of recombinant human FLT4 expressed in insect cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	24.0	CHEMBL1955	Homo sapiens	Activity	%	24.0
	16739445	CHEMBL3857051	Inhibition of GST tagged recombinant human FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	44.0	CHEMBL1955	Homo sapiens	INH	%	44.0
	16739446	CHEMBL3857051	Inhibition of GST tagged recombinant human FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	4.0	CHEMBL1955	Homo sapiens	INH	%	4.0
	16739447	CHEMBL3857051	Inhibition of GST tagged recombinant human FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	4.0	CHEMBL1955	Homo sapiens	INH	%	4.0
	16742589	CHEMBL3857921	Inhibition of FLT4 (unknown origin) preincubated for 60 mins followed by biotinylated-poly (Glu, Tyr) 4:1 substrate addition measured after 1 hr by AlphaScreen assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	2.8	CHEMBL1955	Homo sapiens	IC50	nM	2.8
	16804168	CHEMBL3869759	Inhibition of human recombinant GST-tagged VEGFR3 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	75.0	CHEMBL1955	Homo sapiens	INH	%	75.0
	16815391	CHEMBL3871603	Inhibition of VEGFR3 (unknown origin)	B	CNC(=O)c1ccccc1Sc1ccc2c(CCc3ccccn3)n[nH]c2c1		CHEMBL3939307	=	IC50	nM	0.1	CHEMBL1955	Homo sapiens	IC50	nM	0.1
	16815457	CHEMBL3871618	Inhibition of human recombinant GST-tagged FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	64.0	CHEMBL1955	Homo sapiens	INH	%	64.0
	16896851	CHEMBL3882372	Inhibition of human FLT4 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	Cc1ccc(N/C=C2\C(=O)CCc3c2oc2c(Cl)c(Cl)c(O)cc32)cc1		CHEMBL3920024	=	Activity	%	19.68	CHEMBL1955	Homo sapiens	Activity	%	19.68
214826	17603964	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(C)(C)O)nc21		CHEMBL3644860	=	IC50	nM	23.0	CHEMBL1955	Homo sapiens	IC50	nM	23.0
214827	17603965	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC3(O)CCCC3)nc21		CHEMBL3644861	=	IC50	nM	46.0	CHEMBL1955	Homo sapiens	IC50	nM	46.0
214828	17603966	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(O)C3CC3)nc21		CHEMBL3644862	=	IC50	nM	37.0	CHEMBL1955	Homo sapiens	IC50	nM	37.0
214829	17603967	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC3(O)CCC3)nc21		CHEMBL3644863	=	IC50	nM	21.0	CHEMBL1955	Homo sapiens	IC50	nM	21.0
214830	17603968	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CNC(=O)c1c(N)n(CCOC)c2nc(C#CC(C)(O)COC)ccc2c1=O		CHEMBL3644864	=	IC50	nM	257.0	CHEMBL1955	Homo sapiens	IC50	nM	257.0
214831	17603969	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(C)(O)c3cccc(OC)c3)nc21		CHEMBL3644865	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	nM	6.0
214832	17603970	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CNC(=O)c1c(N)n(C2CCOCC2)c2nc(C#CC(C)(O)COC)ccc2c1=O		CHEMBL3644866	=	IC50	nM	34.0	CHEMBL1955	Homo sapiens	IC50	nM	34.0
214833	17603971	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CNC(=O)c1c(N)n(CC2CCCO2)c2nc(C#CC(C)(C)O)ccc2c1=O		CHEMBL3644867	=	IC50	nM	40.0	CHEMBL1955	Homo sapiens	IC50	nM	40.0
214834	17603972	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CNC(=O)c1c(N)n(Cc2ccccn2)c2nc(C#CC(C)(O)COC)ccc2c1=O		CHEMBL3644868	=	IC50	nM	65.0	CHEMBL1955	Homo sapiens	IC50	nM	65.0
214835	17603973	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(C)(O)CO)nc21		CHEMBL3644869	=	IC50	nM	43.0	CHEMBL1955	Homo sapiens	IC50	nM	43.0
214836	17603974	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(C)(O)c3ccccc3)nc21		CHEMBL3644870	=	IC50	nM	14.0	CHEMBL1955	Homo sapiens	IC50	nM	14.0
214837	17603975	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CNC(=O)c1c(N)n(C2CCCCC2)c2nc(C#CC(C)(O)COC)ccc2c1=O		CHEMBL3644871	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
214838	17603976	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(C)(O)COC)nc21		CHEMBL3644872	=	IC50	nM	23.0	CHEMBL1955	Homo sapiens	IC50	nM	23.0
214839	17603977	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(C)(O)c3ccsc3)nc21		CHEMBL3644873	=	IC50	nM	2.0	CHEMBL1955	Homo sapiens	IC50	nM	2.0
214840	17603978	CHEMBL3705249	ELISA Assay: Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#CC(C)(O)c3ccsc3)nc21		CHEMBL3644873	=	IC50	nM	38.0	CHEMBL1955	Homo sapiens	IC50	nM	38.0
322495	17701532	CHEMBL3887192	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2ccccc2CC(N)=O)n1		CHEMBL3689069	=	IC50	nM	275.0	CHEMBL1955	Homo sapiens	IC50	nM	275.0
322496	17701533	CHEMBL3887192	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	COc1cc(C2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2ccccc2CC(N)=O)n1		CHEMBL3689070	=	IC50	nM	3685.0	CHEMBL1955	Homo sapiens	IC50	nM	3685.0
322497	17701534	CHEMBL3887193	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2ccccc2CC(N)=O)n1		CHEMBL3689071	=	IC50	nM	538.0	CHEMBL1955	Homo sapiens	IC50	nM	538.0
322498	17701535	CHEMBL3887192	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	COc1cc(C2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2cccc(C(N)=O)c2)n1		CHEMBL3689073	=	IC50	nM	5750.0	CHEMBL1955	Homo sapiens	IC50	nM	5750.0
322499	17701536	CHEMBL3887193	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2cccc(C(N)=O)c2)n1		CHEMBL3689074	=	IC50	nM	10440.0	CHEMBL1955	Homo sapiens	IC50	nM	10440.0
322500	17701537	CHEMBL3887192	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	CCN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(Cc4ccccc4C(N)=O)n3)c(OC)c2)CC1		CHEMBL3689075	=	IC50	nM	13260.0	CHEMBL1955	Homo sapiens	IC50	nM	13260.0
322501	17701538	CHEMBL3887193	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	CCc1cc(C2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2ccccc2CC(N)=O)n1		CHEMBL3689076	=	IC50	nM	1176.0	CHEMBL1955	Homo sapiens	IC50	nM	1176.0
322502	17701539	CHEMBL3887193	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	CCc1cc(C2CCN(C)CC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2ccccc2CC(N)=O)n1		CHEMBL3689077	=	IC50	nM	1010.0	CHEMBL1955	Homo sapiens	IC50	nM	1010.0
322503	17701540	CHEMBL3887193	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	NC(=O)Cc1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)cc2OC(F)(F)F)ncc1C(F)(F)F		CHEMBL3689078	>	IC50	nM	66000.0	CHEMBL1955	Homo sapiens	IC50	nM	66000.0
322504	17701541	CHEMBL3887193	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	CN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4CC(N)=O)n3)c(OC(F)(F)F)c2)CC1		CHEMBL3689079	=	IC50	nM	59763.0	CHEMBL1955	Homo sapiens	IC50	nM	59763.0
322505	17701542	CHEMBL3887192	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	Cc1cc(C2CCN(C)CC2)ccc1Nc1ncc(C(F)(F)F)c(CCc2ccccc2CC(N)=O)n1		CHEMBL3689080	=	IC50	nM	240.0	CHEMBL1955	Homo sapiens	IC50	nM	240.0
322506	17701543	CHEMBL3887193	Biochemical Assay: Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu -Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) (SEQ ID NO: 1). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15ul assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, 10mM MgCl2, 0.01% (v/v) Tween-20, 50uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1mM Dithiothreitol, 111 nM peptide substrate, 500uM ATP, and 3.8ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100nl from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree C.	B	CN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4CC(N)=O)n3)c(F)c2)CC1		CHEMBL3689081	=	IC50	nM	205.0	CHEMBL1955	Homo sapiens	IC50	nM	205.0
358484	17734147	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CCC(C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)cc2)ncc1C(F)(F)F		CHEMBL3946227	=	IC50	nM	91.0	CHEMBL1955	Homo sapiens	IC50	nM	91.0
358485	17734148	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC[C@@H](C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)cc2)ncc1C(F)(F)F		CHEMBL4107713	=	IC50	nM	103.0	CHEMBL1955	Homo sapiens	IC50	nM	103.0
358486	17734149	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC[C@H](C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)cc2)ncc1C(F)(F)F		CHEMBL3918323	=	IC50	nM	75.0	CHEMBL1955	Homo sapiens	IC50	nM	75.0
358487	17734150	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)cc3)ncc2C(F)(F)F)CC1		CHEMBL3909401	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
358488	17734151	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cc2)CC1		CHEMBL3948670	=	IC50	nM	9.0	CHEMBL1955	Homo sapiens	IC50	nM	9.0
358489	17734152	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CNC4)cc3)ncc2C(F)(F)F)CC1		CHEMBL3903877	=	IC50	nM	22.0	CHEMBL1955	Homo sapiens	IC50	nM	22.0
358490	17734153	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2C(F)(F)F)CC1		CHEMBL3931458	=	IC50	nM	28.0	CHEMBL1955	Homo sapiens	IC50	nM	28.0
358491	17734154	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cccnc3)ncc2Cl)CC1		CHEMBL3922174	=	IC50	nM	8.0	CHEMBL1955	Homo sapiens	IC50	nM	8.0
358492	17734155	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)cc3)ncc2Cl)CC1		CHEMBL3917694	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
358493	17734156	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN1CCC(c2ccc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cc2)CC1		CHEMBL3893200	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
358494	17734157	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C(F)(F)F)nc3)ncc2Cl)CC1		CHEMBL3908745	=	IC50	nM	26.0	CHEMBL1955	Homo sapiens	IC50	nM	26.0
358495	17734158	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C(F)(F)F)nc3)ncc2Cl)CC1		CHEMBL3908745	=	IC50	nM	92.0	CHEMBL1955	Homo sapiens	IC50	nM	92.0
358496	17734159	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ncco3)ncc2Cl)CC1		CHEMBL3903244	=	IC50	nM	1302.0	CHEMBL1955	Homo sapiens	IC50	nM	1302.0
358497	17734160	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cncnc3)ncc2Cl)CC1		CHEMBL3970850	=	IC50	nM	39.0	CHEMBL1955	Homo sapiens	IC50	nM	39.0
358498	17734161	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3918309	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
358499	17734162	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CNC4)c3)ncc2Cl)CC1		CHEMBL3963494	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	nM	6.0
358500	17734163	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2Cl)CC1		CHEMBL3980022	=	IC50	nM	11.0	CHEMBL1955	Homo sapiens	IC50	nM	11.0
358501	17734164	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN1CCC(c2ccc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)CC1		CHEMBL3891581	=	IC50	nM	1.0	CHEMBL1955	Homo sapiens	IC50	nM	1.0
358502	17734165	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CCNCC4)c3)ncc2Cl)CC1		CHEMBL3954050	=	IC50	nM	9.0	CHEMBL1955	Homo sapiens	IC50	nM	9.0
358503	17734166	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN1CCC(n2cc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)CC1		CHEMBL3982717	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
358504	17734167	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cn[nH]c3)ncc2Cl)CC1		CHEMBL3959306	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
358505	17734168	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CCNC4)c3)ncc2Cl)CC1		CHEMBL3893827	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
358506	17734169	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN1CCC(n2cc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)C1		CHEMBL3970373	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
358507	17734170	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccnnc3)ncc2Cl)CC1		CHEMBL3899188	=	IC50	nM	20.0	CHEMBL1955	Homo sapiens	IC50	nM	20.0
358508	17734171	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccccc3)ncc2Cl)CC1		CHEMBL3981765	=	IC50	nM	11.0	CHEMBL1955	Homo sapiens	IC50	nM	11.0
358509	17734172	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(NC(=O)OC(C)(C)C)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cc1		CHEMBL3908239	=	IC50	nM	2.0	CHEMBL1955	Homo sapiens	IC50	nM	2.0
358510	17734173	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(N)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cc1		CHEMBL3890328	=	IC50	nM	14.0	CHEMBL1955	Homo sapiens	IC50	nM	14.0
358511	17734174	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1n[nH]cc1Nc1ncc(Cl)c(CCc2ccccc2C2(C(N)=O)CC2)n1		CHEMBL3918369	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
358512	17734175	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1nn(C)cc1Nc1ncc(Cl)c(CCc2ccccc2C2(C(N)=O)CC2)n1		CHEMBL3925575	=	IC50	nM	12.0	CHEMBL1955	Homo sapiens	IC50	nM	12.0
358513	17734176	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)n[nH]1		CHEMBL3937825	=	IC50	nM	47.0	CHEMBL1955	Homo sapiens	IC50	nM	47.0
358514	17734177	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cn1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)n1		CHEMBL3912708	=	IC50	nM	268.0	CHEMBL1955	Homo sapiens	IC50	nM	268.0
358515	17734178	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(CC(F)(F)F)c3)ncc2Cl)CC1		CHEMBL3938170	=	IC50	nM	8.0	CHEMBL1955	Homo sapiens	IC50	nM	8.0
358516	17734179	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C)n1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3911152	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
358517	17734180	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	[C-]#[N+]c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3948616	=	IC50	nM	48.0	CHEMBL1955	Homo sapiens	IC50	nM	48.0
358518	17734181	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(=O)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3920100	=	IC50	nM	44.0	CHEMBL1955	Homo sapiens	IC50	nM	44.0
358519	17734182	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(N)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3986325	=	IC50	nM	60.0	CHEMBL1955	Homo sapiens	IC50	nM	60.0
358520	17734183	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(CC(F)F)c3)ncc2Cl)CC1		CHEMBL3891977	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
358521	17734184	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cn[nH]c2)ncc1Cl		CHEMBL3960972	=	IC50	nM	9.0	CHEMBL1955	Homo sapiens	IC50	nM	9.0
358522	17734185	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C)c2)ncc1Cl		CHEMBL3933224	=	IC50	nM	16.0	CHEMBL1955	Homo sapiens	IC50	nM	16.0
358523	17734186	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)nc2)ncc1Cl		CHEMBL3957259	=	IC50	nM	31.0	CHEMBL1955	Homo sapiens	IC50	nM	31.0
358524	17734187	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCN(C)CC3)nc2)ncc1Cl		CHEMBL3892658	=	IC50	nM	32.0	CHEMBL1955	Homo sapiens	IC50	nM	32.0
358525	17734188	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cccnc2)ncc1Cl		CHEMBL3971001	=	IC50	nM	44.0	CHEMBL1955	Homo sapiens	IC50	nM	44.0
358526	17734189	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cncnc2)ncc1Cl		CHEMBL3981693	=	IC50	nM	160.0	CHEMBL1955	Homo sapiens	IC50	nM	160.0
358527	17734190	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1ccc(Nc2ncc(Cl)c(CCc3ccccc3C(C)C(N)=O)n2)cn1		CHEMBL3915153	=	IC50	nM	45.0	CHEMBL1955	Homo sapiens	IC50	nM	45.0
358528	17734191	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2ccnnc2)ncc1Cl		CHEMBL3976872	=	IC50	nM	154.0	CHEMBL1955	Homo sapiens	IC50	nM	154.0
358529	17734192	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCNCC3)c2)ncc1Cl		CHEMBL3906184	=	IC50	nM	12.0	CHEMBL1955	Homo sapiens	IC50	nM	12.0
358530	17734193	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C)CC3)c2)ncc1Cl		CHEMBL3970712	=	IC50	nM	9.0	CHEMBL1955	Homo sapiens	IC50	nM	9.0
358531	17734194	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C(C)(C)C(N)=O)n2)cn1		CHEMBL3981577	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
358532	17734195	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2cn[nH]c2)nc1CCc1ccccc1C1(C(N)=O)CC1		CHEMBL3949389	=	IC50	nM	13.0	CHEMBL1955	Homo sapiens	IC50	nM	13.0
358533	17734196	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2cnn(C)c2)nc1CCc1ccccc1C1(C(N)=O)CC1		CHEMBL3973562	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
358534	17734197	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2cnn(C3CCN(C)CC3)c2)nc1CCc1ccccc1C1(C(N)=O)CC1		CHEMBL3944075	=	IC50	nM	12.0	CHEMBL1955	Homo sapiens	IC50	nM	12.0
358535	17734198	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2ccc(C3CCN(C)CC3)nc2)nc1CCc1ccccc1C1(C(N)=O)CC1		CHEMBL3926124	=	IC50	nM	23.0	CHEMBL1955	Homo sapiens	IC50	nM	23.0
358536	17734199	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2ccc(C(C)N)cc2)nc1CCc1ccccc1C1(C(N)=O)CC1		CHEMBL3901596	=	IC50	nM	46.0	CHEMBL1955	Homo sapiens	IC50	nM	46.0
358537	17734200	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2cnn(C)c2)nc1CCc1ccccc1C(C)C(N)=O		CHEMBL3986746	=	IC50	nM	15.0	CHEMBL1955	Homo sapiens	IC50	nM	15.0
358538	17734201	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2cnn(C)c2)nc1CCc1ccccc1[C@@H](C)C(N)=O		CHEMBL4114236	=	IC50	nM	25.0	CHEMBL1955	Homo sapiens	IC50	nM	25.0
358539	17734202	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cc1cnc(Nc2cnn(C)c2)nc1CCc1ccccc1[C@H](C)C(N)=O		CHEMBL3913700	=	IC50	nM	41.0	CHEMBL1955	Homo sapiens	IC50	nM	41.0
358540	17734203	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	O=C(O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)cc3)ncc2C(F)(F)F)CCC1		CHEMBL4113489	=	IC50	nM	23.0	CHEMBL1955	Homo sapiens	IC50	nM	23.0
358541	17734204	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2cccc(CCc3nc(Nc4cnn(C5CCNCC5)c4)ncc3C(F)(F)F)c2)CC1		CHEMBL3916024	=	IC50	nM	228.0	CHEMBL1955	Homo sapiens	IC50	nM	228.0
358542	17734205	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cn[nH]c2)ncc1C(F)(F)F		CHEMBL3946260	=	IC50	nM	17.0	CHEMBL1955	Homo sapiens	IC50	nM	17.0
358543	17734206	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C)c2)ncc1C(F)(F)F		CHEMBL3975577	=	IC50	nM	15.0	CHEMBL1955	Homo sapiens	IC50	nM	15.0
358544	17734207	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCNCC3)c2)ncc1C(F)(F)F		CHEMBL3950340	=	IC50	nM	27.0	CHEMBL1955	Homo sapiens	IC50	nM	27.0
358545	17734208	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	C[C@@H](C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCNCC3)c2)ncc1C(F)(F)F		CHEMBL4112177	=	IC50	nM	31.0	CHEMBL1955	Homo sapiens	IC50	nM	31.0
358546	17734209	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	C[C@H](C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCNCC3)c2)ncc1C(F)(F)F		CHEMBL3892144	=	IC50	nM	93.0	CHEMBL1955	Homo sapiens	IC50	nM	93.0
358547	17734210	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C)CC3)c2)ncc1C(F)(F)F		CHEMBL3900906	=	IC50	nM	27.0	CHEMBL1955	Homo sapiens	IC50	nM	27.0
358548	17734211	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(=O)N1CCC(n2cc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4C(C)C(N)=O)n3)cn2)CC1		CHEMBL3967214	=	IC50	nM	22.0	CHEMBL1955	Homo sapiens	IC50	nM	22.0
358549	17734212	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CCN1CCC(n2cc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4C(C)C(N)=O)n3)cn2)CC1		CHEMBL3970470	=	IC50	nM	86.0	CHEMBL1955	Homo sapiens	IC50	nM	86.0
358550	17734213	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C(C)C)CC3)c2)ncc1C(F)(F)F		CHEMBL3938601	=	IC50	nM	89.0	CHEMBL1955	Homo sapiens	IC50	nM	89.0
358551	17734214	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	COc1ccc(Nc2ncc(C(F)(F)F)c(CCc3ccccc3C(C)C(N)=O)n2)cn1		CHEMBL3968164	=	IC50	nM	118.0	CHEMBL1955	Homo sapiens	IC50	nM	118.0
358552	17734215	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN(c1ccc(C2CCNCC2)nc1)c1ncc(C(F)(F)F)c(CCc2ccccc2C(N)C(N)=O)n1		CHEMBL3918715	=	IC50	nM	492.0	CHEMBL1955	Homo sapiens	IC50	nM	492.0
358553	17734216	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCN(C)CC3)nc2)ncc1C(F)(F)F		CHEMBL3938508	=	IC50	nM	28.0	CHEMBL1955	Homo sapiens	IC50	nM	28.0
358554	17734217	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	COc1ccc(Nc2ncc(C(F)(F)F)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3963900	=	IC50	nM	8.0	CHEMBL1955	Homo sapiens	IC50	nM	8.0
358555	17734218	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	Cn1cc(Nc2ncc(C(F)(F)F)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3898744	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
358556	17734219	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CCNCC4)c3)ncc2C(F)(F)F)CC1		CHEMBL3907640	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
358557	17734220	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN1CCC(n2cc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)CC1		CHEMBL3928029	=	IC50	nM	7.0	CHEMBL1955	Homo sapiens	IC50	nM	7.0
358558	17734221	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2C(F)(F)F)CC1		CHEMBL3931458	=	IC50	nM	28.0	CHEMBL1955	Homo sapiens	IC50	nM	28.0
358559	17734222	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)CC1		CHEMBL3892145	=	IC50	nM	63.0	CHEMBL1955	Homo sapiens	IC50	nM	63.0
358560	17734223	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(NC(=O)OC(C)(C)C)c1ccc(Nc2ncc(C(F)(F)F)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cc1		CHEMBL3983276	=	IC50	nM	64.0	CHEMBL1955	Homo sapiens	IC50	nM	64.0
358561	17734224	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(N)c1ccc(Nc2ncc(C(F)(F)F)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cc1		CHEMBL3892486	=	IC50	nM	22.0	CHEMBL1955	Homo sapiens	IC50	nM	22.0
358562	17734225	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	CC(=O)NC(C)c1ccc(Nc2ncc(C(F)(F)F)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cc1		CHEMBL3913725	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
358563	17734226	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(CCO)c3)ncc2Cl)CC1		CHEMBL3931510	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
358564	17734227	CHEMBL3887860	VEGFR3 Biochemical Assay: A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2). VEGFR3 cytoplasmic domain (amino acids 798-1298) was purchased as N-terminal GST-fusion protein (the enzyme). The 15 uL assay reactions are run in Greiner brand white 384-well low volume plates. All reactions contained 10 mM HEPES pH 7.4, mM MgCl2, 0.01% (v/v) Tween-20, 50 uM Na3VO4, 0.01% (w/v) albumin from chicken egg white, 1 mM Dithiothreitol, 111 nM peptide substrate, 500 uM ATP, and 3.8 ng/reaction enzyme, with the enzyme being omitted from negative control reactions. Compounds were added in a volume of 100 nL from dilution series prepared in DMSO, positive and negative control reactions receiving the same volume DMSO without compound. The plates were sealed with adhesive seals and incubated for 90 minutes at 30 degree Celsius.	B	COCCn1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3894588	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
358565	17734228	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CCC(C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)cc2)ncc1C(F)(F)F		CHEMBL3946227	=	IC50	nM	173.0	CHEMBL1955	Homo sapiens	IC50	nM	173.0
358566	17734229	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC[C@@H](C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)cc2)ncc1C(F)(F)F		CHEMBL4107713	=	IC50	nM	329.0	CHEMBL1955	Homo sapiens	IC50	nM	329.0
358567	17734230	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC[C@H](C(N)=O)c1ccccc1CCc1nc(Nc2ccc(C3CCNCC3)cc2)ncc1C(F)(F)F		CHEMBL3918323	=	IC50	nM	315.0	CHEMBL1955	Homo sapiens	IC50	nM	315.0
358568	17734231	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)cc3)ncc2C(F)(F)F)CC1		CHEMBL3909401	=	IC50	nM	26.0	CHEMBL1955	Homo sapiens	IC50	nM	26.0
358569	17734232	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CN1CCC(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cc2)CC1		CHEMBL3948670	=	IC50	nM	27.0	CHEMBL1955	Homo sapiens	IC50	nM	27.0
358570	17734233	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CNC4)cc3)ncc2C(F)(F)F)CC1		CHEMBL3903877	=	IC50	nM	38.0	CHEMBL1955	Homo sapiens	IC50	nM	38.0
358571	17734234	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2C(F)(F)F)CC1		CHEMBL3931458	=	IC50	nM	51.0	CHEMBL1955	Homo sapiens	IC50	nM	51.0
358572	17734235	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cccnc3)ncc2Cl)CC1		CHEMBL3922174	=	IC50	nM	17.0	CHEMBL1955	Homo sapiens	IC50	nM	17.0
358573	17734236	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)cc3)ncc2Cl)CC1		CHEMBL3917694	=	IC50	nM	38.0	CHEMBL1955	Homo sapiens	IC50	nM	38.0
358574	17734237	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CN1CCC(c2ccc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cc2)CC1		CHEMBL3893200	=	IC50	nM	19.0	CHEMBL1955	Homo sapiens	IC50	nM	19.0
358575	17734238	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C(F)(F)F)nc3)ncc2Cl)CC1		CHEMBL3908745	=	IC50	nM	75.0	CHEMBL1955	Homo sapiens	IC50	nM	75.0
358576	17734239	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cncnc3)ncc2Cl)CC1		CHEMBL3970850	=	IC50	nM	267.0	CHEMBL1955	Homo sapiens	IC50	nM	267.0
358577	17734240	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3918309	=	IC50	nM	9.0	CHEMBL1955	Homo sapiens	IC50	nM	9.0
358578	17734241	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CNC4)c3)ncc2Cl)CC1		CHEMBL3963494	=	IC50	nM	30.0	CHEMBL1955	Homo sapiens	IC50	nM	30.0
358579	17734242	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2Cl)CC1		CHEMBL3980022	=	IC50	nM	51.0	CHEMBL1955	Homo sapiens	IC50	nM	51.0
358580	17734243	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CN1CCC(c2ccc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)CC1		CHEMBL3891581	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
358581	17734244	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CCNCC4)c3)ncc2Cl)CC1		CHEMBL3954050	=	IC50	nM	62.0	CHEMBL1955	Homo sapiens	IC50	nM	62.0
358582	17734245	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CN1CCC(n2cc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)CC1		CHEMBL3982717	=	IC50	nM	5.0	CHEMBL1955	Homo sapiens	IC50	nM	5.0
358583	17734246	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cn[nH]c3)ncc2Cl)CC1		CHEMBL3959306	=	IC50	nM	11.0	CHEMBL1955	Homo sapiens	IC50	nM	11.0
358584	17734247	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3cnn(C4CCNC4)c3)ncc2Cl)CC1		CHEMBL3893827	=	IC50	nM	38.0	CHEMBL1955	Homo sapiens	IC50	nM	38.0
358585	17734248	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CN1CCC(n2cc(Nc3ncc(Cl)c(CCc4ccccc4C4(C(N)=O)CC4)n3)cn2)C1		CHEMBL3970373	=	IC50	nM	14.0	CHEMBL1955	Homo sapiens	IC50	nM	14.0
358586	17734249	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC(NC(=O)OC(C)(C)C)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cc1		CHEMBL3908239	=	IC50	nM	25.0	CHEMBL1955	Homo sapiens	IC50	nM	25.0
358587	17734250	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cn[nH]c2)ncc1Cl		CHEMBL3960972	=	IC50	nM	64.0	CHEMBL1955	Homo sapiens	IC50	nM	64.0
358588	17734251	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C)c2)ncc1Cl		CHEMBL3933224	=	IC50	nM	76.0	CHEMBL1955	Homo sapiens	IC50	nM	76.0
358589	17734252	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C)CC3)c2)ncc1Cl		CHEMBL3970712	=	IC50	nM	52.0	CHEMBL1955	Homo sapiens	IC50	nM	52.0
358590	17734253	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C(C)(C)C(N)=O)n2)cn1		CHEMBL3981577	=	IC50	nM	23.0	CHEMBL1955	Homo sapiens	IC50	nM	23.0
358591	17734254	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	Cc1cnc(Nc2cnn(C)c2)nc1CCc1ccccc1C(C)C(N)=O		CHEMBL3986746	=	IC50	nM	526.0	CHEMBL1955	Homo sapiens	IC50	nM	526.0
358592	17734255	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCNCC3)c2)ncc1C(F)(F)F		CHEMBL3950340	=	IC50	nM	68.0	CHEMBL1955	Homo sapiens	IC50	nM	68.0
358593	17734256	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C)CC3)c2)ncc1C(F)(F)F		CHEMBL3900906	=	IC50	nM	27.0	CHEMBL1955	Homo sapiens	IC50	nM	27.0
358594	17734257	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	C[C@@H](C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C)CC3)c2)ncc1C(F)(F)F		CHEMBL4110384	=	IC50	nM	38.0	CHEMBL1955	Homo sapiens	IC50	nM	38.0
358595	17734258	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	C[C@H](C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C3CCN(C)CC3)c2)ncc1C(F)(F)F		CHEMBL3895625	=	IC50	nM	19.0	CHEMBL1955	Homo sapiens	IC50	nM	19.0
358596	17734259	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	COc1ccc(Nc2ncc(C(F)(F)F)c(CCc3ccccc3C3(C(N)=O)CC3)n2)cn1		CHEMBL3963900	=	IC50	nM	394.0	CHEMBL1955	Homo sapiens	IC50	nM	394.0
358597	17734260	CHEMBL3887861	VEGFR3 Phospho ELISA Assay: Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat #665180, Greiner Bio-One) in EGM-2MV (Cat# CC-3202, Lonza) at 180,000 cells/well (volume 1 mL), and the plates incubated at 37 C. and 5% CO2 for 6 hours. The media was replaced with EBM-2 (Cat # CC-3156, Lonza)+0.1% BSA (Cat# A8412, Sigma) and cells incubated for a further period (overnight at 37 C. and 5% CO2).96 well Maxisorp immuno plates (Cat #439454, Nunc) were coated with 100 uL of Total VEGFR3 capture antibody (Part #841888, Human Total VEGFR3/FLT4 ELISA Kit, Cat # DYC3491, R&D Systems), or Phospho VEGFR3 Capture antibody (Part #841885, Human Phospho VEGFR3/FLT4 ELISA Kit, Cat# DYC2724, R&D Systems). The plates were covered and incubated at room temperature overnight .The coating antibody was flicked out and the plates washed three times with Wash Buffer (Phosphate buffered saline (137 mM NaCl, 2.7 nM KCl, 8.1 nM Na2HPO4, 1.5 mL KH2PO4, pH 7.2-7.4), 0.05% Tween 20). 300 uL of blocking buffer (5% v/v Tween 20, 5% w/v sucrose in PBS) was then added to wells and plate incubated for 2 hours at room temperature.	B	NC(=O)C1(c2ccccc2CCc2nc(Nc3ccc(C4CCNCC4)nc3)ncc2C(F)(F)F)CC1		CHEMBL3931458	=	IC50	nM	51.0	CHEMBL1955	Homo sapiens	IC50	nM	51.0
431434	17791542	CHEMBL3889044	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	54.2	CHEMBL1955	Homo sapiens	IC50	nM	54.2
	17957987	CHEMBL3993999	Inhibition of recombinant human GST-tagged VEGFR3 cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1		CHEMBL4069394	=	IC50	nM	9.6	CHEMBL1955	Homo sapiens	IC50	nM	9.6
	17957988	CHEMBL3993999	Inhibition of recombinant human GST-tagged VEGFR3 cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
	17979939	CHEMBL3998333	Inhibition of VEGFR3 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	17979950	CHEMBL3998344	Inhibition of recombinant VEGFR3 (unknown origin) expressed in baculovirus infected insect cells using biotinylated peptide substrate GGGGQDGKDYIVLPI in presence of ATP incubated for 1 to 4 hrs by time resolved fluorescence assay	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	8.0	CHEMBL1955	Homo sapiens	IC50	nM	8.0
	17982156	CHEMBL3998831	Inhibition of human FLT4 at 1 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	>	Inhibition	%	80.0	CHEMBL1955	Homo sapiens	INH	%	80.0
	17982168	CHEMBL3998812	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by scintillation counting method	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	=	IC50	nM	114.5	CHEMBL1955	Homo sapiens	IC50	nM	114.5
	17982169	CHEMBL3998812	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by scintillation counting method	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	=	IC50	nM	1.13	CHEMBL1955	Homo sapiens	IC50	nM	1.13
	18021247	CHEMBL4005953	Inhibition of recombinant human N-terminal GST-tagged Flt4 (800 to end amino acid residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCNCC3)cn2)n1		CHEMBL4071812	<	Inhibition	%	10.0	CHEMBL1955	Homo sapiens	INH	%	10.0
	18021248	CHEMBL4005953	Inhibition of recombinant human N-terminal GST-tagged Flt4 (800 to end amino acid residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1nc(Nc2ccc(N3CCN(C)CC3)cn2)ncc1F		CHEMBL4072255	<	Inhibition	%	10.0	CHEMBL1955	Homo sapiens	INH	%	10.0
	18033089	CHEMBL4007905	Inhibition of human VEGFR3 at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	47.0	CHEMBL1955	Homo sapiens	INH	%	47.0
	18053018	CHEMBL4011865	Inhibition of FLT4 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	5.4	CHEMBL1955	Homo sapiens	INH	%	5.4
	18057833	CHEMBL4012666	Inhibition of human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus by ELISA	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	IC50	nM	72.0	CHEMBL1955	Homo sapiens	IC50	nM	72.0
	18057841	CHEMBL4012665	Inhibition of human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus assessed as activity remaining at 1 uM by ELISA assay relative to control	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	Activity	%	7.8	CHEMBL1955	Homo sapiens	Activity	%	7.8
	18057864	CHEMBL4012626	Inhibition of VEGFR3 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4103605	=	IC50	nM	376.0	CHEMBL1955	Homo sapiens	IC50	nM	376.0
	18064287	CHEMBL4013842	Inhibition of human FLT4 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	A	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	410.0	CHEMBL1955	Homo sapiens	IC50	nM	410.0
	18064301	CHEMBL4013856	Inhibition of human FLT4 at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	A	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	18112099	CHEMBL4024292	Inhibition of recombinant human N-terminal GST-tagged FLT4 (800-end residues) expressed in baculovirus infected sf21 cells	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)nc2n1C1CCCC1		CHEMBL4063500	=	IC50	nM	43.0	CHEMBL1955	Homo sapiens	IC50	uM	0.043
	18114337	CHEMBL4025157	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	18141784	CHEMBL4031399	Inhibition of human FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	Activity	%	0.25	CHEMBL1955	Homo sapiens	Activity	%	0.25
	18141807	CHEMBL4031420	Inhibition of GST-tagged human FLT4 (800 to 1297 residues) expressed in Baculovirus expression system by Z'Lyte assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	IC50	nM	141.0	CHEMBL1955	Homo sapiens	IC50	nM	141.0
	18141846	CHEMBL4031444	Binding affinity to FLT4 (unknown origin) by KinomeSCan assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1955	Homo sapiens	Kd	nM	41.0
Active	18149676	CHEMBL4033355	Inhibition of human Flt4 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	18149677	CHEMBL4033355	Inhibition of human Flt4 at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	18203681	CHEMBL4043968	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	2.7	CHEMBL1955	Homo sapiens	Activity	%	2.7
	18225204	CHEMBL4048703	Inhibition of FLT4 (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	89.0	CHEMBL1955	Homo sapiens	INH	%	89.0
	18253819	CHEMBL4055194	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	18253820	CHEMBL4055194	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	86.0	CHEMBL1955	Homo sapiens	Activity	%	86.0
	18265866	CHEMBL4057316	Inhibition of FLT4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	10.0	CHEMBL1955	Homo sapiens	INH	%	10.0
	18266060	CHEMBL4057510	Inhibition of FLT4 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-2.7	CHEMBL1955	Homo sapiens	INH	%	-2.7
	18274427	CHEMBL4059358	Inhibition of human VEGFR3 assessed as remaining activity at 1 uM after 30 mins by qPCR method	B	CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1		CHEMBL4076112	<=	Activity	%	10.0	CHEMBL1955	Homo sapiens	Activity	%	10.0
	18275372	CHEMBL4118506	Inhibition of human FLT4 (821 to 1196 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	8.2	CHEMBL1955	Homo sapiens	Activity	%	8.2
	18276144	CHEMBL4119074	Inhibition of human FLT4 (821 to 1196 residues) expressed in bacterial expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.3	CHEMBL1955	Homo sapiens	Activity	%	0.3
	18282091	CHEMBL4120046	Inhibition of recombinant GST-tagged human FLT4 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	22.1	CHEMBL1955	Homo sapiens	INH	%	22.1
	18282410	CHEMBL4120046	Inhibition of recombinant GST-tagged human FLT4 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	44.6	CHEMBL1955	Homo sapiens	INH	%	44.6
	18282764	CHEMBL4120349	Inhibition of FLT4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	10.0	CHEMBL1955	Homo sapiens	INH	%	10.0
	18282991	CHEMBL4120576	Inhibition of FLT4 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	28.3	CHEMBL1955	Homo sapiens	INH	%	28.3
	18283215	CHEMBL4120800	Inhibition of FLT4 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	5.3	CHEMBL1955	Homo sapiens	INH	%	5.3
	18314195	CHEMBL4132791	Inhibition of N-terminal GST tagged human VEGFR3 (798 to 1298 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(C(=O)N3CCN(C)CC3)cc2c1)c1ccccc1		CHEMBL4165429	=	IC50	nM	18.2	CHEMBL1955	Homo sapiens	IC50	nM	18.2
	18314196	CHEMBL4132791	Inhibition of N-terminal GST tagged human VEGFR3 (798 to 1298 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	3.2	CHEMBL1955	Homo sapiens	IC50	nM	3.2
	18328501	CHEMBL4135863	Inhibition of VEGFR-3 (unknown origin)	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1		CHEMBL4171543	=	IC50	nM	45.0	CHEMBL1955	Homo sapiens	IC50	nM	45.0
	18356033	CHEMBL4140584	Inhibition of VEGFR3 (unknown origin)	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12		CHEMBL4160854	=	IC50	nM	37.0	CHEMBL1955	Homo sapiens	IC50	nM	37.0
	18379920	CHEMBL4145821	Inhibition of VEGFR3 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-1.5	CHEMBL1955	Homo sapiens	INH	%	-1.5
	18379972	CHEMBL4145873	Inhibition of VEGFR3 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.29	CHEMBL1955	Homo sapiens	IC50	nM	2.29
	18431334	CHEMBL4155786	Inhibition of FLT4 (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	52.0	CHEMBL1955	Homo sapiens	INH	%	52.0
	18432395	CHEMBL4155897	Inhibition of human FLT4 by Hotspot assay	B	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4sccc34)cc2)CC1		CHEMBL4075720	=	IC50	nM	4.5	CHEMBL1955	Homo sapiens	IC50	nM	4.5
	18432396	CHEMBL4155897	Inhibition of human FLT4 by Hotspot assay	B	Cc1nc2c(c(Nc3c[nH]nc3C(=O)Nc3ccc(N4CCNCC4)cc3)n1)CCC2		CHEMBL4163870	=	IC50	nM	23.01	CHEMBL1955	Homo sapiens	IC50	nM	23.01
	18432397	CHEMBL4155897	Inhibition of human FLT4 by Hotspot assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.27	CHEMBL1955	Homo sapiens	IC50	nM	3.27
	18432401	CHEMBL4155901	Inhibition of human FLT4 at 0.123 uM by Hotspot assay relative to control	B	Cc1nc2c(c(Nc3c[nH]nc3C(=O)Nc3ccc(N4CCNCC4)cc3)n1)CCC2		CHEMBL4163870	>	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	18440223	CHEMBL4157047	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	18450285	CHEMBL4178293	Inhibition of recombinant human N-terminal GST-tagged FLT4 (800 to end residues) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-3.0	CHEMBL1955	Homo sapiens	Activity	%	-3.0
	18450335	CHEMBL4178293	Inhibition of recombinant human N-terminal GST-tagged FLT4 (800 to end residues) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-3.0	CHEMBL1955	Homo sapiens	Activity	%	-3.0
	18481852	CHEMBL4185094	Inhibition of VEGFR3 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins in presence of ATP by HTRF assay	B	CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1		CHEMBL4204920	=	IC50	nM	23.6	CHEMBL1955	Homo sapiens	IC50	nM	23.6
	18484179	CHEMBL4185826	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	98.0	CHEMBL1955	Homo sapiens	Activity	%	98.0
	18484663	CHEMBL4185826	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	89.0	CHEMBL1955	Homo sapiens	Activity	%	89.0
	18506017	CHEMBL4190477	Inhibition of recombinant human GST-tagged VEGFR3 expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Non standard unit for type	CHEMBL1290072	>	INH	uM	100.0	CHEMBL1955	Homo sapiens	INH	uM	100.0
	18507782	CHEMBL4190980	Inhibition of recombinant human Flt4 (800 to end residues) at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	91.0	CHEMBL1955	Homo sapiens	INH	%	91.0
	18531081	CHEMBL4195391	Inhibition of VEGFR-3 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCCC(=O)NO)cc4)n3)cc2nn1C		CHEMBL4212117	=	IC50	nM	113.0	CHEMBL1955	Homo sapiens	IC50	uM	0.113
	18531082	CHEMBL4195391	Inhibition of VEGFR-3 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)Nc5ccccc5N)cc4)n3)cc2nn1C		CHEMBL4213341	=	IC50	nM	46.0	CHEMBL1955	Homo sapiens	IC50	uM	0.046
	18531083	CHEMBL4195391	Inhibition of VEGFR-3 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	46.0	CHEMBL1955	Homo sapiens	IC50	uM	0.046
	18556331	CHEMBL4200480	Inhibition of recombinant human N-terminal GST-tagged FLT4 (800 to end residues) expressed in baculovirus infected Sf21 cells at 1 uM relative to control	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4218854	=	Inhibition	%	63.0	CHEMBL1955	Homo sapiens	INH	%	63.0
	18568750	CHEMBL4220256	Inhibition of FLT4 (unknown origin)	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	190.0	CHEMBL1955	Homo sapiens	IC50	nM	190.0
	18570773	CHEMBL4220905	Inhibition of recombinant human FLT4 (800-end residues) at 10 uM in presence of ATP relative to control	B	CN(c1ncnc2[nH]ccc12)[C@@H]1CCN(C(=O)CC#N)C1		CHEMBL4224807	=	Inhibition	%	80.0	CHEMBL1955	Homo sapiens	INH	%	80.0
Active	18571120	CHEMBL4221042	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate at 10 uM after 40 mins in presence of [gamma-33P]-ATP by liquid scintillation counting method	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(C4=Nc5cscc5NC(=O)C4)cc3)cc2C(F)(F)F)CC1		CHEMBL4228601		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	18653623	CHEMBL4230092	Inhibition of FLT4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL1955	Homo sapiens	INH	%	99.0
	18653624	CHEMBL4230092	Inhibition of FLT4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	97.0	CHEMBL1955	Homo sapiens	INH	%	97.0
	18655509	CHEMBL4230726	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	18656505	CHEMBL4231213	Inhibition of recombinant human Flt4 using Ulight-CAGAGAIETDKEYYTVKD as substrate after 90 mins by LANCE method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.8	CHEMBL1955	Homo sapiens	IC50	10'-9M	3.8
	18665420	CHEMBL4233327	Inhibition of FLT-4 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL1955	Homo sapiens	IC50	nM	1000.0
	18674682	CHEMBL4235361	Inhibition of FLT4 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL1955	Homo sapiens	Ki	nM	2000.0
	18674683	CHEMBL4235361	Inhibition of FLT4 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL1955	Homo sapiens	Ki	nM	2000.0
Not Determined	18674684	CHEMBL4235361	Inhibition of FLT4 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL1955	Homo sapiens	Ki		
	18737824	CHEMBL4261415	Inhibition of recombinant human Flt4 V1128L/H1146R double mutant (800 to end residues) using KKKSPGEYVNIEF as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	20.0	CHEMBL1955	Homo sapiens	IC50	nM	20.0
	18751104	CHEMBL4263810	Inhibition of FLT4 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	18.0	CHEMBL1955	Homo sapiens	INH	%	18.0
	18751588	CHEMBL4264315	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	88.0	CHEMBL1955	Homo sapiens	Activity	%	88.0
	18761515	CHEMBL4266568	Inhibition of recombinant human N-terminal GST-tagged FLT3 (564 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	85.0	CHEMBL1955	Homo sapiens	INH	%	85.0
	18761786	CHEMBL4266568	Inhibition of recombinant human N-terminal GST-tagged FLT3 (564 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	31.0	CHEMBL1955	Homo sapiens	INH	%	31.0
	18761949	CHEMBL4266568	Inhibition of recombinant human N-terminal GST-tagged FLT3 (564 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	6.0	CHEMBL1955	Homo sapiens	INH	%	6.0
	18765639	CHEMBL4267285	Inhibition of recombinant human GST-tagged FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	47.3	CHEMBL1955	Homo sapiens	INH	%	47.3
	18765640	CHEMBL4267285	Inhibition of recombinant human GST-tagged FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	21.6	CHEMBL1955	Homo sapiens	INH	%	21.6
	18765641	CHEMBL4267285	Inhibition of recombinant human GST-tagged FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	29.4	CHEMBL1955	Homo sapiens	INH	%	29.4
	18765642	CHEMBL4267285	Inhibition of recombinant human GST-tagged FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	28.2	CHEMBL1955	Homo sapiens	INH	%	28.2
	18765643	CHEMBL4267285	Inhibition of recombinant human GST-tagged FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	29.4	CHEMBL1955	Homo sapiens	INH	%	29.4
	18765644	CHEMBL4267285	Inhibition of recombinant human GST-tagged FLT4 cytoplasmic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	9.5	CHEMBL1955	Homo sapiens	INH	%	9.5
	18768305	CHEMBL4267754	Inhibition of FLT4 (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4279457	=	IC50	nM	183.1	CHEMBL1955	Homo sapiens	IC50	nM	183.1
	18784844	CHEMBL4271315	Inhibition of VEGFR3 (unknown origin)	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	IC50	nM	0.1	CHEMBL1955	Homo sapiens	IC50	nM	0.1
	18854175	CHEMBL4307052	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	nM	6.0
	18854176	CHEMBL4307052	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	5.2	CHEMBL1955	Homo sapiens	IC50	nM	5.2
	18854177	CHEMBL4307052	Inhibition of VEGFR3 (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	47.0	CHEMBL1955	Homo sapiens	IC50	nM	47.0
	18854178	CHEMBL4307052	Inhibition of VEGFR3 (unknown origin)	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	34.0	CHEMBL1955	Homo sapiens	IC50	nM	34.0
	18854179	CHEMBL4307052	Inhibition of VEGFR3 (unknown origin)	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	IC50	nM	0.1	CHEMBL1955	Homo sapiens	IC50	nM	0.1
	18857981	CHEMBL4307827	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL1955	Homo sapiens	Activity	%	99.0
	18919447	CHEMBL4322804	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FLT4 (unknown origin) (798 to 1298 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	61.0	CHEMBL1955	Homo sapiens	Kd	nM	61.0
	18919635	CHEMBL4322804	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FLT4 (unknown origin) (798 to 1298 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	78.0	CHEMBL1955	Homo sapiens	Kd	nM	78.0
	18923171	CHEMBL4323944	Inhibition of recombinant human FLT4 (800 to 1297 residues) using poly(Glu:Tyr) as substrate incubated for 30 mins in presence of [gamma33P]-ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4447631	=	IC50	nM	8.0	CHEMBL1955	Homo sapiens	IC50	nM	8.0
	18930932	CHEMBL4325590	Inhibition of recombinant VEGFR3 (unknown origin) at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	100.0	CHEMBL1955	Homo sapiens	INH	%	100.0
	18930956	CHEMBL4325614	Inhibition of recombinant VEGFR3 (unknown origin) at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	69.4	CHEMBL1955	Homo sapiens	INH	%	69.4
	18930980	CHEMBL4325638	Inhibition of recombinant VEGFR3 (unknown origin) at 10 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	27.3	CHEMBL1955	Homo sapiens	INH	%	27.3
	18937943	CHEMBL4327509	Inhibition of human FLT4 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	104.78	CHEMBL1955	Homo sapiens	Activity	%	104.78
	18937944	CHEMBL4327509	Inhibition of human FLT4 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	103.8	CHEMBL1955	Homo sapiens	Activity	%	103.8
	18938542	CHEMBL4328062	Inhibition of human FLT4 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL1955	Homo sapiens	Activity	%	65.0
	18938920	CHEMBL4328426	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.69	CHEMBL1955	Homo sapiens	IC50	10'-9M	2.69
	18955302	CHEMBL4332296	Inhibition of VEGFR3 (unknown origin)	B	COc1cccc(NC(=O)N2CCCc3cc(Nc4ncnc5cc(OC)c(OC)cc45)ccc32)c1		CHEMBL4539051	=	IC50	nM	14.2	CHEMBL1955	Homo sapiens	IC50	nM	14.2
	18955303	CHEMBL4332296	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2ncnc(Nc3ccc4c(c3)CCCN4C(=O)Nc3cccc(Cl)c3)c2cc1OC		CHEMBL4589270	=	IC50	nM	7.8	CHEMBL1955	Homo sapiens	IC50	nM	7.8
	18955304	CHEMBL4332296	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2ncnc(Nc3ccc4c(c3)CCCN4C(=O)Nc3ccc(C(C)=O)cc3)c2cc1OC		CHEMBL4548316	=	IC50	nM	17.3	CHEMBL1955	Homo sapiens	IC50	nM	17.3
	18958894	CHEMBL4333416	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	50.0	CHEMBL1955	Homo sapiens	Activity	%	50.0
	18973966	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)[C@@H](N)/C=C\C[C@H](C)OC2=O		CHEMBL4471009	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	18973967	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)[C@H](O)/C=C\C[C@H](C)OC2=O		CHEMBL4520759	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	18973968	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)CCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4515000	=	IC50	nM	27.0	CHEMBL1955	Homo sapiens	IC50	nM	27.0
	18973969	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4515912	=	IC50	nM	190.0	CHEMBL1955	Homo sapiens	IC50	nM	190.0
	18973970	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4452766	=	IC50	nM	9.2	CHEMBL1955	Homo sapiens	IC50	nM	9.2
	18973971	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4517550	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	18973972	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	C=C1/C=C\C[C@H](C)OC(=O)c2c(O)cc(OC)cc2-c2cccc(c2)[C@@H](O)[C@@H]1O		CHEMBL4438318	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	18973973	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)C/C=C/[C@H](C)OC2=O		CHEMBL4530473	=	IC50	nM	9.9	CHEMBL1955	Homo sapiens	IC50	nM	9.9
	18973974	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304	=	IC50	nM	1.1	CHEMBL1955	Homo sapiens	IC50	nM	1.1
	18973975	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4572320	=	IC50	nM	5300.0	CHEMBL1955	Homo sapiens	IC50	nM	5300.0
	18973976	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4533447	=	IC50	nM	23.0	CHEMBL1955	Homo sapiens	IC50	nM	23.0
	18973977	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	=	IC50	nM	0.73	CHEMBL1955	Homo sapiens	IC50	nM	0.73
	18973978	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	IC50	nM	4900.0	CHEMBL1955	Homo sapiens	IC50	nM	4900.0
	18973979	CHEMBL4337766	Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#C[C@@](C)(O)COC)nc21		CHEMBL4303275	=	IC50	nM	1.2	CHEMBL1955	Homo sapiens	IC50	nM	1.2
	18973994	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#C[C@@](C)(O)COC)nc21		CHEMBL4303275	=	GI50	nM	59.0	CHEMBL1955	Homo sapiens	GI50	uM	0.059
Not Determined	18973995	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982		GI50			CHEMBL1955	Homo sapiens	GI50		
	18973996	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	=	GI50	nM	50.0	CHEMBL1955	Homo sapiens	GI50	uM	0.05
	18973997	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4533447	=	GI50	nM	96.0	CHEMBL1955	Homo sapiens	GI50	uM	0.096
	18973998	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4572320	>	GI50	nM	25000.0	CHEMBL1955	Homo sapiens	GI50	uM	25.0
	18973999	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304	=	GI50	nM	79.0	CHEMBL1955	Homo sapiens	GI50	uM	0.079
	18974000	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)C/C=C/[C@H](C)OC2=O		CHEMBL4530473	=	GI50	nM	130.0	CHEMBL1955	Homo sapiens	GI50	uM	0.13
	18974001	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	C=C1/C=C\C[C@H](C)OC(=O)c2c(O)cc(OC)cc2-c2cccc(c2)[C@@H](O)[C@@H]1O		CHEMBL4438318	>	GI50	nM	25000.0	CHEMBL1955	Homo sapiens	GI50	uM	25.0
	18974002	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4517550	>	GI50	nM	25000.0	CHEMBL1955	Homo sapiens	GI50	uM	25.0
	18974003	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4452766	=	GI50	nM	880.0	CHEMBL1955	Homo sapiens	GI50	uM	0.88
	18974004	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@H](O)[C@@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4515912	=	GI50	nM	2200.0	CHEMBL1955	Homo sapiens	GI50	uM	2.2
	18974005	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)CCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4515000	=	GI50	nM	240.0	CHEMBL1955	Homo sapiens	GI50	uM	0.24
	18974006	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)[C@H](O)/C=C\C[C@H](C)OC2=O		CHEMBL4520759	>	GI50	nM	25000.0	CHEMBL1955	Homo sapiens	GI50	uM	25.0
	18974007	CHEMBL4337763	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by Cell-titer-Glo assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)[C@@H](N)/C=C\C[C@H](C)OC2=O		CHEMBL4471009	>	GI50	nM	25000.0	CHEMBL1955	Homo sapiens	GI50	uM	25.0
	18974052	CHEMBL4337771	Inhibition of human VEGFR3 assessed as enzyme residual activity at 10 uM using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay relative to control	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304	=	Activity	%	2.76	CHEMBL1955	Homo sapiens	Activity	%	2.76
Active	18974058	CHEMBL4337777	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of VEGFR3 phosphorylation at 0.01 to 1 uM incubated for 2 hrs by Western blot analysis	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	18974059	CHEMBL4337778	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of STAT5 phosphorylation at 0.01 to 1 uM incubated for 2 hrs by Western blot analysis	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	18974060	CHEMBL4337779	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of AKT phosphorylation at S473 residue at 0.01 to 1 uM incubated for 2 hrs by Western blot analysis	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	18974061	CHEMBL4337780	Inhibition of TEL-fused VEGFR3 (unknown origin) expressed in mouse BA/F3 cells assessed as inhibition of ERK phosphorylation at 0.01 to 1 uM incubated for 2 hrs by Western blot analysis	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	18985717	CHEMBL4340016	Inhibition of FLT4 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	18989251	CHEMBL4340778	Inhibition of recombinant human N-terminal GST-His6 fused VEGFR3 C-terminal domain (N799 to R1298 residues) expressed in baculovirus infected Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	>	IC50	nM	100000.0	CHEMBL1955	Homo sapiens	IC50	uM	100.0
	18997606	CHEMBL4342907	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	=	IC50	nM	11.0	CHEMBL1955	Homo sapiens	IC50	nM	11.0
	19021490	CHEMBL4347713	Inhibition of recombinant human FLT4 at 20 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	38.0	CHEMBL1955	Homo sapiens	INH	%	38.0
	19021491	CHEMBL4347595	Inhibition of recombinant human FLT4 at 200 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	85.0	CHEMBL1955	Homo sapiens	INH	%	85.0
	19035306	CHEMBL4350402	Inhibition of human FLT4 assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
Active	19041118	CHEMBL4352379	Inhibition of human FLT4 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	19042443	CHEMBL4352764	ATP competitive inhibition of human Flt4	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL3989870	=	Ki	nM	8.0	CHEMBL1955	Homo sapiens	Ki	nM	8.0
	19059603	CHEMBL4357904	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	19069680	CHEMBL4361174	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	<	Activity	%	1.0	CHEMBL1955	Homo sapiens	Activity	%	1.0
	19090171	CHEMBL4365745	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	89.0	CHEMBL1955	Homo sapiens	Activity	%	89.0
	19091935	CHEMBL4366409	Inhibition of human FLT4 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-7.65	CHEMBL1955	Homo sapiens	INH	%	-7.65
	19092273	CHEMBL4366693	Inhibition of FLT4 (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	100.0	CHEMBL1955	Homo sapiens	INH	%	100.0
	19095143	CHEMBL4367364	Inhibition of human VEGFR3 at 1 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]ATP relative to control	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	>	Inhibition	%	90.0	CHEMBL1955	Homo sapiens	INH	%	90.0
	19095144	CHEMBL4367364	Inhibition of human VEGFR3 at 1 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]ATP relative to control	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCOP(=O)(O)O.[CaH2]		CHEMBL4516875	>	Inhibition	%	90.0	CHEMBL1955	Homo sapiens	INH	%	90.0
	19125164	CHEMBL4373582	Inhibition of recombinant human N-terminal GST/His6-tagged VEGFR3 (N799 to R1298 residues) expressed in sf9 cells assessed as equivalents of test compound required to show 50% inhibition using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918	=	Activity	equiv	893.6	CHEMBL1955	Homo sapiens	Activity	equiv	893.6
Dose-dependent effect	19125169	CHEMBL4373577	Inhibition of recombinant human N-terminal GST/His6-tagged VEGFR3 (N799 to R1298 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	19125174	CHEMBL4373577	Inhibition of recombinant human N-terminal GST/His6-tagged VEGFR3 (N799 to R1298 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918	=	IC50	nM	4200.0	CHEMBL1955	Homo sapiens	IC50	nM	4200.0
	19125189	CHEMBL4373577	Inhibition of recombinant human N-terminal GST/His6-tagged VEGFR3 (N799 to R1298 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	C[C@@H]1CN(C(=O)CCCC(=O)N2C[C@@H](C)c3c2cc(O)c2ccccc32)c2cc(O)c3ccccc3c21		CHEMBL4473548	>	IC50	nM	10000.0	CHEMBL1955	Homo sapiens	IC50	nM	10000.0
	19140687	CHEMBL4376516	Inhibition of recombinant human GST-tagged FLT4 catalytic domain (800 to 1297 residues) expressed in baculovirus expression system using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	=	IC50	nM	591.0	CHEMBL1955	Homo sapiens	IC50	nM	591.0
	19140818	CHEMBL4376582	Inhibition of recombinant human GST-tagged FLT4 catalytic domain (800 to 1297 residues) expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	19159431	CHEMBL4382535	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	36.0	CHEMBL1955	Homo sapiens	Activity	%	36.0
	19181037	CHEMBL4387248	Inhibition of recombinant human GST-tagged FLT4 catalytic domain (800 to 1297 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	4.0	CHEMBL1955	Homo sapiens	INH	%	4.0
	19181263	CHEMBL4387248	Inhibition of recombinant human GST-tagged FLT4 catalytic domain (800 to 1297 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	19.0	CHEMBL1955	Homo sapiens	INH	%	19.0
	19191576	CHEMBL4389254	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.55	CHEMBL1955	Homo sapiens	INH	%	0.55
	19191917	CHEMBL4389731	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	16.0	CHEMBL1955	Homo sapiens	INH	%	16.0
	19199867	CHEMBL4391357	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	2.7	CHEMBL1955	Homo sapiens	Activity	%	2.7
	19236737	CHEMBL4398810	Inhibition of VEGFR3 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL1955	Homo sapiens	INH	%	25.0
	19237212	CHEMBL4398903	Inhibition of FLT4 (unknown origin) 1 uM	B	COc1ccc(CC(=O)Nc2ccc3[nH]c(-c4ccc(Cl)cc4)nc3c2)cc1		CHEMBL4557230	=	Inhibition	%	18.5	CHEMBL1955	Homo sapiens	INH	%	18.5
	19266431	CHEMBL4405381	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	19269113	CHEMBL4406253	Inhibition of recombinant human N-terminal GST-tagged FLT4 (800 to end residues) expressed in baculovirus infected Sf21 cells at 1 uM relative to control	B	COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1		CHEMBL4577523	>	Inhibition	%	75.0	CHEMBL1955	Homo sapiens	INH	%	75.0
	19312951	CHEMBL4416506	Inhibition of recombinant human N-terminal GST-tagged FLT4 (800 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using JAK3tide as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	>	Inhibition	%	75.0	CHEMBL1955	Homo sapiens	INH	%	75.0
	19319999	CHEMBL4417593	Inhibition of N-terminal GST tagged human FLT4 cytoplasmic domain (798 to 1298 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	43.58	CHEMBL1955	Homo sapiens	INH	%	43.58
	19433051	CHEMBL4429594	Inhibition of partial length human FLT4 expressed in bacterial expression system assessed as activity remaining at 1 uM by kinome scan assay	B	CCC(=O)NCC1CCN(c2ccc(NC(=O)Nc3cccc(Oc4ccnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1		CHEMBL4445808	=	Activity	%	0.0	CHEMBL1955	Homo sapiens	Activity	%	0.0
	19433057	CHEMBL4429598	Inhibition of TEL-fused partial length human FLT4 expressed in mouse BA/F3 cells after 72 hrs by cell titer-glo assay	B	CCC(=O)NCC1CCN(c2ccc(NC(=O)Nc3cccc(Oc4ccnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1		CHEMBL4445808	=	GI50	nM	240.0	CHEMBL1955	Homo sapiens	GI50	uM	0.24
	19445437	CHEMBL4432486	Inhibition of recombinant VEGFR3 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	94.4	CHEMBL1955	Homo sapiens	INH	%	94.4
	19445471	CHEMBL4432486	Inhibition of recombinant VEGFR3 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	99.1	CHEMBL1955	Homo sapiens	INH	%	99.1
	20600536	CHEMBL4603488	Inhibition of recombinant human GST-tagged FLT4 cytoplasmic domain expressed in baculovirus expression system after 1 using tyrosine 4 as substrate after 1 hr in presence of ATP by ZYLTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL1955	Homo sapiens	IC50	uM	100.0
	20606287	CHEMBL4605026	Inhibition of FLT4 (unknown origin) at 2 uM caliper microfluidic kinase assay relative to control	B	CCN1CCN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)CC1		CHEMBL4636064	=	Inhibition	%	90.0	CHEMBL1955	Homo sapiens	INH	%	90.0
	20669020	CHEMBL4620270	Inhibition of biotinylated ligand binding to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cccc6cnccc56)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4637601	>	Inhibition	%	80.0	CHEMBL1955	Homo sapiens	INH	%	80.0
	20683651	CHEMBL4623630	Inhibition of VEGFR3 (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-5.0	CHEMBL1955	Homo sapiens	INH	%	-5.0
	20683652	CHEMBL4623631	Inhibition of VEGFR3 (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	0.0	CHEMBL1955	Homo sapiens	INH	%	0.0
	22392061	CHEMBL4667156	Inhibition of recombinant human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus expression system using Tyr 04 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-3.5	CHEMBL1955	Homo sapiens	INH	%	-3.5
	22423601	CHEMBL4674376	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	84.7	CHEMBL1955	Homo sapiens	Activity	%	84.7
	22423602	CHEMBL4674376	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	6.48	CHEMBL1955	Homo sapiens	Activity	%	6.48
	22458822	CHEMBL4682599	Inhibition of Flt4 (unknown origin) at 200 nM relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4764463	>	Inhibition	%	80.0	CHEMBL1955	Homo sapiens	INH	%	80.0
	22472877	CHEMBL4685517	Inhibition of FLT4 (unknown origin) at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay relative to control	B	CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1		CHEMBL4747900	>	Inhibition	%	80.0	CHEMBL1955	Homo sapiens	INH	%	80.0
	22472883	CHEMBL4685523	Inhibition of FLT4 (unknown origin) using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay	B	CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1		CHEMBL4747900	=	IC50	nM	116.0	CHEMBL1955	Homo sapiens	IC50	nM	116.0
	22476307	CHEMBL4686393	Inhibition of Flt4 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C(OC(=O)c4ccc(F)cc4)C(C)(C)C)cc3F)c2cc1OC		CHEMBL4779315	=	IC50	nM	540.0	CHEMBL1955	Homo sapiens	IC50	nM	540.0
	22476308	CHEMBL4686393	Inhibition of Flt4 (unknown origin)	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	1.67	CHEMBL1955	Homo sapiens	IC50	nM	1.67
	22809995	CHEMBL4713433	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	5.2	CHEMBL1955	Homo sapiens	IC50	nM	5.2
	22826329	CHEMBL4717514	Inhibition of N-terminal GST-tagged human FLT4 (800 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Activity	%	60.0	CHEMBL1955	Homo sapiens	Activity	%	60.0
	22836228	CHEMBL4718860	Inhibition of recombinant human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	44.0	CHEMBL1955	Homo sapiens	INH	%	44.0
	22836229	CHEMBL4718860	Inhibition of recombinant human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	20.0	CHEMBL1955	Homo sapiens	INH	%	20.0
	22836230	CHEMBL4718860	Inhibition of recombinant human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	27.0	CHEMBL1955	Homo sapiens	INH	%	27.0
	22836231	CHEMBL4718860	Inhibition of recombinant human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	21.0	CHEMBL1955	Homo sapiens	INH	%	21.0
	22836232	CHEMBL4718860	Inhibition of recombinant human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	12.0	CHEMBL1955	Homo sapiens	INH	%	12.0
	22836233	CHEMBL4718860	Inhibition of recombinant human GST-tagged FLT4 (800 to 1297 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	6.0	CHEMBL1955	Homo sapiens	INH	%	6.0
	22843738	CHEMBL4720724	Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.7	CHEMBL1955	Homo sapiens	IC50	10^-10M	7.0
	22844090	CHEMBL4721076	Inhibition of human FLT4 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	70.05	CHEMBL1955	Homo sapiens	Activity	%	70.05
	22844716	CHEMBL4721391	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	106.42	CHEMBL1955	Homo sapiens	Activity	%	106.42
	22853496	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	-97.0	CHEMBL1955	Homo sapiens	Activity	%	-97.0
	22853497	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Activity	%	-17.0	CHEMBL1955	Homo sapiens	Activity	%	-17.0
	22853498	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CN1CCN(CCCOc2ccc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3c2)CC1		CHEMBL4749477	=	Activity	%	4.0	CHEMBL1955	Homo sapiens	Activity	%	4.0
	22853499	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1)c1ccc(CNCCO)cc1		CHEMBL4782561	=	Activity	%	57.0	CHEMBL1955	Homo sapiens	Activity	%	57.0
	22853500	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	Cc1cccc(Oc2ccc(Nc3ncnc4ccc(NC(=O)CNCCO)cc34)cc2Cl)c1		CHEMBL4753194	=	Activity	%	-8.0	CHEMBL1955	Homo sapiens	Activity	%	-8.0
	22853501	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1		CHEMBL4777529	=	Activity	%	28.0	CHEMBL1955	Homo sapiens	Activity	%	28.0
	22853502	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4757576	=	Activity	%	47.0	CHEMBL1955	Homo sapiens	Activity	%	47.0
	22853503	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL3637894	=	Activity	%	-12.0	CHEMBL1955	Homo sapiens	Activity	%	-12.0
	22853504	CHEMBL4724270	Effect on human FLT4 in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CNCCO)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4783947	=	Activity	%	-23.0	CHEMBL1955	Homo sapiens	Activity	%	-23.0
	22874809	CHEMBL4725500	Inhibition of human VEGFR3 assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	0.0	CHEMBL1955	Homo sapiens	Activity	%	0.0
	22874844	CHEMBL4725535	Inhibition of human VEGFR3 assessed as remaining enzyme activity at 0.1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	1.0	CHEMBL1955	Homo sapiens	Activity	%	1.0
	22874870	CHEMBL4725561	Inhibition of human VEGFR3 assessed as remaining enzyme activity at 0.01 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	38.0	CHEMBL1955	Homo sapiens	Activity	%	38.0
	22916317	CHEMBL4735610	Inhibition of Flt4 (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(-n2ccc3cc(NC(=O)Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc32)ccn1		CHEMBL4797840	=	Inhibition	%	93.5	CHEMBL1955	Homo sapiens	INH	%	93.5
	22916318	CHEMBL4735610	Inhibition of Flt4 (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1	Outside typical range	CHEMBL1336	=	Inhibition	%	9934.0	CHEMBL1955	Homo sapiens	INH	%	9934.0
	22916327	CHEMBL4735615	Inhibition of Flt4 (unknown origin) in presence of [gamma33]-ATP by liquid scintillation counting analysis	B	CNC(=O)c1cc(-n2ccc3cc(NC(=O)Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc32)ccn1		CHEMBL4797840	=	IC50	nM	95.7	CHEMBL1955	Homo sapiens	IC50	nM	95.7
	22916328	CHEMBL4735615	Inhibition of Flt4 (unknown origin) in presence of [gamma33]-ATP by liquid scintillation counting analysis	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	36.5	CHEMBL1955	Homo sapiens	IC50	nM	36.5
	22952845	CHEMBL4766782	Inhibition of recombinant human FLT4 (800 to end residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	-1.0	CHEMBL1955	Homo sapiens	Activity	%	-1.0
	22953069	CHEMBL4767006	Inhibition of recombinant human FLT4 (800 to end residues) using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	uM	0.006
	22956523	CHEMBL4767791	Inhibition of VEGFR3 (unknown origin) at 0.1 uM incubated for 1 hr by ELISA relative to control	B	Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1		CHEMBL3634506	>	Inhibition	%	50.0	CHEMBL1955	Homo sapiens	INH	%	50.0
	22960870	CHEMBL4768785	Inhibition of human FLT4 at 100 nM in presence of ATP relative to control	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	Inhibition	%	89.0	CHEMBL1955	Homo sapiens	INH	%	89.0
	22960871	CHEMBL4768786	Inhibition of human FLT4 in presence of ATP	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	IC50	nM	23.8	CHEMBL1955	Homo sapiens	IC50	nM	23.8
	22969943	CHEMBL4770459	Binding affinity to human FLT4	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL1955	Homo sapiens	Kd	nM	10000.0
	22972849	CHEMBL4771082	Inhibition of FLT-4 (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COCC/C(=N\S(=O)(=O)Cc1ccc(Cl)cc1)Nc1ccc(Oc2ccnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(F)c1		CHEMBL4799113	=	IC50	nM	358.0	CHEMBL1955	Homo sapiens	IC50	nM	358.0
	22972850	CHEMBL4771082	Inhibition of FLT-4 (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	4.95	CHEMBL1955	Homo sapiens	IC50	nM	4.95
	22979771	CHEMBL4772653	Binding affinity to wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	45.0	CHEMBL1955	Homo sapiens	Kd	nM	45.0
	22979805	CHEMBL4772687	Inhibition of wild-type human partial length FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL1955	Homo sapiens	Activity	%	90.0
	23122589	CHEMBL4804940	Inhibition of human FLT4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	97.0	CHEMBL1955	Homo sapiens	Activity	%	97.0
	23123284	CHEMBL4805528	Inhibition of human FLT4 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	80.0	CHEMBL1955	Homo sapiens	Activity	%	80.0
	23123611	CHEMBL4805855	Inhibition of DNA-tagged human FLT4 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL1955	Homo sapiens	Activity	%	100.0
	23124658	CHEMBL4806545	Inhibition of human FLT4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL1955	Homo sapiens	Activity	%	92.0
	23124659	CHEMBL4806545	Inhibition of human FLT4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL1955	Homo sapiens	Activity	%	98.0
	23128698	CHEMBL4808041	Inhibition of VEGFR3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL1955	Homo sapiens	Activity	%	50.0
	23128699	CHEMBL4808041	Inhibition of VEGFR3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL1955	Homo sapiens	Activity	%	75.0
	23128700	CHEMBL4808041	Inhibition of VEGFR3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL1955	Homo sapiens	Activity	%	75.0
	23128918	CHEMBL4808094	Inhibition of FLT4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4870763	=	Inhibition	%	25.0	CHEMBL1955	Homo sapiens	INH	%	25.0
	23188162	CHEMBL4818004	Binding affinity to VEGFR3 (unknown origin)	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc1OC		CHEMBL3918385	=	Activity	%	50.0	CHEMBL1955	Homo sapiens	Activity	%	50.0
	23213416	CHEMBL4822950	Inhibition of human recombinant FLT4 in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	1.9	CHEMBL1955	Homo sapiens	INH	%	1.9
	23284726	CHEMBL4838036	Inhibition of recombinant human FLT4 V1128L/H1146R double mutant (800 to end residues) at 10 uM using GGEEEEYFELVKK as substrate at 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	>	Inhibition	%	90.0	CHEMBL1955	Homo sapiens	INH	%	90.0
	23289441	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCOCC5)cc4)cc23)CC1		CHEMBL4851492	=	Inhibition	%	56.16	CHEMBL1955	Homo sapiens	INH	%	56.16
	23289442	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(C#N)cc4)cc23)CC1		CHEMBL4862615	=	Inhibition	%	75.36	CHEMBL1955	Homo sapiens	INH	%	75.36
	23289443	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(OC)cc4)cc23)CC1		CHEMBL4863820	=	Inhibition	%	48.68	CHEMBL1955	Homo sapiens	INH	%	48.68
	23289444	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(C(F)(F)F)cc4)cc23)CC1		CHEMBL4874787	=	Inhibition	%	32.1	CHEMBL1955	Homo sapiens	INH	%	32.1
	23289445	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ccnc3ccc(-c4ccccc4)cc23)CC1		CHEMBL4875890	=	Inhibition	%	25.43	CHEMBL1955	Homo sapiens	INH	%	25.43
	23289446	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3ccc(-c4ccccc4)cc23)CC1		CHEMBL4854184	=	Inhibition	%	47.88	CHEMBL1955	Homo sapiens	INH	%	47.88
	23289447	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ccn3ncc(-c4ccc(N5CCOCC5)cc4)c3n2)CC1		CHEMBL4850345	=	Inhibition	%	42.48	CHEMBL1955	Homo sapiens	INH	%	42.48
	23289448	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ccn3ncc(-c4ccccc4)c3n2)CC1		CHEMBL4855983	=	Inhibition	%	38.28	CHEMBL1955	Homo sapiens	INH	%	38.28
	23289449	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccccc4)cc23)CC1		CHEMBL4869104	=	Inhibition	%	54.23	CHEMBL1955	Homo sapiens	INH	%	54.23
	23289450	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CCn1c(N)c(C(=O)NC)c(=O)c2ccc(C#C[C@@](C)(O)COC)nc21		CHEMBL4303275	=	Inhibition	%	97.99	CHEMBL1955	Homo sapiens	INH	%	97.99
	23289451	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4846769	=	Inhibition	%	78.87	CHEMBL1955	Homo sapiens	INH	%	78.87
	23289452	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4875668	=	Inhibition	%	62.7	CHEMBL1955	Homo sapiens	INH	%	62.7
	23289453	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4cccc5ccccc45)cc23)CC1		CHEMBL4851276	=	Inhibition	%	40.11	CHEMBL1955	Homo sapiens	INH	%	40.11
	23289454	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4cccc5ncccc45)cc23)CC1		CHEMBL4878266	=	Inhibition	%	43.07	CHEMBL1955	Homo sapiens	INH	%	43.07
	23289455	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)cc23)CC1		CHEMBL4851140	=	Inhibition	%	35.91	CHEMBL1955	Homo sapiens	INH	%	35.91
	23289456	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccnc(Cl)c4)cc23)CC1		CHEMBL4846791	=	Inhibition	%	38.28	CHEMBL1955	Homo sapiens	INH	%	38.28
	23289457	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(OC)nc4)cc23)CC1		CHEMBL4858955	=	Inhibition	%	65.71	CHEMBL1955	Homo sapiens	INH	%	65.71
	23289458	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(F)nc4)cc23)CC1		CHEMBL4865226	=	Inhibition	%	36.6	CHEMBL1955	Homo sapiens	INH	%	36.6
	23289459	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4cc(Br)cnc4F)cc23)CC1		CHEMBL4878964	=	Inhibition	%	45.18	CHEMBL1955	Homo sapiens	INH	%	45.18
	23289460	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4cn(C)nc4C(F)(F)F)cc23)CC1		CHEMBL4869290	=	Inhibition	%	51.02	CHEMBL1955	Homo sapiens	INH	%	51.02
	23289461	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4cnn(Cc5ccccc5)c4)cc23)CC1		CHEMBL4853588	=	Inhibition	%	48.28	CHEMBL1955	Homo sapiens	INH	%	48.28
	23289462	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4c(C)noc4C)cc23)CC1		CHEMBL4867304	=	Inhibition	%	39.59	CHEMBL1955	Homo sapiens	INH	%	39.59
	23289463	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4cccs4)cc23)CC1		CHEMBL4849886	=	Inhibition	%	30.18	CHEMBL1955	Homo sapiens	INH	%	30.18
	23289464	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(C4=CCCCC4)cc23)CC1		CHEMBL4856965	=	Inhibition	%	15.99	CHEMBL1955	Homo sapiens	INH	%	15.99
	23289465	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(C#N)cc4)cc23)CC1		CHEMBL4867206	=	Inhibition	%	10.01	CHEMBL1955	Homo sapiens	INH	%	10.01
	23289466	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OCC3CCCCN3C)nc3sc(-c4ccc(C#N)cc4)cc23)CC1		CHEMBL4860067	=	Inhibition	%	10.61	CHEMBL1955	Homo sapiens	INH	%	10.61
	23289467	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4872344	=	Inhibition	%	22.8	CHEMBL1955	Homo sapiens	INH	%	22.8
	23289468	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)[C@@H](C)C1		CHEMBL4865775	=	Inhibition	%	11.2	CHEMBL1955	Homo sapiens	INH	%	11.2
	23289469	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(OC)nc4)cc23)CC1		CHEMBL4870910	=	Inhibition	%	19.22	CHEMBL1955	Homo sapiens	INH	%	19.22
	23289470	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4847330	=	Inhibition	%	32.34	CHEMBL1955	Homo sapiens	INH	%	32.34
	23289471	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)[C@@H](C)C1		CHEMBL4874965	=	Inhibition	%	18.33	CHEMBL1955	Homo sapiens	INH	%	18.33
	23289472	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sccc23)CC1		CHEMBL4868324	=	Inhibition	%	50.55	CHEMBL1955	Homo sapiens	INH	%	50.55
	23289473	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)[C@@H](C)C1		CHEMBL4866700	=	Inhibition	%	66.15	CHEMBL1955	Homo sapiens	INH	%	66.15
	23289474	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(S(=O)(=O)/C=C/c6ccccc6)CC5)ncnc4s3)cc2)CC1		CHEMBL4872724	=	Inhibition	%	82.97	CHEMBL1955	Homo sapiens	INH	%	82.97
	23289475	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CCS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4874409	=	Inhibition	%	73.21	CHEMBL1955	Homo sapiens	INH	%	73.21
	23289476	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(S(=O)(=O)N6CCCCC6)CC5)ncnc4s3)cc2)CC1		CHEMBL4855422	=	Inhibition	%	72.39	CHEMBL1955	Homo sapiens	INH	%	72.39
	23289477	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(S(=O)(=O)C6CC6)CC5)ncnc4s3)cc2)CC1		CHEMBL4873339	=	Inhibition	%	75.36	CHEMBL1955	Homo sapiens	INH	%	75.36
	23289478	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CCCNC(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4849461	=	Inhibition	%	76.44	CHEMBL1955	Homo sapiens	INH	%	76.44
	23289479	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccccc6)CC5)ncnc4s3)cc2)CC1		CHEMBL4866580	=	Inhibition	%	80.42	CHEMBL1955	Homo sapiens	INH	%	80.42
	23289480	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	COc1ccc(NC(=O)N2CCN(c3ncnc4sc(-c5ccc(N6CCN(C)CC6)cc5)cc34)CC2)cc1		CHEMBL4863333	=	Inhibition	%	73.53	CHEMBL1955	Homo sapiens	INH	%	73.53
	23289481	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(C#N)cc6)CC5)ncnc4s3)cc2)CC1		CHEMBL4859341	=	Inhibition	%	89.26	CHEMBL1955	Homo sapiens	INH	%	89.26
	23289482	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)cc6)CC5)ncnc4s3)cc2)CC1		CHEMBL4871658	=	Inhibition	%	85.42	CHEMBL1955	Homo sapiens	INH	%	85.42
	23289483	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(OC(F)(F)F)cc6)CC5)ncnc4s3)cc2)CC1		CHEMBL4875689	=	Inhibition	%	87.19	CHEMBL1955	Homo sapiens	INH	%	87.19
	23289484	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccccc6F)CC5)ncnc4s3)cc2)CC1		CHEMBL4858075	=	Inhibition	%	74.78	CHEMBL1955	Homo sapiens	INH	%	74.78
	23289485	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6cccc(F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4873681	=	Inhibition	%	71.6	CHEMBL1955	Homo sapiens	INH	%	71.6
	23289486	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	COc1ccccc1NC(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4878907	=	Inhibition	%	70.53	CHEMBL1955	Homo sapiens	INH	%	70.53
	23289487	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(F)cc6F)CC5)ncnc4s3)cc2)CC1		CHEMBL4850140	=	Inhibition	%	73.78	CHEMBL1955	Homo sapiens	INH	%	73.78
	23289488	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448	=	Inhibition	%	93.47	CHEMBL1955	Homo sapiens	INH	%	93.47
	23289489	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CC(C)c1cccc(C(C)C)c1NC(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4879073	=	Inhibition	%	75.09	CHEMBL1955	Homo sapiens	INH	%	75.09
	23289490	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6cc(C(F)(F)F)ccc6F)CC5)ncnc4s3)cc2)CC1		CHEMBL4847888	=	Inhibition	%	77.82	CHEMBL1955	Homo sapiens	INH	%	77.82
	23289491	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CCS(=O)(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4848735	=	Inhibition	%	12.8	CHEMBL1955	Homo sapiens	INH	%	12.8
	23289492	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	C=CC(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3sc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)CC1		CHEMBL4854481	=	Inhibition	%	20.08	CHEMBL1955	Homo sapiens	INH	%	20.08
	23289493	CHEMBL4839128	Inhibition of VEGFR3 (unknown origin) at 1 uM incubated for 1 hr by ELISA relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(S(=O)(=O)c6ccccc6)CC5)nc(OCC5CCCCN5C)nc4s3)cc2)CC1		CHEMBL4857959	=	Inhibition	%	36.09	CHEMBL1955	Homo sapiens	INH	%	36.09
	23289600	CHEMBL4839131	Inhibition of human FLT4/VEGFR3 assessed as residual kinase activity at 1 uM relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448	=	Activity	%	0.0	CHEMBL1955	Homo sapiens	Activity	%	0.0
	23289606	CHEMBL4839137	Inhibition of human FLT4/VEGFR3	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448	=	IC50	nM	110.4	CHEMBL1955	Homo sapiens	IC50	nM	110.4
Dose-Dependent Effect	23289627	CHEMBL4839151	Inhibition of VEGFR3 phosphorylation in human dermal lymphatic endothelial cells incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Dose-Dependent Effect	23289628	CHEMBL4839152	Inhibition of VEGFR3 in human dermal lymphatic endothelial cells assessed as inhibition of STAT5 phosphorylation incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Dose-Dependent Effect	23289629	CHEMBL4839153	Inhibition of VEGFR3 in human dermal lymphatic endothelial cells assessed as inhibition of AKT phosphorylation incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Dose-Dependent Effect	23289630	CHEMBL4839154	Inhibition of VEGFR3 in human dermal lymphatic endothelial cells assessed as inhibition of ERK1/2 phosphorylation incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289652	CHEMBL4839176	Inhibition of VEGFR3 phosphorylation in human MDA-MB-231 cells at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289653	CHEMBL4839177	Inhibition of VEGFR3 in human MDA-MB-231 cells assessed as inhibition of STAT5 phosphorylation at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289654	CHEMBL4839178	Inhibition of VEGFR3 in human MDA-MB-231 cells assessed as inhibition of AKT phosphorylation at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289655	CHEMBL4839179	Inhibition of VEGFR3 in human MDA-MB-231 cells assessed as inhibition of ERK1/2 phosphorylation at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289656	CHEMBL4839180	Inhibition of VEGFR3 phosphorylation in human MDA-MB-436 cells at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289657	CHEMBL4839181	Inhibition of VEGFR3 in human MDA-MB-436 cells assessed as inhibition of STAT5 phosphorylation at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289658	CHEMBL4839182	Inhibition of VEGFR3 in human MDA-MB-436 cells assessed as inhibition of AKT phosphorylation at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
Active	23289659	CHEMBL4839183	Inhibition of VEGFR3 in human MDA-MB-436 cells assessed as inhibition of ERK1/2 phosphorylation at 2.5 uM incubated for 24 hrs by Western blot analysis	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448		Inhibition	%		CHEMBL1955	Homo sapiens	INH		
	23289715	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	20.0	CHEMBL1955	Homo sapiens	IC50	nM	20.0
	23289716	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	=	IC50	nM	4.0	CHEMBL1955	Homo sapiens	IC50	nM	4.0
	23289717	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	IC50	nM	3.0	CHEMBL1955	Homo sapiens	IC50	nM	3.0
	23289718	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	47.0	CHEMBL1955	Homo sapiens	IC50	nM	47.0
	23289719	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	10.0	CHEMBL1955	Homo sapiens	IC50	nM	10.0
	23289720	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	110.0	CHEMBL1955	Homo sapiens	IC50	nM	110.0
	23289721	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	IC50	nM	6.0	CHEMBL1955	Homo sapiens	IC50	nM	6.0
	23289722	CHEMBL4839223	Inhibition of VEGFR3 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	5.2	CHEMBL1955	Homo sapiens	IC50	nM	5.2
Not Active	23317424	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23317892	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	80.0	CHEMBL1955	Homo sapiens	% Control	%	80.0
Not Active	23318561	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	77.0	CHEMBL1955	Homo sapiens	% Control	%	77.0
Not Active	23319042	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	90.0	CHEMBL1955	Homo sapiens	% Control	%	90.0
Not Active	23319679	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23320154	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23320832	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23321300	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23321930	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	90.0	CHEMBL1955	Homo sapiens	% Control	%	90.0
Not Active	23322398	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23323087	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	91.0	CHEMBL1955	Homo sapiens	% Control	%	91.0
Not Active	23323555	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	97.0	CHEMBL1955	Homo sapiens	% Control	%	97.0
Not Active	23324016	CHEMBL4880635	Flt4 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	26.0	CHEMBL1955	Homo sapiens	% inhibition	%	26.0
Not Active	23324409	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	89.5	CHEMBL1955	Homo sapiens	% Control	%	89.5
Not Active	23325044	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	81.0	CHEMBL1955	Homo sapiens	% Control	%	81.0
Not Active	23325512	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23326159	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	79.0	CHEMBL1955	Homo sapiens	% Control	%	79.0
Not Active	23326627	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	67.0	CHEMBL1955	Homo sapiens	% Control	%	67.0
Not Active	23327327	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	92.0	CHEMBL1955	Homo sapiens	% Control	%	92.0
Not Active	23327795	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23328382	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23328850	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	91.0	CHEMBL1955	Homo sapiens	% Control	%	91.0
Not Active	23329350	CHEMBL4881057	Flt4(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	98.0	CHEMBL1955	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23329796	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23330264	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	75.0	CHEMBL1955	Homo sapiens	% Control	%	75.0
Not Active	23331020	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23331488	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23331883	CHEMBL4881423	Bayer in-house kinase assay with FLT4	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1	Non standard unit for type	CHEMBL3907057		IC50	M	0.44	CHEMBL1955	Homo sapiens	IC50	M	0.44
Not Active	23332075	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	77.6	CHEMBL1955	Homo sapiens	% Control	%	77.6
Not Active	23332541	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	82.3	CHEMBL1955	Homo sapiens	% Control	%	82.3
Not Active	23333259	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23333658	CHEMBL4881461	Flt4(h) Eurofins Kinase panel	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% residual kinase activity	%	82.0	CHEMBL1955	Homo sapiens	% residual kinase activity	%	82.0
Not Active	23333898	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	83.0	CHEMBL1955	Homo sapiens	% Control	%	83.0
Not Active	23334366	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23335345	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	98.0	CHEMBL1955	Homo sapiens	% Control	%	98.0
Not Active	23335813	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	96.0	CHEMBL1955	Homo sapiens	% Control	%	96.0
Not Active	23336440	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	88.0	CHEMBL1955	Homo sapiens	% Control	%	88.0
Not Active	23336908	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23337603	CHEMBL4881974	FLT4 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	69.5	CHEMBL1955	Homo sapiens	% Ctrl	%	69.5
Not Active	23337989	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	88.0	CHEMBL1955	Homo sapiens	% Control	%	88.0
Not Active	23338457	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	95.0	CHEMBL1955	Homo sapiens	% Control	%	95.0
Not Active	23339069	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	95.0	CHEMBL1955	Homo sapiens	% Control	%	95.0
Not Active	23339537	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	90.0	CHEMBL1955	Homo sapiens	% Control	%	90.0
Not Active	23340174	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23340642	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23341299	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	89.0	CHEMBL1955	Homo sapiens	% Control	%	89.0
Not Active	23341767	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	98.0	CHEMBL1955	Homo sapiens	% Control	%	98.0
Not Active	23342383	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	97.0	CHEMBL1955	Homo sapiens	% Control	%	97.0
Not Active	23342851	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23343481	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	97.0	CHEMBL1955	Homo sapiens	% Control	%	97.0
Slightly Active	23343949	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	43.0	CHEMBL1955	Homo sapiens	% Control	%	43.0
Not Active	23344587	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	92.0	CHEMBL1955	Homo sapiens	% Control	%	92.0
Not Active	23345160	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23345628	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	93.0	CHEMBL1955	Homo sapiens	% Control	%	93.0
Not Active	23346205	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	91.3	CHEMBL1955	Homo sapiens	% Control	%	91.3
Not Active	23346674	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23347279	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23347765	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23348344	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23348812	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23349399	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23350017	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23350485	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23351090	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	95.0	CHEMBL1955	Homo sapiens	% Control	%	95.0
Not Active	23351558	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23352054	CHEMBL4882745	FLT4 (VEGFR3) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.711	CHEMBL1955	Homo sapiens	% Inhibition	%	8.7112
Not Active	23352582	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23353050	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	85.0	CHEMBL1955	Homo sapiens	% Control	%	85.0
Not Active	23353932	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23354400	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23355132	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	88.0	CHEMBL1955	Homo sapiens	% Control	%	88.0
Not Active	23355600	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23356236	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23356704	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	91.0	CHEMBL1955	Homo sapiens	% Control	%	91.0
Not Active	23357313	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	95.0	CHEMBL1955	Homo sapiens	% Control	%	95.0
Not Active	23357960	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	80.0	CHEMBL1955	Homo sapiens	% Control	%	80.0
Not Active	23358428	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23359014	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23359612	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	80.0	CHEMBL1955	Homo sapiens	% Control	%	80.0
Not Active	23360080	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	89.0	CHEMBL1955	Homo sapiens	% Control	%	89.0
Not Active	23360665	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	96.0	CHEMBL1955	Homo sapiens	% Control	%	96.0
Not Active	23361133	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	86.0	CHEMBL1955	Homo sapiens	% Control	%	86.0
Not Active	23361706	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23362242	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	97.0	CHEMBL1955	Homo sapiens	% Control	%	97.0
Not Active	23362710	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23364352	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	89.0	CHEMBL1955	Homo sapiens	% Control	%	89.0
Not Active	23364820	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23365559	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23366102	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	82.0	CHEMBL1955	Homo sapiens	% Control	%	82.0
Not Active	23366692	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23367160	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23367778	CHEMBL4884131	VEGF-R3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	100.0	CHEMBL1955	Homo sapiens	% Residual activity with Skepinone-L	%	100.0
Not Active	23368038	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	96.0	CHEMBL1955	Homo sapiens	% Control	%	96.0
Not Active	23368506	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	96.0	CHEMBL1955	Homo sapiens	% Control	%	96.0
Not Active	23369105	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	92.0	CHEMBL1955	Homo sapiens	% Control	%	92.0
Not Active	23369573	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	63.0	CHEMBL1955	Homo sapiens	% Control	%	63.0
Not Active	23370072	CHEMBL4884316	Flt4(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	73.0	CHEMBL1955	Homo sapiens	% residual kinase activity	%	73.0
Not Active	23370541	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	85.0	CHEMBL1955	Homo sapiens	% Control	%	85.0
Not Active	23371009	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23371818	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	95.0	CHEMBL1955	Homo sapiens	% Control	%	95.0
Not Active	23372286	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	81.0	CHEMBL1955	Homo sapiens	% Control	%	81.0
	23372750	CHEMBL4884715	FLT4(FLT4LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL1955	Homo sapiens	pIC50		6.0
	23373159	CHEMBL4885006	FLT4(FLT4LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL1955	Homo sapiens	pIC50		6.0
	23373520	CHEMBL4885297	FLT4(FLT4LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL1955	Homo sapiens	pIC50		6.0
Not Active	23374985	CHEMBL4885978	Flt4 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	13.0	CHEMBL1955	Homo sapiens	% Inhibition	%	13.0
Not Active	23375255	CHEMBL4886237	fms-related tyrosine kinase 4 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-4.0	CHEMBL1955	Homo sapiens	% inhibition	%	-4.0
Not Active	23375713	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	97.0	CHEMBL1955	Homo sapiens	% Control	%	97.0
Not Active	23376181	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23376758	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	84.0	CHEMBL1955	Homo sapiens	% Control	%	84.0
Not Active	23377227	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	70.0	CHEMBL1955	Homo sapiens	% Control	%	70.0
Not Active	23378086	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	89.0	CHEMBL1955	Homo sapiens	% Control	%	89.0
Not Active	23378554	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23379721	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23380189	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	86.0	CHEMBL1955	Homo sapiens	% Control	%	86.0
Not Active	23380883	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	75.0	CHEMBL1955	Homo sapiens	% Control	%	75.0
Not Active	23381531	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Not Active	23381999	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL1955	Homo sapiens	% Control	%	100.0
Slightly Active	23382623	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	39.0	CHEMBL1955	Homo sapiens	% Control	%	39.0
Not Active	23383091	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	92.0	CHEMBL1955	Homo sapiens	% Control	%	92.0
Not Active	23383798	CHEMBL4887434	FLT4 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	97.0	CHEMBL1955	Homo sapiens	% Ctrl	%	97.0
Not Active	23384281	CHEMBL4887876	Flt4(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	12.93	CHEMBL1955	Homo sapiens	% inhibition	%	12.93
Not Active	23385006	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	89.0	CHEMBL1955	Homo sapiens	% Control	%	89.0
Not Active	23385473	CHEMBL4879730	KinomeScan assay: inhibition of FLT4	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	84.0	CHEMBL1955	Homo sapiens	% Control	%	84.0
